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1. Overall abstract 
Suicide is a leading cause of death. Non-lethal suicidal behavior, the single most salient risk 
marker of future death by suicide, is a major reason for emergency medical care with an 
increasing incidence globally. Reversing this trend constitutes a crucial public health challenge. 
The period following a suicide attempt entails great reattempt risk, hence providing an 
opportunity window for individual-level suicide prevention efforts. Most post-discharge suicide 
prevention interventions seek to bolster contact between suicide attempters and mental health 
providers, in order to reduce the sense of social isolation and increase treatment compliance 
with outpatient visits and treatments. Psychotherapeutic interventions can also prevent suicidal 
behaviors among recent attempters. However, whether psychotherapy provides additional value 
as compared to simpler, less costly, and more practicable contact interventions remains partially 
unanswered. This real-world study evaluated three post-discharge suicide prevention interventions 
currently in use in the Community of Madrid, Spain. First, we estimated the degree of 
implementation and effectiveness of the Suicide Risk Prevention Program (ARSUIC is its Spanish 
acronym), an emergency-department scheduled priority visit at an outpatient clinic within one week 
after hospital discharge that is currently considered treatment as usual throughout Madrid. We found 
that, compared to the previous standard of care, ARSUIC reduced time between discharge and first 
visit an average 1.5 days, and lowered the risk of suicide re-attempt by 24% over a three-year follow-
up. Then, we compared ARSUIC to two augmentation strategies based on increased telephone and 
in-person brief contacts (Enhanced Contact) and on 8 sessions of individual problem-solving 
therapy (Psychotherapy), finding that both outperformed ARSUIC by an additional 40% risk 
reduction over a one-year follow-up. The difference in effectiveness between Enhanced Contact and 
Psychotherapy was negligible. Last, we compared the three interventions in terms of cost-
effectiveness, finding that both augmentation strategies are probably cost-effective, in comparison 
to ARSUIC, under a variety of possible scenarios, and that Enhanced Contact attained similar 
effectiveness at a slightly lower cost than Psychotherapy. Further research is warranted to identify 
the predictors of success for each of the studied interventions: although contact interventions seem 
the most efficient choice of treatment for an unselected sample of high-risk individuals, certain 
subtypes of patients may benefit greatly from individual psychotherapy. 
 
Keywords: suicide, suicide attempt, self-harm, suicide prevention, implementation science, target 
trial, comparative effectiveness and outcomes research, cost-effectiveness, real-world data, brief 




1. Resumen general 
El suicidio es una de las principales causas de muerte. La conducta suicida no letal, el más 
relevante marcador de riesgo de futura muerte por suicidio, es un motivo destacado de urgencia 
médica con una incidencia en aumento globalmente. Invertir esta tendencia es un desafío crucial 
para la salud pública. El periodo que sigue a un intento de suicidio conlleva gran riesgo de 
reintento y supone una oportunidad para la prevención individual. La mayor parte de las 
intervenciones a este nivel buscan aumentar el contacto entre el paciente y el profesional de 
salud mental, para reducir la sensación de soledad y aumentar el cumplimiento terapéutico con 
las consultas ambulatorias y tratamientos. La psicoterapia también previene las conductas 
suicidas después de un intento. Sin embargo, no está claro si la psicoterapia genera valor 
añadido al de intervenciones de contacto, más simples, baratas y viables. Este estudio de mundo 
real evaluó tres intervenciones para la prevención del suicidio al alta actualmente instauradas 
en la Comunidad de Madrid. Primero, estimamos la implementación y efectividad del Programa 
de Atención al Riesgo Suicida (ARSUIC), una visita ambulatoria durante la semana posterior 
al alta, programada desde el servicio de urgencias, considerada actualmente el tratamiento 
habitual en Madrid. En comparación con el estándar previo, ARSUIC redujo el tiempo entre el 
alta y la primera cita ambulatoria 1,5 días de media, disminuyendo el riesgo de reintento un 
24% durante un seguimiento de tres años. A continuación, comparamos ARSUIC con dos 
estrategias de intensificación basadas en contactos añadidos telefónicos y presenciales 
(Contacto Aumentado) y en 8 sesiones de terapia de resolución de problemas individual 
(Psicoterapia). Ambas superaron a ARSUIC, con una reducción de riesgo adicional del 40% en 
un seguimiento de un año. La diferencia de efectividad entre Contacto Aumentado y 
Psicoterapia fue insignificante. Finalmente, comparamos las tres intervenciones en términos de 
coste-efectividad. Ambas estrategias de intensificación resultaron probablemente coste-
efectivas, en comparación con ARSUIC, considerando una variedad de escenarios potenciales, 
y Contacto Aumentado logró similar efectividad con un coste ligeramente menor que 
Psicoterapia. Es preciso identificar predictores de éxito para cada intervención: si bien las 
intervenciones de contacto parecen más eficientes para una población no seleccionada, algunos 
subtipos de pacientes pueden beneficiarse considerablemente de psicoterapia individual.  
 
Palabras clave: suicidio, intento de suicidio, autolesiones, prevención, ciencia de 
implementación, ensayo ideal, investigación comparativa de efectividad y resultados, coste -






Suicide, a major public health concern, takes around 800 000 lives globally every year. 
Attempted suicide, the most faithful risk marker of future suicide, is a leading cause 
of emergency care with a rising incidence. Prevention strategies for suicidal behaviors 
can be implemented at the population and the individual level. For high-risk 
individuals, most psychosocial prevention interventions seek to either enhance contact 
maintenance with mental healthcare providers or use manualized psychotherapy to 
improve the patient’s ability to cope with triggers of suicidal crises. Although several 
of such strategies have been deployed throughout the Community of Madrid, to date 
no study has evaluated their actual performance systematically. The following section 
describes recent trends in suicide and non-lethal self-harm globally and in Spain, 
reviews the existing evidence regarding suicide prevention strategies from a multi-
level framework, and provides a justification to the real-world comparative study of 
contact maintenance and psychotherapeutic interventions for individuals at high risk 
of suicide. 
Resumen 
El suicidio, un problema principal de la salud pública, se lleva cerca de 800 000 vidas 
globalmente cada año. El intento de suicidio, el marcador más fidedigno de futuro 
riesgo de suicidio, es una de las principales causas de tratamiento urgente y tiene una 
incidencia en aumento. La prevención del suicidio se puede ejercer en los niveles 
poblacional e individual. Para individuos con alto riesgo, la mayor parte de 
intervenciones psicosociales buscan aumentar el contacto con los profesionales de 
salud mental o utilizar psicoterapias manualizadas para mejorar la habilidad del 
paciente para afrontar los disparadores de las crisis suicidas. Aunque varias de estas 
intervenciones han sido implementadas en la Comunidad de Madrid, ningún estudio 
ha evaluado sistemáticamente su rendimiento real. Esta sección describe las 
tendencias recientes de suicidio y conducta suicida no letal globales y en España, 
revisa la evidencia sobre estrategias de prevención del suicidio desde una perspectiva 
multinivel, y justifica el estudio comparativo de mundo real de las intervenciones 
basadas en contactos y en psicoterapia para individuos con alto riesgo de suicidio.  
 
2.1 Suicide and non-fatal self-harm: a major public health concern 
2.1.1 Global trends in suicide 
Suicide, the “only one really serious philosophical problem” (Camus, 1955), is a major public 
health concern that takes around 800 000 lives globally every year. Death by suicide is the 
second leading cause of death among youth, and accounts for 57% of all violent deaths and 
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roughly 1.5% of all mortality - more than malaria or breast cancer (World Health Organization, 
2019). Because suicide “is of all modes of death that which leaves in the hearts of the sorrowing 
survivors the most poignant and the most enduring sting” (Wade, 1879), its impact on families 
and communities is far-reaching: grief, stigma and subsequent increases in psychiatric 
conditions and suicide rates reverberate over generations. 
Suicide ranks currently as the 18th leading cause of death worldwide – second in ages 15 to 29 
and third in ages 15 to 45 (WHO, 2019). Given the fact that considerable limitations exist in the 
detection and registration, the number of deaths by suicide are likely underestimated (WHO, 
2014; AbouZahr et al., 2015). While a recent study suggests that the global age-standardized 
mortality rate due to suicide has decreased by 32.7% between 1990 and 2016 (Naghavi, 2019), 
trends in suicide rates vary substantially between countries. From 195 countries included in 
Naghavi’s analysis, 63 registered noticeable decreases, 132 reported not significant differences 
and only 8 increases in suicide rates (2019). Notably, substantial declines in China (-64.1% 
decrease in age-standardized suicide mortality rate between 1990 and 2016), a country that had 
constant increases in suicide rates between years 1900 and 1970 (Phillips et al., 2002), and India 
(-15.2% decrease) drive most of the global decrease in suicide rates, given that these two 
countries account for approximately 36% of the world population (United Nations, 2017) and 
44.2% of deaths by suicide globally in 2016. The countries with the highest observed recent 
increases in suicide rate are Zimbabwe (+96.2%), Jamaica (+70.9%), Paraguay (+70.4%), 
Uganda (+61.6%), several Western sub-Saharan African countries like Liberia (+45.9%) or 
Cameroon (+37.6%), and Mexico (+35.6%).  
Interestingly, the estimated global male to female ratio in suicide has seemingly increased in 
the recent decades from 1.40:1 in 1990 to 2.17:1 in 2016 (Naghavi et al., 2019), and suicide 
mortality between ages 15 and 19, an age stratum where females traditionally displayed higher 
suicide rates, shows now virtually no age-specific differences (Rhodes et al., 2014; Wasserman 
et al., 2005). Age distribution of suicide mortality varies considerably across the globe, but it 
generally distributes in a bimodal fashion, peaking first around adolescence and again in adults 
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over 70 years of age. There are noticeable differences between low/middle- and high-income 
countries in this respect. Middle-aged males have higher suicide rates in high income countries 
than their counterparts in low and middle-income countries, where suicide rates are higher 
among adolescents and elderly females (WHO, 2014). 
2.1.2 Global trends in non-fatal self-harm 
Global non-fatal self-injury rates are difficult to study since no international entity has been 
able to maintain a systematic registry, and most nationwide or international suicide statistic 
reports do not include information on non-lethal self-injury (WHO, 2014). Based on data 
available from both regional studies using medical records or surveys and from the World 
Mental Health Surveys conducted in 21 countries between 2001 and 2007 and using the WHO 
Composite International Diagnostic Interview (CIDI) (Nock, 2012; Kessler et al., 2008), WHO 
estimates that over 20 suicide attempts take place globally for each death by suicide (WHO, 
2018).  
However, the number of estimated suicide attempts, as well as the relationship between 
attempted and completed suicide, varies remarkably across countries. For example, while the 
United States reported around a 5% 12-month prevalence of suicide attempts, in Italy, the 
prevalence was just 0.5% for the same time period (Borges et al., 2010). Further, Spain reports 
174.4 attempts per death by suicide, a figure that lowers to 64.1 in Italy (Blasco-Fontecilla et 
al., 2018). Of note, Blasco-Fontecilla et al. have recently proposed the use of a ratio between 
attempted and completed suicides across countries as a means of evaluation of health care 
delivery for people at high risk of suicide (2018).  
2.1.3 Trends in suicide and non-fatal self-harm in Spain 
Spain has traditionally shown one of the lowest rates of suicide among Western European 
countries, in line with other Mediterranean countries, with around 12 suicides per 100,000 
inhabitants in men and 4 in women (Instituto Nacional de Estadística, 2019). Notwithstanding, 
suicide is the most frequent cause of death among the youth and, although there has been 
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substantial debate regarding whether there have been recent increases in the national rates 
(Ayuso-Mateos, 2013), it seems now plausible that such increases can be detected at least 
among women (Cayuela et al., 2018) and, in particular, immigrant women (Martínez-Alés et 
al., 2019a). Given the lack of a faithful national registry of self-harm, there is no clear consensus 
as to whether self-harm is on the rise in Spain. However, some studies suggest that this is the 
case: the number of telephone calls related to suicide attempting that were made to the 
emergency healthcare system of a region in Andalusia, Spain, increased steadily between 2010 
and 2013 (Mejías-Martín et al., 2017). In addition, despite the important limitations that suicide 
attempts entail for accounting practices in nationwide electronic healthcare records based on 
ICD coding, data from Spain’s hospital discharge database indicate annual increases in the 
number of diagnoses indicating self-harm (ICD-9-CM E-950 codes) between 2010 and 2015 
(Ministerio de Sanidad, Consumo y Bienestar Social, 2018). 
2.2 Suicide prevention: an unmet clinical need 
2.2.1 A multi-level approach to suicide risk factors 
There is substantial evidence that certain characteristics are associated (causally, in most cases) 
with a higher risk of suicidal behaviors. These risk factors, that can be classified in biological, 
behavioral and social (Chan et al., 2016; Franklin et al., 2017), interact in complex hierarchical 
networks (O’Connor & Nock, 2014). Mental disorders are considered among the strongest 
predictors (Holmstrand et al., 2015). For instance, suicide is 20 times more likely if a previous 
diagnosis of major depression is present. Suicide is also associated to bipolar disorder, drug and 
alcohol addiction disorders and psychoses, as well as to a broad variety of social stressors, such 
as socioeconomic disadvantage and the lack of social support (Bertolote et al., 2002).  
It should be noted that suicide rates are determined, at least partially, by causal factors that 
affect entire societies and thus operate beyond the level of the individual, but impact individuals 
within those societies (Martínez-Alés & Keyes, 2019b). Emile Durkheim’s seminal book Le 
Suicide captured these “(causes) of suicide as a collective phenomenon”, “whose action is felt 
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by society as a whole” (1966). Geoffrey Rose discussed such population-level effects when 
discussing blood pressure with “why some individuals have high blood pressure is a different 
question than why some populations have more burden of high blood pressure?” (2001). 
Echoing Durkheim and Rose’s work, while we term “individual-level factors“ those that predict 
who will die by suicide and who will not within a population, we also term “group-level factors“ 
as those that predict which populations will have higher or lower suicide rates. Over the 20 th 
century, these group-level factors have been commonly used to explain health outcomes in 
psychiatric epidemiology: Morris referred to this as the “ecology of mental disorders” in his 
Uses of Epidemiology (1957).  For instance, in a classic study, Faris and Duhham described a 
direct correlation between level of urbanicity and rate of schizophrenia in Chicago (1939), a 
finding that lead to a century of hypotheses and empirical data analysis regarding environmental 
risk factors of psychotic disorders (Susser & Martínez-Alés, 2018; Plana-Ripoll et al., 2018). 
Mervyn Susser coined the term “integral variables” (1994a) to refer to variables that are shared 
by a whole social group, such as economic downturns or urban dwelling. By definition, a 
comparison between individuals who comprise the target social group will not allow to estimate 
the causal effect of an integral variable. Instead, ecologic designs that consider the whole group 
as a legitimate unit of analysis and perform between-groups comparisons are required (Susser, 
1994b; Susser, 1973). In words of Durkheim, “the social rate must be taken directly as the object 
of analysis” (1966). For example, the 10-fold difference in suicide rates between Lithuania or 
Russia and Peru or Lebanon (Naghavi et al., 2019) can illustrate the need of the 
conceptualization of suicide using an ecological perspective. Similarly, remarkable differences 
can be found across countries within Europe (Organization for Economic Co-operation and 
Development, 2019), states and regions within the United States (Centers for Disease Control, 
2018) or areas within the city of London (Rezaeian et al., 2005). Such variation prompts 
questions about how a region’s political, socioeconomic and cultural context might impact 
suicide risk (Martínez-Alés et al., 2019c) 
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Notwithstanding, traditional and innovative risk prediction tools have characteristically 
approached suicide from an individual-level perspective (Roy et al., 1982; Ursano et al., 2014; 
Vahabzadeh et al., 2016); and may be overlooking central determinants of risk that include 
country-level and area-level social and political factors, such as general area industry and 
employment, past suicide rates in the geographic area, and economic growth and contraction 
(Fountoulakis et al., 2016). Futher, beyond geopolitical concerns are actual environmental 
factors that influence risk, including temperature, elevation, both synthetical and natural 
chemical exposures, and other topographical and toxicological features of the physical 
environment (Deisenhamer, 2003; Akkaya-Kalayci et al., 2017; Fountoulakis et al., 2016).  
2.2.2 The importance of suicidal behaviors 
Non-lethal suicidal behaviors are considered the most specific risk marker for death by suicide 
(Turecki & Brent, 2015; Arias et al., 2016). Some researchers find that these behaviors may 
involve almost 30 times more incidence of accomplished suicide (Finkelstein et al., 2015). 
Addressing suicidal behavior, therefore, offers a great opportunity to prevent future suicide 
attempts and, accordingly, substantial attention has been directed towards individuals who 
engage in non-lethal suicidal behaviors.  
Moreover, suicidal behaviors and non-lethal self-harm constitute a leading reason for 
emergency medical care on their own, driving high direct medical costs (Czernin et al., 2012) 
and generating over $93 billion in total burden per year, only in the US (Shepard et al., 2016) – 
roughly a 1.36% of the total disability-adjusted life years globally (Global Burden of Disease, 
2019). As mentioned, recent reports suggest that the incidence of suicidal behaviors is 
increasing globally (Olfson et al., 2017) and in Spain (Mejías-Martín et al., 2017). Reversing 
this trend constitutes a major public health challenge. 
2.2.3 Population-level interventions to reduce suicide risk 
Several population-level interventions have proved effective for suicide risk reduction. In 
general terms, they fall within three main categories: education campaigns, regulations in mass 
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media coverage and restriction of access to means. Among evidence-based educational 
approaches, we would like to highlight the implementation of school-based programs for suicide 
prevention (Zenere et al., 1997; Wasserman et al., 2015) and “gatekeeper training” strategies, 
directed towards individuals who have high probability of contacting suicidal individuals but 
are not designated specifically as mental health professionals, such as teachers or general 
practitioners (Isaac et al., 2009).  
Media reporting of high-profile suicides has a large evidence base as a causal catalyst to 
subsequent increases in population level suicide rates (Sisask et al., 2012; Pirkis et al., 2006; 
Fink et al., 2018). This phenomenon is sometimes referred to as the “Werther effect”, after the 
protagonist of a 1774 German novel who dies by suicide, prompting so-called “copy-cat” 
suicides reported throughout Europe at the time. Increases in suicide after wide-spread media 
coverage of a suicide event are framed within the broader behavioral contagion theory (Gould, 
2001). Notably, recent studies point out the importance of the social context at shaping the 
harmful, neutral or protective impact of suicide media portrayals (VanderWeele et al., 2019). 
Opportunities for effective suicide prevention at this level generally consist on a variety  of 
reporting recommendation guidelines seeking to enhance responsible, non-sensationalist 
coverage of suicide and related events (American Association of Suicidology, 2019).  
Mass media also plays a role in the regulation of a population’s “cognitive -access” to suicide 
means and methods (Florentine et al., 2010; Fink et al., 2018). However, the term “means 
reduction” usually refers to evidence-based interventions aimed at preventing the population 
from physically accessing potentially lethal means (e.g. Gunnell et al., 2003; for a review, see 
Pirkis et al., 2015). This approach builds on empirical studies providing a substantial body of 
evidence that ease of access greatly impacts the risk of attempting suicide (Marzuk et al., 1992) 
and the method choice (Eddleston et al., 2006), especially in impulsive suicidal behaviors - the 
most frequent type (Hawton et al., 2013). Of note, Deisenhammer et al. estimated that half of 
suicide attempt survivors report an interval between the onset of a serious suicidal thought and 
subsequent suicide attempt of 10 minutes or less (2009).  
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While reductions in access to lethal means is associated with lives saved, there remains concern 
about subsitution of method as an additional risk for suicide. Indeed, reducing the access to 
lethal means is more effective if an alternative method available for substitution has a lower 
associated lethality – this can be due to a higher ability to abort mid-attempt or to a lower 
inherent deadliness. Firearms, present in almost 33% of homes in the US and in 51% of total 
suicides in the US, entail 50 times the potential lethality of drug overdose (Marzuk et al., 1992). 
A range of epidemiological studies have confirmed higher suicide rates in states with higher 
gun ownership levels (Miller et al., 2007), and higher suicide risk for people living in a 
household with firearms (Brent et al., 1993; Kellermann et al., 1992). 
In sum, the contribution of population-level causes of suicide is significant, and in terms of their 
potential to reduce the burden of harm, quite influential when taken seriously. As suicide 
prevention efforts continue, a sustained and serious focus on population-level effects is critical. 
2.2.4 Individual-level interventions to reduce suicide risk 
The key first step to suicide risk prevention at the individual level involves the detection of 
individuals at high risk of suicidal behaviors based on the abovementioned risk factors 
(Hernández-Calle et al., 2020). The healthcare setting is considered adequate for risk detection, 
since up to 45% who die by suicide have been seen by a physician during the previous month. 
For instance, Emergency Departments (ED) can play a key role in such strategies: suicide 
attempters treated at the ED frequently repeat self-harm during the following year (Olfson et 
al., 2017) and a single ED visit for self-harm increases future suicide risk nearly 6-fold (Owens 
et al., 2005). In addition, suicidal ED patients have low rates of outpatient treatment engagement 
(Lizardi & Stanley, 2010). Hence, there is a growing interest in interventions initiated at the ED 
(Arias et al., 2016).  
The referral of high-risk individuals to general mental health services following risk detection 
(Van der Feltz-Cornelis et al., 2011) is another key step to address suicidal risk. There is also 
extensive literature on interventions that specifically target suicidality among high-risk 
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individuals, as evidence indicates that programs directly addressing suicidal behaviors 
(Meerwijk, 2016) entail additional benefits to those of receiving general mental healthcare. 
Indeed, several clinical interventions are effective at lowering suicide risk among individuals 
classified as high-risk and, accordingly, they are considered best practice in psychiatry 
(Zalsman et al., 2016). For example, in terms of pharmacotherapy, there is consensus that 
suicidal patients with schizophrenia and bipolar disorder benefit, respectively, from receiving 
treatment with clozapine and lithium carbonate (Meltzer et al., 2003; Goodwin et al., 2003).   
The following section reviews the current evidence on psychosocial interventions aimed 
reducing suicide risk among high risk individuals detected at the healthcare setting. In 
particular, we focus on suicide risk reduction among suicide attempters, a clinical subgroup 
with markedly high risk of suicide. 
Given that the first weeks following an attempted suicide entail an exceptionally high reattempt 
risk (Owens et al., 2002; Parra-Uribe et al., 2017), they offer a critical opportunity for indicated 
tertiary prevention. Several high-risk case-management programs focus on enhancing patient 
engagement and contact with mental health providers, favoring access to medical resources after 
discharge through contact maintenance strategies (Mann et al., 2005; McMain et al., 2017). The 
rationale behind contact interventions is twofold. First, regular contacts reduce the sense of 
social isolation, one of the main risk factors for suicidal outcomes (Calati et al., 2019). Second, 
as mentioned, patients who engage in suicidal behaviors often experience barriers to access to 
proper care, and frequently disengage from follow-up visits (Lizardi & Stanley, 2010). Personal 
contacts provide emotional support, increase treatment compliance with outpatient visits and 
medications and enhance the odds that the patient will seek help in the event of a new suicidal 
crisis. In a pioneer randomized trial including 843 suicide attempters who did not engage in 
follow-up treatment, Motto and Bolstrom assigned half of participants to receive personalized 
letters over the following 5 study years (2001). After just two years, the suicide rate among the 
control group doubled that of those assigned to the intervention. Variations of this approach 
include the use of short text messages, postcards, telephone calls, et cetera (Hassanian-
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Moghaddam et al., 2011; Cebria et al., 2013; Vaiva et al., 2018). The Safety Planning 
Intervention is an interesting evidence-based augmentation of brief contact strategies that is 
widely implemented across the globe that seeks to reduce the patient’s access to lethal means, 
prioritize the most adequate coping strategies during suicidal crises and enhance outreach to 
mental health providers (Stanley et al., 2012). 
Manualized psychotherapies, including problem-solving (McLeavey et al., 1994) cognitive-
behavior (Brown et al., 2005), dialectical-behavior (Linehan et al., 2006), or psychodynamic 
therapy (McMain et al., 2017) are also seemingly effective. However, psychotherapy for suicide 
behaviors has been called into question when compared to more feasible programs aimed at 
simply favouring continuation of care after discharge: an emerging body of literature suggests 
that evidence-based psychotherapeutic treatments do not outperform contact maintenance. In a 
recent RCT meta-analysis, the WHO Brief Intervention and Contact (BIC), a program of 9 
follow-up contacts significantly lowered the odds of suicide after an attempt by 80% (OR=0.20, 
95% CI = 0.09-0.42), whereas Cognitive-Behavioral Therapy (CBT) did so by 66% (OR=0.34, 
95% CI 0.12-1.03) (Riblet et al., 2017). A common misunderstanding of this widely cited meta-
analysis is that psychotherapy does not reduce suicide risk “significantly” among high -risk 
individuals. However, this interpretation is incorrect due to at least two reasons (Martínez-Alés 
et al., 2019d): first, conflating statistical significance with decision-making is prone to errors 
(Greenland et al., 2016); and second, most trials compared CBT to some safety planning or 
contact maintenance intervention, while the WHO BIC was, in turn, compared to treatment as 
usual in several settings where no suicide-specific intervention is standard: comparing any 
intervention to an effective intervention can be challenging and yet the meta-analysis found 
over a 60% risk reduction. As a result, the question whether individualized psychotherapy 




2.2.5 Using real-world data to inform decision-making 
Generating evidence that informs clinical and decision-making efficiently can pose additional 
methodological challenges. Randomized trials, widely viewed as the gold-standard study design 
to test interventions in terms of efficacy and safety, have been called into question regarding 
their ability to yield effectiveness estimates that are transportable to the target population where 
the study sample was drawn from, or to populations with different characteristics (Deaton and 
Cartwright, 2018). Although randomization generates comparison groups that, absent errors, 
can be viewed as comparable in expectation, whether the evidence generated by these highly 
internally valid designs is readily applicable for real-world decisions depends on the extent to 
which the conditions of the trial resemble those of the target population. In addition, critics 
argue that, for psychotherapeutic interventions, comparative effectiveness estimated obtained 
from randomized trials are “inappropriate, and sometimes impossible” (Bothwe ll et al., 2016), 
because of the inherent difficulty to assign participants at random to a highly individualized 
intervention that may be tailored to the client increasingly over time. Also, many trials have 
excluded suicidal individuals systematically over the last decades due to bioethical tensions that 
can be difficult to overcome (Oquendo et al., 2004). 
As a result, there is a growing call for comparative effectiveness estimates obtained from data 
from the clinical practice that can either complement the information obtained from randomized 
designs, by providing key insights for transportability and, in general terms, a greater external 
validity (Sherman et al., 2016); or emulate the ideal target trial when randomization is 
unfeasible due to technical or bioethical reasons (Hernán et al., 2016). 
2.2.6 The need for cost-effectiveness estimates 
Another key aspect in for the development and scaling-up of effective interventions for suicide 
risk is conducting economic evaluations. According to the World Health Organization, 
conducting accurate economic evaluations of interventions for suicidal behaviors is essential 
for the development of suicide prevention strategies (2014). Cost-effectiveness studies are 
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particularly useful to assist resource prioritization in service planning, because they help 
identify treatment alternatives that “optimally allocate resources to maximize health gains” 
(Bernecker et al., 2019). Nevertheless, there is very limited good quality information published 
on the cost-effectiveness of interventions for suicide prevention (Bustamante Madsen et al., 
2018). Thus far, no study has conducted a comparison in terms of cost-effectiveness between a 
brief contact intervention and a psychotherapeutic program.  
2.3 Individual-level suicide risk prevention in the Community of 
Madrid 
The Community of Madrid’s Regional Office of Mental Health established suicidal behavior 
prevention as a priority in its 2010-2014 Mental Health Strategy. This implied to launch the 
Suicide Risk Attention Program (ARSUIC is its Spanish acronym). Its main purpose is to offer 
priority specialized care to those patients who have attempted suicide, in order to prevent 
potential relapses. Even though ARSUIC is a multi-faceted program that includes several 
interventions at different levels (Comunidad Autónoma de Madrid, 2019), the current study uses 
the term “the ARSUIC intervention” to refer to a priority appointment with an outpatient 
psychiatrist, within 7 days following discharge after a suicide attempt. Additionally, other 
Psychiatry Departments of the Community of Madrid deployed program augmentations that 
include either the implementation of an enhanced contact strategy or of individual problem-
solving psychotherapy. 
2.3.1 The ARSUIC intervention 
The Suicide Risk Attention Program (ARSUIC, by its Spanish acronym) seeks to ensure a 
prioritized and specialized care for those individuals who have attempted suicide, fostering 
potential contacts with mental health workers during the more dangerous first days after the 
attempt. It was implemented across the Community of Madrid during the last trimester of 2012. 
Previously, priority specialized appointments could take up to 19 days (Comunidad Autónoma de 
Madrid, 2017). The program considers that every suicide attempter must have an appointment 
33 
 
with a general psychiatrist with no specific suicide prevention training within the first 7 days after 
hospital discharge. Hence, it does not imply any specific contact maintenance strategy or 
therapeutic intervention other than scheduling a priority outpatient visit in the next 7 days. The 
date and time of the appointment is explained to the patient and indicated in the hospital discharge 
report by the ED psychiatrist or, if the patient has been admitted to the hospital, by the treating 
psychiatrist. Following the priority appointment, the patient continues the usual psychiatric care; 
no further follow-up contacts are used, and no specific materials are shared. No new staff has been 
hired to conduct the program; instead, every community psychiatrist should devote a number of 
weekly consultation hours to the program. 
2.3.2 The Enhanced Contact intervention 
Participants from Madrid’s western catchment area received an enhanced contact maintenance 
intervention framed within the greater “Código 100” Suicide Prevention Program, a strategy 
delivered in collaboration with Madrid’s extra-hospitalary emergency service in order to 
guarantee an appropriate continuity of care (López-Castroman et al, 2015a). Inclusion criteria 
to “Código 100” are: to have attempted suicide, to be 18 y-o or older and to sign an informed 
consent form. The intervention starts with an appointment 3 days after discharge, followed by 
6-12 months of an intensified frequency of outpatient visits, depending upon the patient’s 
severity and his/her personal preference, with a specifically devoted psychiatrist trained in 
suicide prevention. In addition, every patient receives telephone calls from the hospital at 
follow-up months 1, 6 and 12. The content of these calls was explanatory and supportive, 
seeking to reassure patients, clarify their doubts regarding treatment, enhance their adherence 
to follow-up visits and remind them of the available emergency treatment options in case of a 
new crisis. It does not include a specific psychotherapeutic approach. Then, the patient 
continues usual treatment at a CMHC. 
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2.3.3 The Psychotherapy intervention 
Participants from Madrid’s southern catchment area received a modified ARSUIC intervention, 
adding individual psychotherapy. Inclusion criteria are to have attempted suicide, to be 18 y-o 
or older and not to have a concurrent ongoing therapeutic treatment at an outpatient clinic. The 
psychotherapy is held at the General Hospital. It includes 2 months of weekly, 30-minute-long 
individual, non-suicide-specific therapy sessions, focused on problem-solving, stress reduction 
and cognitive reformulation. Therapy sessions are conducted by trained clinical psychologists, 
under a general psychiatrist’s supervision. Then, the patient  is referred to a General Practitioner 
(GP) or a CMHC. In case the participant fails to attend the sessions, reminder telephone calls 
are made from the hospital.  
2.3.4 Justification of the study 
The ARSUIC intervention was implemented globally throughout all healthcare catchment areas 
of the Community of Madrid. However, no prior study has evaluated the actual uptake and 
impact of the program in the clinical setting, in terms of its effective implementation lowering 
the average time between discharge and the first outpatient visit or its effectiveness lowering 
the risk of suicidal behaviors among suicide attempters. Also, other catchment areas deployed 
additional augmentations based on contact maintenance strategies or psychotherapy, but no 
study has assessed whether these strategies are in fact more effective compared to the ARSUIC 
intervention, which of the two augmentation approaches is comparatively more fruitful and, 
last, which intervention has the highest probability of being cost-effective and at which level of 
willingness-to-pay. Notably, while the ARSUIC intervention and the two augmentation 
strategies seem reasonable given the existing evidence, very few of the studies evaluating 
similar interventions have been conducted elsewhere, hence leading to reasonable doubts 
regarding transportability to the Spanish context, and no study has used real clinical data to 




This dissertation to qualify as a Doctor of Philosophy includes 4 original research articles 
evaluating the implementation, effectiveness, and cost-effectiveness of the ARSUIC 
intervention and two augmentation strategies based on enhancing contact maintenance and 
problem-solving psychotherapy, and 8 additional research articles completed within the 

















3. Objectives and hypotheses 
Abstract 
This study evaluated three suicide prevention strategies (ARSUIC, Enhanced Contact 
and Psychotherapy) currently deployed in the Community of Madrid. The overall 
objective was to provide decision-makers with real-world estimates of the actual 
uptake, effectiveness and cost-effectiveness of the interventions. First, we estimated 
the degree of implementation of the ARSUIC intervention, currently considered 
treatment as usual throughout Madrid. Then, we calculated this intervention’s clinical 
effectiveness at lowering suicide risk among suicide attempters.  Last, we estimated 
the comparative effectiveness and cost-effectiveness of the Enhanced Contact and 
Psychotherapy interventions, both in comparison to ARSUIC and comparing them 
head-to-head. 
Resumen 
Este estudio evaluó tres estrategias para la prevención del suicidio (ARSUIC, Contacto 
Aumentado y Psicoterapia) actualmente en uso en la Comunidad de Madrid. El 
objetivo general era proveer a los decisores con estimadores del nivel de adopción, 
efectividad y coste-efectividad de estas intervenciones en la práctica clínica real. 
Primero, estimamos el grado de implementación de la intervención ARSUIC, 
actualmente considerada el tratamiento habitual en Madrid. A continuación, 
calculamos la efectividad clínica de ARSUIC reduciendo el riesgo de suicidio en 
personas que han intentado suicidarse. Finalmente, estimamos la efectividad y coste -
efectividad comparativas de las intervenciones de Contacto Aumentado y 
Psicoterapia, en comparación con ARSUIC y comparándolas entre ellas. 
 
3.1 Study objectives 
3.1.1 Overall study objective 
The overall objective of this study was to estimate the implementation and comparative 
effectiveness and cost-effectiveness of three interventions for suicide prevention following 
hospital discharge after a suicide attempt. The three studied interventions were the Suicide Risk 
Attention Program (ARSUIC is the Spanish acronym), a priority appointment with a psychiatrist 
at an outpatient clinic within one week from discharge, scheduled at the hospital before 
discharge, followed by treatment as usual at the same clinic; a priority appointment with a 
specifically devoted psychiatrist trained in suicide prevention, within three days from discharge, 
followed by a flexible, individualized schedule of additional brief telephone and in-person 
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contacts (with at least three telephone contacts) over the following 6-month period, in tandem 
with treatment as usual at an outpatient clinic (this schedule is called Enhanced Contact 
throughout the rest of the study); and a priority appointment with a psychiatrist, at the same 
hospital, within one week from discharge, followed by 8 sessions of individual problem-solving 
psychotherapy over a 2-month period, and subsequent referral to an outpatient clinic for 
treatment as usual (this schedule is called Psychotherapy henceforth). 
3.1.2 Specific study objectives 
We conducted the following sequence of four studies, using a variety of methods for causal 
inference from observational data collected for healthcare and administrative purposes.  
First, we estimated the actual degree of implementation and uptake of the ARSUIC intervention 
in the Community of Madrid. For this, we calculated the degree of fulfillment of the 
requirements of the intervention and analyzed changes over time in the average time between 
discharge and first outpatient visit following a suicide attempt in the years before and after 
implementation.  
Second, we evaluated the clinical effectiveness of ARSUIC at reducing the risk of relapse 
among suicide attempters discharged from emergency departments, in comparison to treatment 
as usual before the deployment of the program, using a before-and-after design.  
Third, we compared ARSUIC to two augmentation programs deployed in specific catchment 
areas of the Community of Madrid during the same period, Enhanced Contact and 
Psychotherapy, emulating a large clinical trial that compared individuals assigned to the three 
interventions over a one-year period.  
Last, we used the comparative effectiveness estimates obtained in the previous step, combined 
with data on the real direct (medical and non-medical) and indirect costs of each interventions 
to estimate the comparative cost-effectiveness of TAU, Enhanced Contact and Psychotherapy 




Our a-priori hypotheses were based on the literature on the comparative effectiveness of brief 
psychotherapeutic programs and contact maintenance interventions for lowering suicide risk 
among attempters. We hypothesized: 
First, that ARSUIC would have an elevated degree of uptake, lowering significantly the average 
time between hospital discharge and first outpatient visit in suicide attempters, and  that the 
degree of implementation would increase progressively over the years following program 
deployment. 
Second, that ARSUIC would be effective at lowering the risk of relapse in suicide attempters 
treated at the emergency department, mainly due to a reduced risk during the time period 
immediately following discharge. 
Third, that the two augmentation programs, Enhanced Contact and Psychotherapy, would 
outperform ARSUIC in terms of effectiveness at lowering suicide relapse risk and that the effect 
size of both interventions, in comparison to ARSUIC, would be roughly comparable. 
Fourth, that the two augmentation programs, Enhanced Contact and Psychotherapy, would be 
cost-effective compared to ARSUIC under reasonable thresholds (i.e. those used commonly in 
the literature) of costs per averted suicide attempt, and that Enhanced Contact would be cost 
saving compared to Psychotherapy, although the increase in cost incurred by Psychotherapy in 









Using information retrieved from electronic healthcare records, we applied a variety 
of data science methods for causal inference from observational data. First, we 
conducted an ecological-level evaluation of the level of implementation of the 
ARSUIC intervention, using the time between hospital discharge and the first 
outpatient visit as the outcome variable. Then, we emulated two unfeasible target 
pragmatical trials comparing, first, participants receiving the ARSUIC intervention 
with a historical cohort using a mirror design and, second, participants receiving 
ARSUIC, Enhanced Contact and Psychotherapy, using similar ascertainment methods 
for the follow-up period across centers. All individual-level studies were adjusted for 
potential confounding using multivariable Cox regression models informed by 
theoretical information summarized in directed acyclic graphs. Lastly, we conducted 
a cost-effectiveness study, from a societal perspective, deriving deterministic and 
probabilistic sensitivity analyses, to inform decision-makers for funding allocation 
purposes. 
Resumen 
Empleando información obtenida a partir de registros sanitarios electrónicos, 
aplicamos una variedad de métodos de ciencia de datos para la inferencia causal 
basada en datos observacionales. Primero, realizamos una evaluación a nivel 
ecológico del nivel de implementación de la intervención ARSUIC, empleando el 
tiempo entre el alta hospitalaria y la primera cita ambulatoria como variable resultado. 
Después, emulamos dos ensayos clínicos pragmáticos inviables comparando, en 
primer lugar, participantes que recibieron la intervención ARSUIC con una cohorte 
histórica en un diseño de tipo espejo y, posteriormente, participantes que recibieron 
ARSUIC, Contacto Aumentado y Psicoterapia, empleando un método de seguimiento 
y medición similar para los tres centros. Todos los estudios de nivel individual fueron 
ajustados para reducir sesgo de confusión, empleando modelos multivariables de 
riesgos proporcionales de Cox informados por información teórica que se expresó en 
forma de gráficos acíclicos direccionales. Finalmente, condujimos un estudio de coste-
efectividad, desde la perspectiva de la sociedad, derivando análisis de sensibilidad de 
tipo determinista y probabilístico, para orientar la toma de decisiones en materia de 
gestión de recursos. 
 
4.1 Study setting, data source, and overall methodological approach 
4.1.1 Study setting and data source 
In Spain, a National Health Service (NHS) funded by taxes provides universal access to medical 
care. The Community of Madrid’s Health Council coordinates 25 healthcare catchment areas. 
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Each area features a General Hospital and includes a Psychiatry Department offering a range of 
in- and out-patient care and rehabilitation resources, to which General Practitioners and other 
specialists refer patients who require mental healthcare. Most of the patients with psychiatric 
needs use this network, and they usually come from primary care.  
In addition, all catchment areas have implemented longitudinal electronic healthcare records for 
data collection for healthcare and administrative purposes. Even though these records are 
specific to each catchment area and, as a result, not all records include all variables, they feature 
a high number of non-selected patients, followed-up for several years. Applying adequate data 
science methods and under a correctly specified framework, large healthcare records are useful 
for several tasks within epidemiology (Hernán et al., 2019): for instance, they can be used for 
description (Martínez-Alés et al., 2019e; Bouza et al., 2019; López-Cuadrado et al., 2019) or 
for prediction (Kessler et al., 2015; Simon et al., 2018). Likewise, these large electronic 
healthcare records can be viewed as an opportunity to draw causal inferences with high external 
validity that can be readily applicable by decision-makers. Notwithstanding, data retrieved from 
electronic healthcare records are, by definition, observational. The following section reviews 
specific characteristics and assumptions of the thinking framework under which we conducted 
our analyses and drew our conclusions. 
4.1.2 Overall methodological approach: using administrative 
healthcare databases for causal inference 
The objective of our study implied calculating several causal effects. First, we wanted to know 
the causal effect of deploying a mandatory program on the distribution of time to first 
consultation following hospital discharge after a suicide attempt. Second, we wanted to estimate 
and compare the causal effects of three different strategies on the individual risk of suicide re-
attempt. However, answering causal questions with observational data poses inherent 
challenges (Hernán and Robins, 2019). The following section examines the theoretical and 
methodological framework under which we conducted our causal analyses. 
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Mackie (1965) and Rothman (1976) defined a cause of a given outcome as a factor preceding 
the outcome so that, in the absence of that factor, the outcome would not have occurred, or it 
would have occurred at a different moment. This widely accepted definition of cause and effect 
implies what has been called the fundamental problem of causal inference (Holland, 1986): 
causal inference would require, in theory, the comparison of the factual, observable universe to 
another counterfactual (and hence unobservable) one where everything but the potential cause 
under study was held equal.  
In an attempt to bypass this fundamental problem , researchers usually resort to study designs 
that randomly assign participants to the causal factor (treatment) under study. In short, random 
assignment generates treatment groups that are exchangeable, or comparable in expectation 
(Deaton and Cartwright, 2017), because randomization ensures that the mechanism of 
assignment of the causal factor under study is independent of the individual’s characteristics. 
Observational studies, on the contrary, must deal with the possibility that characteristics of the 
individual may, at the same time, be associated (causally or not) with both the treatment and 
the outcome. This phenomenon, commonly termed confounding, can lead to spurious 
correlations between the cause and effect under study and bias the study’s findings. 
Accordingly, several analytical methods, mostly based on multivariable regression analysis, 
have been developed for researchers to adjust for confounding in observational research and 
obtain exchangeability to some degree (Hernán and Robins, 2019). All of these methods require 
a correct specification of the causal structure underlying the research question of  interest 
(Hernán et al., 2002) and, in turn, depend on how correct this model is. First introduced in 
philosophy and computer science (Pearl, 2009), directed acyclic graphs (DAGs) are an 
increasingly used approach to guide confounding adjustment in observational epidemiology and 
to enhance communication between scientists, by forcing the researcher to clarify the 
assumptions underlying their model specification and the choice of variables for adjustment 
control. Hernán and Robins (2019) provide a succinct tutorial on the use of DAGs for 
confounding control. For clarification purposes, figure 1 depicts the general DAG that we 
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followed to guide our multivariable adjustments for confounding. In situations where we were 
not sure of the most correct multivariable model according to our theoretical framework, two 
different models were undertaken as a means of sensitivity analysis. 
An additional consideration should be made when using observational data for comparative 
effectiveness research or, in other words, when emulating an unfeasible target trial with non -
experimental data. Even in the presence of exchangeability, extensive research has shown that 
observational data provide better estimates of what would be observed in a randomized trial if 
the intervention under study is well-defined (Hernán et al., 2008), a requirement that has also 
been termed the Stable Unit Treatment Value Assumption (SUTVA) (Cox, 1958). In our study, 
we adopt a target trial approach by specifying the interventions under study, setting time zero 
of our participants’ follow-up when they are admitted to their treatments, adopting similar 
criteria for participant admission and comparable follow-up methods across treatments, and 
analyzing the data from an intention-to-treat perspective. In addition, we evaluate the degree of 
fulfillment of the interventions as a means to evaluate the validity of this intention-to-treat 
approach. 
Last, it should be noted that causes can act at several levels of organization (the ecological, the 
individual, the molecular, and their variations) (Susser, 1972), and be variably distal or proximal 
in relation to the outcome of interest (Phelan and Link, 1995). For example, for suicide, while 
a high rate of gun ownership may act at the ecological level, enduring a psychiatric disorder 
may act at the individual one; and while having been born in a socioeconomically deprived 
neighbourhood may be a distal cause, an acute state of alcohol intoxication may be a proximal 
one. Public health practice often deals with causes that act on several levels, following complex 
hierarchical networks - we have examined the multilevel framework of causation in detail 
elsewhere (Martínez-Alés et al., 2019c). In clinical settings, however, comparative 
effectiveness and outcomes research is typically interested in estimating the causal effects of 
treatments – proximal causes that act at the individual level.  
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Our study considered distinct research questions that can be framed at different causation levels. 
In particular, our first specific aim looked at the result of deploying the ARSUIC program, a 
mandatory and universal intervention, on the average time between hospital discharge and the 
first outpatient visit following a suicide attempt, and on the proportion of patients fulfilling the 
objective of the intervention. While caution is required before concluding causal relations at the 
individual level, because of the risk of engaging in what is commonly referred to as an 
ecological fallacy, we chose an ecological unit of analysis because the unit of intervention here 
was supra-individual (indeed, the program was effectively deployed at the province level). 
Using individual-level data to inform decision-makers regarding these specific implementation 
outcomes would entail a similar risk of a cross-level inference bias, in this case called atomistic 
fallacy (Schwartz, 1994).  The rest of our specific aims, on the other hand, considered cause 
and effect at the level of individual participants. 
4.2 Methods for the specific study aims 
4.2.1 Evaluation of the implementation of the ARSUIC intervention 
4.2.1.1 Study design, subjects, and variables 
Information regarding dates of admission and discharge was obtained from the hospital’s 
electronic healthcare records (EHR). These records are filed as a requirement before any 
discharge, and they also include sociodemographic variables: gender, age and whether the 
suicide attempt was an index attempt or a reattempt. Information regarding the first outpatient 
visit following discharge, and whether the patient complied with it, was retrieved from each 
CMHC’s EHR. To evaluate the degree of implementation, we computed the time between 
hospital discharge and the first CMHC outpatient visit within the first 30 days. By doing so, we 
prevented other visits, most likely unrelated to the suicide attempt, from biasing our estimates. 
This bias would have favored most recently registered cases, because their follow-up periods 
encompass shorter time windows.  
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We studied time-to-first outpatient visit as a continuous variable, as well as an implementation 
dichotomous variable (proportion of patients actually seen within a maximum 7 days). In 
addition, we computed the proportion of subjects who did not had an outpatient visit after the 
attempt. Using the dates of hospital admission and discharge, we were able to calculate the 
interval of time between attempts in those patients who had more than a suicide attempt during 
the study period. Then, to estimate the effectiveness of the program, we obtained the time 
between attempts within the first follow-up year after each attempt, and the suicide attempt rate 
per person-year in each of the study years. 
4.2.1.2 Statistical analyses 
We obtained descriptive statistics of the study population’s sociodemographic variables. They 
were summarized as percentages in categorical variables, and as the medianstandard deviation 
in continuous ones. Then, we calculated: time between discharge and the first outpatient visit; 
time between different attempts; and suicide attempt rate per person-year. We tested that 
continuous variables were followed a parametric distribution using Kolmogorov-Smirnoff’s 
test, we studied temporal trends using Pearson’s R coefficients, and we tested before -after 
implementation differences using Student’s t-test for repeated measures. Last, we studied time 
trends in suicide attempt rates per person-year by fitting a generalized linear model (GLM). 
Inter-annual rate logarithm comparisons were adjusted for multiple comparisons using 
Bonferroni’s method. We conducted all analyses using SPSS v.22 for Windows  (IBM Corp, 
2013, Armonk, NY, USA). Graphics were programmed using Stata v. 13 for Mac (Statacorp, 
2013, College Station, TX, USA).  
4.2.2 Evaluation of the clinical effectiveness of the ARSUIC intervention 
4.2.2.1 Study design, subjects, and variables 
We conducted an observational study. Between January 1st, 2010, and December 31st, 2015, 
every suicide attempt receiving medical and psychiatric attention at the ED entered the study, 
regardless of whether admission to a medical or psychiatric ward was indicated following ED 
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discharge. In this particular ED, every subject in an emergency psychiatric need first undergoes 
general medical assessment and treatment and then receives psychiatric care. In addition, 
anybody presenting with suicidal ideation or a suicide attempt has to be seen by a psychiatry 
consultant before hospital discharge. If medical damage due to the suicide attempt requires 
admission in a medical ward, a psychiatrist evaluates the patient once stabilized. If the 
psychiatrist considers that the relapse risk remains excessively high, voluntary or involuntary 
psychiatric admission can be indicated. We defined suicide attempt as any self-injurious act 
committed with at least some intent to die as a result. Therefore, we excluded patients exhibiting 
suicidal ideation without suicidal behavior. Otherwise, every suicide attempt was admitted to 
the study and included in the analyses. We considered each attempt a unit of analysis given that 
the intervention was widely administered at discharge, regardless of whether it was a first 
suicide attempt or a relapse. The study protocol complies with the Declaration of Helsinki for 
Human Rights and has the approval of the La Paz General Hospital’s Ethical and Clinical 
Research Committee. Data were anonymized before extracting sociodemographic and clinical 
information from patient records.  
Information of prognostic interest was selected according to prior existing knowledge (Turecki 
& Brent, 2015; Arias et al., 2016). By protocol, an individual semi-structured interview is 
performed prior to hospital discharge and stored in computer databases for clinical purposes. In 
addition, we reviewed each subject’s historical medical records to identify previous attempts 
and psychiatric diagnoses. Clinical variables included the following: personal history of 
psychiatric disorder, previous suicide attempts, concurrent alcohol or abuse drugs use and 
hospital admission after the attempt. Sociodemographics considered age (continuous variable), 
and gender and family support after discharge (dichotomous variables). Additional dichotomous 
variables regarding psychiatric diagnoses in medical records were included, according to the 
presence or absence of ICD-10, chapter V, F10-69 diagnostic groups (mental and behavioral 
disorders due to psychoactive substance use; schizophrenia, schizotypal and delusional 
disorders; mood disorders; neurotic, stress-related and somatoform disorders; behavioral 
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syndromes associated with physiological disturbances and physical factors; and disorders of 
adult personality and behavior) (World Health Organization, 1992). We defined the outcome of 
interest as being admitted to the emergency department due to a new suicide attempt (any self-
injurious act committed with at least some intent to die) during the follow-up after a previous 
suicide attempt. If a recurrence happened during follow-up time, it was considered a relapse, 
and the time between attempts was measured. Time to the event of interest was obtained from 
hospital’s records. Every attempt, and its follow-up time, was considered.  
4.2.2.2 Statistical analyses 
Suicide attempts were divided according to whether they had happened in the three years prior 
to the program implementation, the “control period” (2010-2012), or the three ones during the 
“intervention period” (2013-2015). Initially, we compared baseline clinical and 
sociodemographic correlates in both periods, using Student’s T test for differences in 
continuous variables and Pearson’s Chi-square test for those in categorical ones. Then, we 
conducted a survival analysis. We censored those subjects who had not suffered the outcome of 
interest by the end of each period’s follow-up. We obtained Kaplan-Meier estimates of the 
survival function, both for the whole study time and by periods. We tested the difference 
between periods using Log-Rank test. In order to estimate the intervention’s influence in the 
risk of relapse, we conducted Cox proportional hazard regressions, obtaining crude and adjusted 
risk estimates (Hazard Ratio, HR). For the multivariate models, we retained those covariates 
remaining significant to the p<.10 level, utilizing a non-automatic method for their introduction, 
as well as those variables considered to be clinically relevant according to prior knowledge. 
Number of relapses during the follow-up was included as a continuous variable, in order to 
control its possible role as a source of confounding. Then, we estimated the Number Needed to 
Treat (NNT) and its 95% CI from the multivariate model B, following widely accepted methods 
(Altman and Andersen, 1999). The fulfillment of proportional hazards assumption requirements 
was ascertained both through graphic methods and using Schoenfeld’s test. Analyses were 
carried on Stata v13 software for Mac (StataCorp, 2013. College Station, TX, USA). 
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4.2.3 Comparative effectiveness of Enhanced Contact, Psychotherapy and 
ARSUIC 
4.2.3.1 Study design, subjects, and variables 
We conducted an observational study. We included all suicide attempters who, after discharge, 
had entered each center’s suicide prevention program between January 1st, 2013, and December 
31st, 2016, and followed them for 1 year. We considered a suicide attempt any self-injurious 
act committed with at least some intent to die as a result of the act. Thus, we excluded 
individuals with suicidal ideation but without suicidal behavior. The study protocol complies 
with the Declaration of Helsinki for Human Rights. Approval was obtained from the 
corresponding ethics committees in each catchment area. Data from patient records were 
anonymized before extracting sociodemographic and clinical details.  
Our primary outcome was relapse after a suicide attempt. We defined it as being treated again 
at the reference hospital, due to another suicide attempt, after hospital discharge and during a 
1-year long follow-up. Time to relapse was obtained from the hospital’s records. For subjects 
experiencing multiple relapses, we retained only the first one after entering the study. Data on 
clinical and sociodemographic variables of prognostic interest was obtained from pre-discharge 
semi-structured interviews, regularly performed by psychiatrists and stored in computer 
databases for clinical purposes. We selected the following sociodemographics: age (continuous 
variable), gender, immigrant status and cohabitation status (binary variables). Clinical variables 
recorded as dichotomous included: personal history of a diagnosed psychiatric  disorder, 
personal history of suicide attempts, concurrent alcohol or drug consumption at the moment of 
the attempt, presence of comorbid medical conditions and main diagnosis at discharge –encoded 
according to ICD-10, chapter V, F10-69 diagnostic groups (mental and behavioral disorders due 
to psychoactive substance use; schizophrenia, schizotypal and delusional disorders; mood 
disorders; neurotic, stress-related and somatoform disorders; behavioral syndromes associated 
with physiological disturbances and physical factors; and disorders of adult personality and 
behavior) (World Health Organization, 1992). 
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4.2.3.2 Statistical analyses 
Continuous variables were reported as mean (standard deviation) and categorical variables as 
proportions. In order to analyze baseline differences between the intervention groups in clinical 
and sociodemographic variables, we used Wilcoxon signs, Pearson’s Chi-square and Fisher’s 
exact tests.  
We then conducted a survival analysis. Subjects who had not relapsed within one year of follow-
up were censored. We obtained Kaplan-Meier estimates of the survival function by treatment 
group. We tested the difference using log-rank tests. In order to control for potential 
confounders, we conducted Cox porportional hazard regressions and obtained crude and 
adjusted risk estimates (hazard ratio, HR) for the different groups. For the multivariate model, 
we retained those covariates remaining significant to the p<.10 level, utilizing a non-automatic 
method for their introduction, as well as those variables considered to be clinically relevant 
according to prior knowledge. We followed widely accepted schemes for the adjustments  
(Hernán and Robins, 2019). Proportional hazards assumption fulfilment was ascertained both 
through graphic methods and using Schoenfeld’s test. Then, we obtained Number Needed to 
Treat (NNT) estimates for both interventions compared to TAU, using an accepted method for 
studies where the outcome of interest is the time to an event (Altman and Andersen, 1999).  
Gender and age-group differences exist in suicide and self-harm rates, and recent research 
shows that the young women stratum is becoming increasingly more affected (Ajdacic-Gross et 
al., 2008; Rockett et al., 2016). Accordingly, we conducted gender and age group-stratified Cox 
proportional hazard regressions, seeking for differences between programs across subgroups. 
We defined three different subgroups: female and <= 35 y-o, female and >35 y-o; and male. In 
order to keep reasonable statistical power for comparisons, we did not differentiate age groups 




4.2.4 Comparative cost-effectiveness  
4.2.4.1 Study design, subjects, and variables (See 4.2.3.1.) 
4.2.4.2 Cost-effectiveness statistical analyses 
4.2.4.2.1 EFFECTIVENESS 
Our outcome of interest was relapse within 1 year of follow-up after hospital discharge defined 
as being treated again at the emergency department for a new suicide attempt using the same 
definition. For patients with >1 suicide attempt over the follow-up period, we retained only the 
first re-attempt. Time to relapse was calculated using each hospital’s electronic records. 
Comparisons used TAU as the reference group and were adjusted using multivariable Cox 
regression models and expressed as hazard ratios (HR) with 95% confidence intervals (95% CI) 
(Martinez-Ales et al., 2019f). We derived adjusted proportions of relapses (95% CI) for 
Enhanced Contact and Psychotherapy by multiplying the proportion of relapses among the TAU 
group by the adjusted HR (95% CI) of the Enhanced Contact and the Psychotherapy groups. 
Then, we modeled effectiveness as (1 - the probability of suicide re-attempt) for each 
intervention. In addition, we obtained estimates of the head-to-head comparison between 
Enhanced Contact and Psychotherapy, expressed as HR (95% CI). 
4.2.4.2.2 RESOURCE USE AND COSTS 
We considered a societal perspective that includes the healthcare perspective (all direct medical 
and non-medical costs) as well as the indirect costs due to work productivity lost because of 
sick leave or death.  
We calculated the rate of service use per intervention based on information retrieved from 
electronic healthcare records (EHRs) for TAU, and on the protocol for Enhanced Contact and 
Psychotherapy. The assumption underlying this choice is that the cost for each participant 
pertaining to the Enhanced Contact and Psychotherapy groups equaled the cost of TAU plus the 
cost of each intervention’s per-protocol service use, regardless of participants’ adherence. All 
relapses were considered to incur in a minimum cost due to emergency department visit, unless 
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the re-attempt had been fatal. Unfortunately, the EHRs of the areas where the three interventions 
were implemented were found to not contain the same information regarding key variables. 
Accordingly, we used EHRs from the Psychotherapy catchment area to calculate the probability 
of receiving extra-hospitalary care and ambulance transportation, and EHRs from the Enhanced 
Contact catchment area to calculate the probability of hospital admission (including admission 
to an intensive care unit, a medical or surgical ward, or a psychiatric ward). This decision 
assumes that the proportions of extra-hospitalary care and ambulance transportation and of 
hospital admission after emergency department visit, as well as the distribution of costs after 
hospital admission, were similar across study centers. Then, we imputed direct costs based on 
the official list of public healthcare prices and fees that the Community of Madrid uses to fund 
medical providers (BOCM, 2017). In this list, extra-hospitalary emergency care interventions 
and emergency department/outpatient visits are valued on a flat rate basis, while in -patient 
medical costs are calculated based on Diagnostic-Related Groups (DRGs). 
These data, that represent the healthcare perspective, were combined with estimates of the 
indirect costs due to death and sick leave to obtain the societal perspective. Again in this case, 
not all EHRs contained enough information regarding the probability of death and sick leave, 
and we had to assume a similar distribution across centers. The probability of death per relapse 
was obtained from the EHRs of the Psychotherapy area, and the probability of  sick leave per 
relapse, as well as the distribution of sick leave days, from the EHRs of the Enhanced Contact 
area. To consider the cost of death, we used the present value of lifetime earnings (PVLE) 
methodology, hence assuming a loss of productive years calculated considering Spain’s current 
average retirement age, 65y (Instituto Nacional de Estadística, 2019) and the mean age of the 
deceased participants. Despite valid critiques to this methodology, we consider that it yields 
conservative, conceptually comprehensible estimates. Costs of death and indirect costs due to 
sick leaves were estimated based on Spain’s average annual monthly wage over the study period 
(EUR 1880) (Instituto Nacional de Estadística, 2017). We did not have to impute any cost or 
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probability based on the literature. Given the 1 year-long follow-up, we did not include any 
discount or inflation in cost calculations.  
4.2.4.2.3 COST-EFFECTIVENESS AND SENSITIVITY ANALYSES 
We calculated incremental cost-effectiveness ratios (ICERs: incremental cost divided by the 
incremental effectiveness) comparing Enhanced Contact vs TAU and Psychotherapy vs TAU 
(see below formula 1). The expected value cost of each intervention was obtained by 
multiplying the rate of service use and the probabilities of each outcome (death; medical care 
including extra-hospitalary care, emergency visit, and admission to an intensive care unit or a 
medical or psychiatric ward; and sick leave) by their cost (formula 2).  
We conducted a deterministic sensitivity analysis to estimate the role that potential uncertainty 
may have on our cost-effectiveness estimates. To that end, we considered 3 potential scenarios: 
base case (formula 1), most favorable (formula 3), and least favorable (formula 4) to the studied 
interventions, using the 95% CI upper and lower limits (UL and LL, respectively) of the 
effectiveness estimates, and adding and subtracting a 15% to the estimates of the costs. To 
calculate ICERs in the most and least favorable scenarios, respectively, we used the lowest cost 
estimate and the highest effectiveness estimate, and the highest cost estimate and the lowest 
effectiveness estimate.  
𝐼𝐶𝐸𝑅𝐴 𝑣𝑠 𝐵 =  
𝐶𝐴−𝐶𝐵 
𝐸𝐴−𝐸𝐵
           
 (1) 
𝐶𝑥 = 𝐶𝑖𝑥 + 𝐶𝐷 𝑃(𝑅|𝑋)𝑃(𝐷|𝑅) + 𝐶𝐴𝑃(𝑅|𝑋)𝑃(𝐴|𝑋) + 𝐶𝑆𝐿𝑃(𝑅|𝑋)𝑃(𝑆𝐿|𝑅)   
 (2) 
Where,  
C = Cost; E = Effectiveness; x ∈ {A, B}; ix= X Intervention; D = Death; R = Relapse; A = 
Admission; and SL = Sick Leave 
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𝐼𝐶𝐸𝑅𝑚𝑜𝑠𝑡 𝑓𝑎𝑣𝑜𝑟𝑎𝑏𝑙𝑒 𝐴 𝑣𝑠 𝐵 =  
𝐶−15%𝐴−𝐶−15%𝐵 
𝐸 95% 𝐶𝐼 (𝑈𝐿) 𝐴−𝐸 95% 𝐶𝐼 (𝑈𝐿)𝐵
            
 (3) 
𝐼𝐶𝐸𝑅𝑙𝑒𝑎𝑠𝑡 𝑓𝑎𝑣𝑜𝑟𝑎𝑏𝑙𝑒 𝐴 𝑣𝑠 𝐵 =  
𝐶+15%𝐴−𝐶+15%𝐵 
𝐸 95% 𝐶𝐼 (𝐿𝐿) 𝐴−𝐸 95% 𝐶𝐼 (𝐿𝐿)𝐵
              
 (4) 
Because Enhanced Contact and Psychotherapy showed identical performance regarding clinical 
effectiveness, we compared them conducting a cost-minimization analysis. 
Finally, we conducted a probabilistic sensitivity analysis where we ran 10,000 simulations of 
the base case scenario varying all possible parameters at random, based on the distribution of  
our data, following Bernecker et al’s method (2019). All analyses were conducted in Stata 






For the ARSUIC intervention, we found that median time between discharge and the 
first visit decreased from 8.5 to 6 days after program deployment, with the proportion 
of visits within 7 days increasing from 32 to 48.5%. Compared to the prior treatment 
as usual, we obtained that receiving ARSUIC entailed a 24% adjusted risk reduction 
of the risk of suicide re-attempt. Both individual Psychotherapy and Enhanced Contact 
were more effective than ARSUIC, with a similar 40% lower relapse risk in adjusted 
models for both study treatments and resulted cost-effective with a high probability. 
Enhanced Contact was slightly cost saving in comparison to Psychotherapy. 
Resumen 
Al estudiar ARSUIC, encontramos que el tiempo mediano entre el alta y la primera 
visita ambulatoria se redujo de 8,5 a 6 días después de implementar el programa, y la 
proporción de visitas en menos de 7 días aumentó de 32 a 48,5%. En comparación con 
el tratamiento habitual previo, ARSUIC implicó una reducción del riesgo de reintento 
de suicidio del 24%. Tanto la Psicoterapia individual como el Contacto Aumentado 
resultaron más efectivos que ARSUIC, con una reducción del riesgo del 40% en ambos 
casos en modelos ajustados, y coste-efectivas con alta probabilidad. Contacto 
Aumentado implicó gastos ligeramente menores en comparación con Psicoterapia. 
 
5.1 Overall study results 
The ecological-level assessment of the implementation of the ARSUIC intervention showed 
that, after program deployment, median time between discharge and the first visit decreased 
from 8.5 to 6 days, and the percentage of visits that fulfill the program’s objective increased 
from 32 to 48.5%. Between years 2012 and 2015, the suicide attempt rate per person and year 
decreased from 1.20 to 1.08 and the proportion of attempts corresponding to relapses from 
26.6% to 12.8%. When studying the effectiveness of ARSUIC, compared to the prior treatment 
as usual, we obtained that subjects exposed to ARSUIC had a lower risk of relapse after a suicide 
attempt, with a 24% adjusted risk reduction estimate. Moreover, the comparison of ARSUIC 
and Enhanced Contact and Psychotherapy indicated that the psychotherapy group had a lower 
presence of known risk factors for suicide attempt, and that both individual Psychotherapy and 
Enhanced Contact were more effective at reducing suicide reattempt than a single priority 
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appointment, with a similar 40% lower relapse risk in adjusted models for both study treatments. 
Notably, these results did not differ after gender and age-stratification. Finally, we found that 
both Enhanced Contact and Psychotherapy were cost-effective with a high probability, 
considering reasonable thresholds of willingness-to-pay in accordance with the literature. In 
addition, given that both interventions were equally effective, Enhanced Contact was slightly 
cost saving in comparison to Psychotherapy. 
5.2 Specific study results 
5.2.1 Evaluation of the implementation of the ARSUIC intervention 
During the study period, a total 886 suicide attempts fulfilling inclusion criteria received 
medical assistance at La Paz University Hospital. The majority of them corresponded with 
females (68.2%). Table 1 summarizes the demographic characteristics of the study population, 
divided by study year. 
5.2.1.1 Time between discharge and the first outpatient visit. 
Studying the distribution of the intervals of time between hospital discharge and first outpatient 
visit within 30 days, we found that year 2012’s medianstandard deviation 8.57.6 days were 
reduced, after the implementation of the program, to 67.3 in 2013 (p=0.03). We found an 
inverse correlation between study year and time between discharge and first visit, indicating a 
progressive increase in the program’s real uptake (R= -0.11; p<0.001). Figure 2 represents this 
association. Table 2 displays the percentage of cases who were compliant with the program’s 
main goal – having a consultation within 7 days, per study year. It also features the proportion 
of cases with no outpatient consultation. Given that a longer follow-up period increases the odds 
of having at least one visit after the index suicide attempt, this variable became slightly lower 
as the study advanced. 
57 
 
5.2.1.2 Proportion of suicide reattempts, attempt rate per person-year and time between 
attempts 
The distribution of suicide attempts per year was as follows: 199 cases in 2012, 242 cases in 
2013, 265 cases in 2014, and 180 cases in 2015. Figure 3 shows the evolution in the proportion 
of attempts that corresponds to reattempts, a figure that decreased every study year. Figure 4 
represents the evolution of the attempt rate per person-year throughout the study period. The 
rate decreased from 1.20 attempts in 2012 to 1.08 attempts in 2015 (p=0.01). Figure 5 shows 
the distribution of the intervals of time to reattempt, within a maximum 1-year follow-up, per 
study year: time between attempts progressively increased as the study advanced.  
5.2.2 Evaluation of the clinical effectiveness of the ARSUIC intervention 
5.2.2.1 Clinical and demographic characteristics 
We included data from 2,347 suicide attempts treated at the ED by a psychiatrist, between 
January 1st, 2010 and December 31st 2015. “Control period” comprised 1,176 attempts, while 
“intervention period” included 1,171. Globally, 1,775 subjects attempted suicide. Figure 6 
illustrates the attempt-reattempt distribution across the study subjects. Thirty-nine subjects were 
excluded due to computer-related data mistakes. The two major repeaters suffered 14 suicide 
attempts during the time of study. Table 3 shows baseline characteristics of the included cases, 
both for the whole study period and by treatment groups. In most cases, the subject was female 
(68.3%) and the mean age in years was 40.5. As for the most relevant risk factors, 73.9% had a 
personal history of at least one psychiatric disorder, 40.3% had a substance abuse disorder, and 
48.4% had previously attempted suicide at least once. Most frequent psychiatric diagnoses were: 
“Mental and behavioral disorders due to psychoactive substance use” (37.5%), “Neurotic, 
stress-related and somatoform disorders” (37.5%) and “Mood (affective) disorders” (39.4%). 
Comparing both groups showed that control period had a lower prevalence of family support 
(62.3% vs. 74.5%), a lower presence of concurrent alcohol/drug abuse (39.1% vs. 41.4%) and 
a higher percentage of inpatient admission after the suicide attempt (24.5% vs. 20.5%).  
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5.2.2.2 Follow-up and relapse 
A total 497 (21.2%) cases relapsed during follow-up. The intervention group had a lower 
incidence of relapse during follow-up (18.3% vs. 24.1%; P<.01). Curves obtained from Kaplan-
Meier survival probability and multivariate adjusted survivor functions are shown in Figure 7. 
Median follow up was 434 days for the whole study, 394 for the control group and 468 for the 
intervention group. Differences between control and intervention group’s survival probability 
estimates are statistically significant (Log-Rank test P<.01). Table 4 displays results from the 
adjusted and unadjusted Cox proportional hazard models. Univariate models showed an 
association between a higher risk of relapse and the following risk factors: personal history of 
psychiatric disorders, personal history of suicide attempts and concurrent alcohol or drug abuse. 
The presence of social support was a protective factor. For the multivariate models, we retained 
those variables that were significant at the p<.05 level (multivariate model A), as well as those 
variables considered clinically relevant (multivariate model B). Results show that attempts 
followed by a scheduled priority appointment had a lower risk of relapse, with little difference 
between estimates from the unadjusted model, HR (95%CI) = 0.72(0.60-0.82), and the 
multivariate models A, HR(95%CI) = 0.76(0.62-0.93) and B, HR(95%CI) = 0.69(0.54-0.87). 
The proportional hazards assumption was fulfilled (Schoenfeld’s Residuals test P=.30; P =.15 
and P =.14 for the univariate and multivariate models A and B, respectively). The NNT (95% 
CI) estimate obtained from the multivariate model B was 7.7 (4.5-20.0). 
5.2.3 Comparative effectiveness of Enhanced Contact, Psychotherapy and 
ARSUIC 
5.2.3.1 Clinical and demographic characteristics 
We included data from 1,492 patients who had attempted suicide and subsequently entered the 
suicide prevention program at one of the three hospitals, between January 1st , 2013 and 
December 31st, 2016. Table 5 summarizes baseline characteristics of the study subjects, both 
globally and per intervention group. 
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5.2.3.2 Intervention group baseline differences 
Baseline covariates showed comparable inter-group age distribution, a higher percentage of 
females in the Enhanced Contact group, along with several differences regarding clinical and 
social covariables. Subjects receiving TAU (the majority of the study participants) had 
proportions of psychiatric history (70.3%), previous suicide attempts (34.5%) and concurrent 
alcohol or drug abuse (35.7%) that fall halfway to that of the other two treatment groups, 
suggesting that this cohort had an intermediate level of clinical severity. As for social correlates, 
subjects receiving TAU had the lowest levels of both immigration and household cohabitation. 
The sample receiving psychotherapy, formed by one third of the subjects, had the lowest 
prevalence of the abovementioned clinical covariables, intermediate levels of immigration and 
relatively high levels of cohabitation. Participants receiving enhanced contact, the smallest 
group, had the highest prevalence of previous psychiatric conditions, immigration, and previous 
suicide attempts and drug/alcohol abuse. Regarding main diagnoses at discharge, the 
Psychotherapy and Enhanced Contact groups had similar rates of neurotic, stress-related and 
somatoform disorders, and the latter also showed a high presence of disorders of adult 
personality and behavior, while TAU participants were more frequently diagnosed as having 
mood disorders. These findings, suggesting the Psychotherapy group included a less severe 
sample, make sense as this intervention only included subjects who did not have an ongoing 
outpatient therapeutic treatment. 
5.2.3.3 Follow-up and relapse 
A total 133 (8.9%) subjects experienced a relapse during follow-up. TAU had twice the crude 
incidence of the psychotherapy group, while the enhanced contact group had an intermediate 
figure. Mean days (95% confidence interval) of follow up were: TAU: 335.8 (329.7-341.9), 
Enhanced Contact: 347.4 (337.2-357.6) and Psychotherapy: 349.6 (343.8-355.3), for a global: 
342.0 (338.0-346.1).  
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Curves obtained from Kaplan-Meier survival probability function estimates per intervention 
group, as well as multivariate adjusted survivor functions, are presented in figure 8. Differences 
between TAU and both Psychotherapy and Enhanced Contacts groups in Kaplan-Meier 
estimates are statistically significant (log-rank test p=0.001).  
Table 6 displays results arising from Cox proportional hazard models, including unadjusted and 
adjusted estimates. Univariate regressions showed an association between a higher  risk of 
relapse and several measured risk factors: a personal history of suicide attempts, concurrent 
alcohol or drug abuse and a comorbid condition. Among psychiatric conditions diagnosed, 
mood and personality disorders stood out as risk factors, and adjustment and stress disorders 
behaved as protective factors. Immigration also showed a protective effect. On the other hand, 
female gender did not achieve statistical significance, and neither did cohabitation or age in 
years. We fitted a subsequent multivariate regression, following a non-authomatic method, and 
delivered an adjusted model. We controlled for age, gender, previous suicide attempts, alcohol 
or drug abuse, mood (affective) and personality disorders. The fulfilment of the proportional 
hazards assumption was checked: Schoenfeld’s Residuals test p=.26 and p=.13 for the univariate 
and multivariate models, respectively. Using the adjusted regression, we estimated the NNT 
(95%CI) for each intervention compared to TAU, resulting on 6.7 (3.3-100.0) for Psychotherapy 
and 5.3 (2.6-1000.0) for Enhanced Contact. An alternative multivariate model, including the 
more general personal history of a psychiatric disorder instead of specific diagnoses, resulted 
in similar estimates and served as a sensitivity analysis (table 7). 
We obtained age- and gender-stratified multivariate estimates (table 8). Although the smaller 
resulting sample of subjects per stratum made the confidence intervals wider, the effect 
estimates of both interventions were not altered across gender groups or between younger and 
older females. Mood (affective) and personality disorders, previous suicide attempts and 
concurrent alcohol or drug abuse also had comparable effect sizes with wider confidence 
intervals across groups. 
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5.2.4 Comparative cost-effectiveness  
5.2.4.1 Effectiveness 
For subjects who received TAU, the probability of relapse over a one-year follow-up was 11.4% 
(95% CI: 10.2-12.6). Table 9 summarizes the adjusted relapse rates (95% CI) for Enhanced 
Contact and Psychotherapy. Notably, the head-to-head comparison between Enhanced Contact 
and Psychotherapy showed practically identical effectiveness estimates (HR=0.99; 95% CI= 
0.51-1.96). 
5.2.4.2 Costs 
First, we computed the direct medical cost per patient receiving each of the interventions. We 
estimated the basic annual cost of TAU to be EUR 311 per participant. Psychotherapy costed 
an estimated additional EUR 664 (total cost EUR 975 per participant), and Enhanced Contact 
an additional EUR 468 (total cost EUR 779 per participant).  
Then, per each suicide re-attempt, we calculated a direct medical cost of EUR 190 if it only 
required a one-day stay at the Emergency Department, and an additional EUR 4,163 if the 
patient was hospitalized. Direct non-medical costs due to transportation by ambulance were 
EUR 280. Finally, we estimated indirect costs worth EUR 543,696 in case of death and EUR 
62.6 per day of sick leave following the re-attempt. Figure 9 shows the decision-analytic model 
of distribution of costs. Based on information retrieved from EHRs, we weighted each of these 
costs by the probability of each potential outcome per suicide re-attempt. 
Table 10 includes information on how we computed the base case scenario costs for each 
intervention and of each suicide re-attempt, including the source of each datum, as well as when 
considering the less and most favorable scenarios for the deterministic sensitivity analysis, and 




Table 11 shows the ICER estimates of each of the possible comparisons under the three 
proposed scenarios. Under the base case scenario, Enhanced Contact entailed an ICER of EUR 
2,340 per averted attempt compared to TAU, a figure that rose to EUR 6,260 for Psychotherapy. 
As Enhanced Contact and Psychotherapy were similarly effective, a cost -minimization 
assessment indicated that the former was slightly cost saving compared to the latter (base case 
scenario: EUR -196, best case scenario: EUR -167, and worst case scenario: EUR -225 per 
participant). 
5.2.4.4 Sensitivity analysis 
Under the most favorable case scenario of the deterministic sensitivity analysis, Enhanced 
Contact was dominant, and Psychotherapy remained more costly when compared to TAU (EUR 
-27 and 489 per averted attempt, respectively) (table 11). Under the least favorable scenario, 
both interventions under study were markedly more costly than TAU (EUR 30,356 and 20,186 
per averted attempt, respectively) (table 11). Figure 10 displays the distribution of the 











This is the first study to evaluate three strategies for suicide prevention at the 
individual level currently deployed in the Community of Madrid. The implementation 
ARSUIC intervention, a priority appointment scheduled before hospital discharge, had 
a reasonable uptake, effectively reducing the average time between discharge and the 
first outpatient visit among participants. Moreover, ARSUIC was effective at lowering 
the risk of relapse among suicide attempters, reducing re-attempts by 24%. The two 
augmentation strategies under study, Enhanced Contact and Psychotherapy, posed a 
similar, additional benefit to that of ARSUIC, lowering the risk an additional 40%. In 
addition, both interventions were cost-effective compared to ARSUIC under 
acceptable thresholds of willingness to pay, and Enhanced Contact was slightly cost 
saving compared to Psychotherapy. Our results, based on data retrieved from the real 
clinical practice, should provide decision-makers with readily applicable estimates for 
treatment and healthcare planning purposes. 
Resumen 
Este es el primer estudio que evalúa las estrategias para la prevención del suicidio a 
nivel individual que actualmente están en uso en la Comunidad de Madrid. La 
implementación de la intervención ARSUIC, una cita prioritaria establecida antes del 
alta hospitalaria, tuvo una recepción razonable, reduciendo efectivamente el tiempo 
medio entre alta hospitalaria y primera cita ambulatoria. Además, ARSUIC fue 
efectivo reduciendo el riesgo de recaída entre personas que habían intentado el 
suicidio, reduciendo los reintentos un 24%. Las dos estrategias de potenciación 
estudiadas, Contacto Aumentado y Psicoterapia, tuvieron un similar beneficio 
adicional al de ARSUIC, reduciendo el riesgo un 40% añadido. Las dos intervenciones 
resultaron coste-efectivas, en comparación con ARSUIC, considerando límites de 
disposición a pagar aceptables, y Contacto Aumentado fue levemente menos costoso 
que Psicoterapia. Nuestros resultados, basados en datos de la práctica clínica real, 
deberían proveer a los decisores con estimadores directamente aplicables en términos 
de tratamiento y planificación sanitaria. 
 
6.1 Overall study discussion 
Ours is the first study to analyze the implementation, effectiveness and cost-effectiveness of 
three individual-level suicide prevention strategies currently deployed in the Community of 
Madrid. These results contribute to the literature on interventions to lower suicide risk among 
high-risk individuals by providing readily applicable estimates completely based on a 
naturalistic study analyzed using a variety of methods for causal inference from observational 
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data. Accordingly, these estimates should prove useful for decision making at several levels, 
including the clinical practice and healthcare planning.  
The results to our first aim indicate that implementing the ARSUIC Program lowered the time 
between discharge and the first outpatient visit following a suicide attempt. In addition, the 
proportion of suicide attempts due to relapses and the suicide attempt rate per person decreased 
progressively. The program fulfilment proportion was under 50%, suggesting between-user 
differences regarding their effective access to the program. Building on those results, the 
evaluation of the program’s clinical effectiveness suggests that an additional early appointment, 
scheduled before discharging suicide attempters, reduced suicide reattempt risk. Further, the 
comparison between ARSUIC, Enhanced Contact and Psychotherapy shows that, in a 
naturalistic clinical setting, patients exposed to individual psychotherapy or an enhanced contact 
intervention had a similar, lower relapse risk than the single priority appointment group. Finally, 
both programs proved cost-effective under reasonable thresholds of willingness to pay, and it 
seems that Enhanced Contact may be considered the treatment of choice for a general population 
of suicide attempters. 
6.2 Specific study discussions 
6.2.1 Evaluation of the implementation of the ARSUIC intervention 
This retrospective study analyzed the degree of implementation and fulfillment of  the ARSUIC 
Suicide Risk Care Program, as well as its effectiveness. Our results show that, after ARSUIC 
was implanted, the median time wait between a suicide attempt and the first outpatient follow-
up was reduced from 8.5 to 6 days, and then it stabilized in 7 days – the exact maximum that 
the program allows for. Moreover, the proportion of suicide attempts seen at the ED that 
correspond to reattempts decreased, and time between attempts in patients with multiple 
attempts increased. This is the first study to evaluate this program, adopted in all hospitals 
across the Autonomous Community of Madrid since 2013.  
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Since the establishment of the program, a number of voices have rightfully pointed out the need 
for an evaluation of its results (Asociación Madrileña de Salud Mental, 2012). In fact, 
implementing suicide prevention programs that are innovative and effective, and evaluating 
such programs with observational designs in real-world settings, are two global priorities 
(Brown and Green, 2014). According to our results, median time to follow-up, considering only 
the first 30 days after discharge, has decreased until becoming compliant with the study’s 
objectives. In addition, our study shows high adherence to follow-ups after suicide attempting 
– over 88% patients were seen at a CMHC at some point, following discharge. Notwithstanding, 
there is a marked proportion of patients who do not turn up to these outpatient visits within the 
maximum 7 days established in the program. During the study period, this proport ion has 
lowered from 68% to roughly 50%. The figure is in keeping with a study from Barcelona, where 
up to 50% did not comply with a suicide risk reduction protocol based on telephone calls  (Cebriá 
et al., 2013). Hence, while central tendency indicators suggest that ARSUIC’s goals have been 
fulfilled, there seem to exist substantial between-subject differences in effective access to care. 
The marked increase of absolute suicide attempts we observed between 2012 and 2014 is in line 
with trends reported elsewhere (Ting et al., 2012). Our ecological assessment of the program’s 
effectiveness is promising: the proportion of attempts corresponding to reattempts and the 
suicide attempt rate per person-year have decreased every year since the program was 
implemented.   
Our study includes several limitations that may somewhat affect its validity, and the 
applicability of our results. First, a proportion of all patients seen at the ED was under long -
term treatment in a different catchment area, indicating the possibili ty that some suicide 
attempts pertaining to our studied area were, in turn, seen at other EDs, and are not included 
among our study population. Other authors, from comparable healthcare settings  (Parra-Uribe 
et al., 2017), maintain that, in Spain, most attempts are derived to the correspondent catchment 
area’s ED. Overall, Madrid’s healthcare planning has not suffered major changes during the 
study period, and we consider unlikely the possibility that this limitation affects between-study 
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year differences. Thus, we believe that our findings are valid. Second, due to technical and 
ethical limitations, our effectiveness assessment is based on suicide reattempt, rather than death 
by suicide, as the measure of effect. Most authors agree that suicide attempt, as a relatively 
frequent event that can be registered in the clinical setting, is a useful proxy for death by suicide, 
an infrequent and difficult-to-detect outcome (Harris et al., 1997; Finkelstein et al., 2015; 
Tejedor et al., 1999). Notwithstanding, other studies have reported profile differences between 
people who attempt suicide and those who die by suicide (Parra-Uribe et al., 2013), and we 
consider that including suicide as an outcome should be a priority in future assessments of the 
program. Last, our study uses an ecological and historical design to evaluate the program’s 
effectiveness, two characteristics that limit our ability to draw causal inferences. The 
retrospective design increases the possibility of a potential undetected historical artifact 
affecting our results. For example, some authors have reported an association between the 2000s 
decade’s economic downturn and suicide rates in Europe (López Bernal et al., 2013). The 
ecological approach somewhat limits our study’s applicability to the clin ical practice, in terms 
of individual-level decision-making. 
Our study’s main strength is its naturalistic character that allows for the assessment of a recently 
implemented intervention in unselected patients. There is a growing demand for pragmatic 
intervention studies for comparative effectiveness research that favor the generation of external 
rather than internal validity and expedite the implementation of evidence-based programs 
(Sherman et al., 2016). The age and gender distribution of our study population are in line with 
those observed in comparable settings (Cebriá et al., 2013). We believe that our implementation 
estimates can be generalized to the rest of the Autonomous Community of Madrid, and that the 
effectiveness estimates are valid for other universal coverage healthcare systems. In addition, 
evidence suggests that, just as other subpopulations of patients under mental healthcare, people 
who attempt suicide have lower rates of adherence to outpatient care, as well as other inequities 
in access to care, than the general population (Miller et al., 2017; Larkin et al., 2010). Hence, 
hospital contexts such as the ED are an opportunity to enhance their access to effective 
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interventions. Our study contributes with novel information to the field of hospital-initiated 
interventions for suicide prevention in high-risk individuals. Last, the ecological approach to 
estimating the program’s effectiveness makes our results especially useful for decision -making 
at the healthcare policy and management level. Although most clinical studies opt for an 
individual-level approach, it should be noted that suicide is, by definition, a complex problem 
that requires the assessment of ecological-level factors and how these interact with individual-
level ones (Hawton and Pirkis, 2017).  
Further research is needed for a deeper understanding of the ARSUIC Suicide Risk Care 
Program. Clarification of the barriers and facilitators that suicidal individuals face in the process 
of accessing the program is a priority, in order to reduce access inequality. Also, building on 
other authors’ findings that similar, early contact enhancement programs might not be effective 
in the long-run (Cebriá et al., 2015), future repetitions of this evaluation will be required. Last, 
Lopez-Castroman and colleagues have pointed out that most suicides take place in low and 
middle income countries, while research in mainly conducted in high income countries  (2015b). 
Direct comparisons to programs deployed in the same and other contexts will allow for the 
identification of common components, to estimate is the program is adaptable and scalable 
(López-Castroman et al., 2015a). 
6.2.2 Evaluation of the clinical effectiveness of the ARSUIC intervention 
In this observational study, scheduling a priority outpatient psychiatry appointment lowered the 
risk of relapse among suicide attempters by up to 25% over a three-year follow-up. This is the 
first study to confirm the effectiveness of the ARSUIC Suicide Risk Attention Program, a 
contact enhancement intervention, currently in use throughout the Community of Madrid, 
Spain. Because we stuck to a strictly naturalistic design and included data from the real clinical 
practice, recruiting all suicide attempt patients treated at the ED level with no exclusion criteria, 
the results likely capture the implemented program’s true effectiveness. The effect estimates 
are consistent with those of other interventions aimed at contact maintenance (Zalsman et al., 
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2016), including studies conducted in other European countries (Reijas et al., 2013; Cebriá et 
al., 2013), the US (Miller, 2017) and several low and middle-income countries (Riblet, 2017). 
In keeping with the literature, risk factors for re-attempts included a personal history of previous 
suicide attempts, the presence of a diagnosed psychiatric disorder, female gender and concurrent 
alcohol or drug abuse, while family support was a protective factor.  
Emergencies because of attempted suicide have steadily increased throughout the last decades 
worldwide (Zalsman et al., 2016; Ting, 2012), and their frequency typically peaks amongst the 
younger age groups (Canner et al., 2018). Our results contribute with relevant information 
regarding the effectiveness of ED-initiated outpatient preventive programs directed towards 
attempters, considered exceptionally high-risk individuals. Given that discharge after a suicide 
attempt entails a remarkably high risk of relapse, a majority of prevention strategies have 
focused in this period (Meerwijk et al., 2016; Milner et al., 2015). Contact-enhancing programs, 
specifically directed at establishing brief contacts and maximizing access to clinical and social 
resources, are considered effective: accordingly, a range of evidence-based contact maintenance 
programs including the use of letters, telephone calls, messages or case management have been 
successfully developed, deployed and scaled-up (Vaiva et al., 2011; Berrouiguet et al., 2014; 
Dekker et al., 2017). Recently, the WHO Brief Intervention and Contact (WHO BIC), a strategy 
searching to enhance contact after a suicide attempt, was the only intervention to significantly 
lower the risk of suicide in a recent meta-analysis of randomized control trials (RCT) including 
other therapeutic and pharmacologic strategies and a variety of different locales (Riblet et al., 
2017). In the ED-Safe study, an RCT conducted in North American subjects, a brief ED-based 
intervention, consisting on post-discharge resources and telephone calls, significantly decreased 
re-attempts, with an incidence rate ratio (95% CI) of 0.72 (0.52-1.00) (Miller et al., 2017). 
However, studying suicide behaviors using experimental designs can be technically and 
ethically challenging, and a call has been made to conduct effectiveness and implementation 
studies on naturalistic settings, in order to obtain externally-valid real-world data that can 
inform decision-makers (Sherman et al., 2016). Along these lines, an observational study 
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conducted among suicidal ED patients from Veterans Health Administration hospitals found 
that a brief structured intervention, including an outpatient appointment and telephone calls, 
increased engagement and reduced suicidal behaviors after discharge (Stanley et al., 2018).  
Building on the tradition of suicide prevention among high-risk individuals, our study 
contributes with data from the clinical practice suggesting that contact maintenance, by 
scheduling a single priority appointment before discharging suicide attempters from the ED, 
can lower the risk of suicide attempt relapse. 
Suicide, a global public health concern, is the second cause of death among the Spanish youth 
(Instituto Nacional de Estadística, 2017). In the US, it is the only one, among the 10 leading 
causes of death, with an increasing rate over the last decade (Swanson et al., 2015). Suicide 
attempts are considered the most accurate markers for completed suicide: attempters from a 
multicenter controlled study in England had a 43 times higher risk of suicide (Hawton et al., 
2015). However, suicide attempts demand further attention beyond their predicting role. Not 
only they are an opportunity for prevention but also a frequent clinical entity by themselves (for 
example, around 10% of Spanish citizens have attempted suicide at least once) (Gabilondo et 
al., 2007), with an important associated burden of economic and emotional costs and a tendency 
to relapse. In fact, the presence of previous suicide attempts stood out as the major risk factor, 
with a HR of 2.32 in our adjusted models. In our study, more than 1 out of 5 attempts 
subsequently relapsed, and most reattempts took place during the first months of follow-up. 
This figure is consistent with that of a prospective study conducted in 150 Spanish subjects after 
hospital discharge (Tejedor et al., 1999), while a Danish cohort including 3,690 attempts 
exhibited an even higher risk, around 28% (Christiansen et al., 2007).  
As an addition, our study offers updated information on several clinical and socio-
demographical risk factors for suicide and suicide attempts. As previously published in studies 
from a variety of international locations, female gender, previously diagnosed psychiatric 
disorders and drug or alcohol abuse carried higher risk (Holmstrand et al., 2015; Christiansen 
et al., 2007; Beghi et al., 2013). A recent cohort study, conducted in Barcelona, Spain, found an 
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increased risk in younger groups (Parra-Uribe et al., 2017), a finding that was absent in our 
study. However, differences could be explained because we considered age in years a 
continuous variable, whereas the aforementioned study used age groups, established >60 years-
old as the reference group and found an almost constant risk increase across the rest of age 
groups. 
Our main strength is an easy-to-implement, well-defined intervention – an outpatient 
appointment with a psychiatrist within 7 days after the ED discharge –. In the studied catchment 
area, ordinary consultations with specialists usually have waiting times over 19 days 
(Comunidad Autónoma de Madrid, 2017). We have found that median time to the first 
consultation after a hospital discharge, after a suicide attempt, decreased to 7 days after 
ARSUIC program was implemented, over 50% of the subjects were seen in the desired time 
window, and compliance with the program is above 88% (Jiménez-Sola et al., 2019). Previous 
authors have emphasized the necessity to focus on suicide prevention at the ED, where most of 
the highest risk patients seek help, including those with a low adherence to conventional 
outpatient treatment (Larkin & Beautrais, 2010). In order to evaluate the program from a 
pragmatic point of view, we did not exclude any of the 2,347 suicide attempts treated during 
the study period, regardless of clinical profiles or inpatient admissions. As a consequence, our 
real-world results, obtained from a naturalistic setting, may provide critical evidence for 
decision makers. The effect estimates remained almost unchanged across the different 
univariate and multivariate models, suggesting an elevated robustness. The studied location, a 
catchment area with universal health coverage, combines different city districts and rural areas, 
including a wide range of ages, nationalities and socio-economical contexts (Hortas and 
Onrubia, 2017). In addition to the mentioned coincidence with previous results from other 
places and health systems, the heterogeneity of patient profiles and social contexts included 
provides grounds for our results to be considered widely generalizable, especially to settings 
with universal medical coverage. 
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Our study includes several limitations. First, we lack information regarding completed suicide 
among the study participants. As we have mentioned, suicide attempt and death by suicide are 
closely associated (Olfson et al., 2017b). Suicide is a less frequent phenomenon and using re-
attempt as the main outcome allowed us to detect differences between groups. Nevertheless, 
certain authors have found differences between the profiles of suicide attempters and achievers 
(Parra-Uribe et al., 2013). Hence, further research should be conducted to ascertain to which 
level this program also reduces suicide risk. Secondly, it is possible that certain subjects 
relapsed and were evaluated at a different hospital during follow-up. However, we consider this 
possibility unlikely: as previously published, in our setting, treated suicide attempts are 
systematically referred to the catchment area’s General Hospital ED (Parra-Uribe et al., 2017). 
In addition, Madrid has high residential stability: for example, during 2017, only 2.88% of the 
studied area’s population moved to a different catchment area (Ayuntamiento de Madrid, 2018). 
Besides, even though our reduced sensitivity to deaths and relapses evaluated elsewhere could 
lead to an underestimation of the incidence of relapse, this limitation would equally affect both 
treatment phases and thus not imply systematic error at the comparison level. Finally, the 
observational nature of our study makes it vulnerable to unascertained sources of bias. In 
particular, because we used a historical control group, we cannot rule out a potential sentinel or 
historical artifact. Notwithstanding, we consider this possibility unlikely because there is no 
evidence of a contemporary decrease of suicidal behaviors either in Madrid or elsewhere in 
Spain. On the contrary, data from outpatient and inpatient facilities suggest a general increase 
in such behaviors, in line with what has been observed in several samples from the US (Olfson 
et al., 2017a; Wester et al., 2017). A study conducted in Andalusia, Spain, analyzed data on 
suicide attempts using telephone call records from the public emergency healthcare system: they 
found that the number and rate of attempts increased annually between 2010 and 2013, the last 
year of study (Mejías-Martín et al., 2017). Furthermore, data from nationwide electronic 
registries indicate that the number of hospital discharges including any form of suicide attempt 
as a diagnosis also increased annually, both in Madrid (1.747 registries in 2010 and  2,418 in 
72 
 
2015) and in Spain (11,476 registries in 2010 and 15.857 in 2015) (Ministerio de Sanidad, 
Consumo y Bienestar Social, 2018).  
Further studies should include evaluations considering a longer follow-up, as previous research 
has called into question the long-term effectiveness of brief contact programs (Cebriá et al., 
2015). Head-to-head comparisons with more complex interventions implemented in other 
catchment areas of the same location will help clarify the differential suicide risk reduction 
potential of their respective components (López-Castroman et al., 2015a). Implementation 
studies in different locations, especially from low and middle-income countries, will define our 
findings’ implications for Global Mental Health. As López-Castroman et al. have pointed out, 
most of completed suicides take place in low and middle-income, while most suicide prevention 
research is conducted elsewhere (2015b). In addition, comparison studies across countries can 
yield findings concerning supra-individual determinants of interest (Susser and Martínez-Alés, 
2018). For example, recent ecological studies suggest that the late 2000s financial recession had 
an increased impact on suicides in Spain (Fernández-Navarro et al., 2016) and that the 
substantial variation in national suicide rates can be partially explained by ecological variables 
(Schomerus et al., 2015). Suicide is, by definition, a “complex problem” that requires a careful 
assessment of the interactions between risk factors and multi-level preventive interventions 
(Hawton and Pirkis, 2017; Hegerl and Kohl, 2016).     
6.2.3 Comparative effectiveness of Enhanced Contact, Psychotherapy and 
ARSUIC 
In this observational study, two programs, consisting of a 2-month long weekly problem-solving 
psychotherapy intervention followed by scheduled telephone calls (Psychotherapy) and on an 
early appointment followed by a 6 to 12-month long schedule of in-person visits and telephone 
calls (Enhanced Contact) could lower the risk of relapse after an attempted suicide by 38 and  
44% during a 1-year follow-up, respectively, compared to a single priority outpatient psychiatry 
appointment within 7 days (TAU). The NNT estimates were 6.7 (Psychotherapy) and 5.3 
(Enhanced Contact). Building on the tradition of natural experiments including real-world 
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clinical settings (Sherman et al., 2016), our study contributes to the identified need of head-to-
head comparative effectiveness studies between detailed suicide prevention programs, in order 
to develop a means for a better understanding of the underlying mechanisms of different 
interventions (Milner et al., 2015). 
The period following discharge after a suicide attempt is a time of extremely high relapse risk  
(Turecki and Brent, 2016). In this cohort, 8.9% of the subjects relapsed during a 12-month 
follow-up, a somewhat lower figure than reported during longer follow-ups in comparable 
settings (Tejedor et al., 1999). This is probably because contact maintenance with suicide 
attempters can reduce repetition of suicidal behaviors (Milner et al., 2015). Our control 
intervention, an early follow-up after self-harm, has shown effectiveness reducing recurrence 
both in our setting (Martínez-Alés et al., 2019) and in others (Inagaki et al., 2015). Also, we did 
not include subsequent relapses, hence excluding attempts conducted by heavy repeaters.  
In keeping with the literature (Vaiva et al., 2006; Exbrayat et al., 2017), our results suggest that 
repeated scheduled telephone calls lower postdischarge relapse risk. Some psychotherapeutic  
approaches have proved useful in lowering suicide risk among certain subtypes of patients  
(Brown et al., 2005; Linehan et al., 2015). However, in our study, the group receiving individual 
problem-solving psychotherapy did not significantly differ from those only receiving intensive 
contact maintenance. This is unsurprising: RCTs and systematic reviews have found no benefits 
in adding psychotherapy to conventional treatments for unselected suicidal subjects  (Goodman 
et al., 2016; Crawford et al., 2007). 
Our study has limitations we would be remiss not to report. In order to have enough power to 
detect differences between groups, we chose suicide re-attempt as our outcome of interest and 
did not include information concerning death by suicide, an important but infrequent event. As 
we have mentioned, there is a close association between suicide attempt and death by suicide  
(Olfson et al., 2017a; Hawton and Pirkis, 2017). For example, Finkelstein et al. reported that 
first-time self-poisoning survivors had a completed suicide HR of 41.96 when compared to 
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controls (2015). Nonetheless, differences between suicide attempters and completers have been 
reported elsewhere (Parra-Uribe et al., 2013). Thus, we can only focus on the programs’ 
protective role against attempted suicide. As a real-world study, we did not randomly assign the 
interventions. Instead, each center has different criteria for inclusion. As a matter of fact, 
baseline characteristics show differences across groups. Accordingly, we fitted two different 
multivariate models and obtained similar estimates across models, suggesting robust results. 
Nevertheless, we cannot rule out residual confounding or selection bias due to unmeasured 
correlates such as lethality, suicide attempt method or family history of  suicide, and therefore 
the effect estimates should be carefully considered. A comparison with historical controls from 
each catchment area might provide useful additional effect estimates. Also, there is a possibility 
that certain relapses were evaluated at a different hospital during follow-up. In our context, this 
possibility is unlikely. First, as other authors from comparable areas of the same healthcare 
system have previously published, treated suicide attempts are systematically referred to the 
subject’s catchment area’s General Hospital (Parra-Uribe et al., 2017). Second, Madrid’s 
population shows high residential stability through time: using official data from 2017, only 
3.49% of the people living in one of the three studied catchment areas moved to a different 
district (Ayuntamiento de Madrid, 2018). All in all, this possibility does not differentially affect 
our studied catchment areas; thus, we consider our comparative effectiveness estimates 
internally valid. Lastly, it has been suggested that, just as in most complex phenomena, risk 
factors for suicide and suicide behaviors not only act at the individual level, but also at 
overarching ecological levels (Hawton and Pirkis, 2017; López-Castroman et al., 2015b). For 
example, the frequency of suicide ideation and attempts show remarkable differences across 
countries (López-Castroman et al., 2015b). However, the three intervention groups are 
contemporary and belong to comparable catchment areas of the same city, so we consider 
differences in such factors unlikely.  
The strictly naturalistic enrolment of the study yields results that can be considered directly 
applicable. Most clinical guidelines prioritize evidence arising from RCTs. However, although 
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strict inclusion criteria, randomization and close follow-up provide highly internally valid 
efficacy estimates, their ability to also produce clinically-generalizable effectiveness estimates 
has been called into question.27 In line with this, effectiveness estimates from clinical settings 
are progressively becoming a valuable source, sought after by decision-makers (Mahajan, 
2015). This “real-world” approach most likely captures an intervention’s actual impact in the 
management of most psychiatric conditions, deeply shaped by interactions with the environment 
(such as suicide risk or schizophrenia) (Tiihonen et al., 2017). As previously mentioned, the 
results are in line with most published research on suicide attempters, both regarding the 
sample’s characteristics (a mean age of around 40 years, a higher percentage of females, 
frequent co-occurrence of alcohol or drug consumption and main diagnoses of mood, 
adjustment and personality disorders) (Parra-Uribe et al., 2017; Zalsman et al., 2016; Bagge et 
al., 2017) and the effect estimates of the implemented measures. Hence, we consider these 
estimates as widely generalizable, especially to contexts where, as in ours, a catchment area-
based public system provides universal coverage to the population. Besides, patients were 
enrolled right before discharge from the General Hospital, mostly at the Emergency 
Department. Our study therefore supports recent studies’ claim for a focus towards suicide 
prevention at such settings, because of the concentration of subjects with high suicide risk and 
low adherence to outpatient resources (Olfson et al., 2014). 
Suicide behaviors are a growing, critical public health issue: in the US, 1.1 million persons 
attempt suicide every year (Hogan, 2016). Even though several preventive strategies have 
proved useful at lowering such behaviors, selecting and promoting measures that entail an 
additional staff burden requires both political will and adequate evidence. Because RCTs of 
suicide attempt prevention interventions often have ethical limitations (Courtet, 2017), 
pragmatic designs using real-world data offer an advantageous approach. Nonetheless, the 
question if psychotherapy adds value to contact maintenance for suicidal behavior prevention 
remains partially unanswered.  
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6.2.4 Comparative cost-effectiveness  
This is the first study to compare the real-world cost-effectiveness of a priority appointment, a 
brief contact intervention, and an individual psychotherapy program for post-discharge suicide 
risk prevention following an attempted suicide. Compared to a single emergency department -
appointed priority visit within one week after hospital discharge (TAU), the two interventions 
under study (an Enhanced Contact schedule based on an increased frequency of visits and 
additional telephone calls and a 2-month long weekly problem-solving Psychotherapy 
intervention) were similarly effective at lowering the risk of suicide re-attempt over a one-year 
follow-up. Even though there are no official recommendations regarding willingness-to-pay per 
averted suicide in the literature (Park et al., 2018; Bernecker et al., 2019), both Enhanced 
Contact and Psychotherapy incurred incremental costs per suicide attempt averted that fall 
below what other researchers have considered acceptable thresholds, under any of the pre -
specified scenarios (Park et al., 2018; Bernecker et al., 2019). Given that economic assessments 
of suicide prevention strategies are still scarce in the literature (Bustamante-Madsen, 2018), our 
results should provide decision-makers with key information for resource prioritization 
purposes. 
Because the time period immediately following hospital discharge of suicide attempters entails 
a markedly high risk of suicidal behaviors (Turecki & Brendt, 2016) and death by suicide 
(Olfson et al., 2017a), it provides a critical window of opportunity for prevention efforts. 
Accordingly, several psychosocial interventions have been specifically developed for post-
discharge suicide prevention with overall comparable effectiveness rates associated to contact 
maintenance and psychotherapy (Riblet et al., 2017). Along those lines, we found that both 
Enhanced Contact and Psychotherapy were similarly effective for secondary prevention 
purposes. Compared to TAU, Enhanced Contact was dominant under the most favorable 
scenario (EUR -27 per averted attempt) and incurred in additional costs under the case-base and 
less favorable scenarios (EUR 2,340 and 30,356 per averted attempt, respectively), and 
Psychotherapy entailed additional incremental costs under all three scenarios (EUR 3,450; 
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6,260; and 20,186, respectively). These results do not lend themselves to easy interpretation, 
given the lack of consensus regarding the willingness-to-pay per averted suicide. Park and 
colleagues, in a recent study based on a randomized controlled trial (2018), used a willingness 
to pay level of CHF 30,000 (approximately EUR 28,000) to evaluate the cost-effectiveness of a 
contact intervention based on a combination of in-person visits and personalized letters (the 
ASSIP intervention). Another study evaluated the cost-effectiveness of a brief cognitive 
behavioral therapy intervention for suicidal US Army soldiers, finding an ICER per averted 
suicide ranging between USD 40,650-44,530(approximately EUR 36.556-40,045) under the 
worst-case scenario (Bernecker et al., 2019). Extrapolating those figures to our study, it would 
be safe to conclude that both Enhanced Contact and Psychotherapy have a high probability of 
being cost-effective. In addition, given that both augmentation strategies had identical 
effectiveness (HR=0.99; 95% CI= 0.51-1.96), Enhanced Contact resulted slightly more 
advantageous than Psychotherapy in terms of cost minimization. 
Notably, Park et al. (2018) found ASSIP to be cost saving, mainly through a shift towards less 
costly outpatient treatment in their participants’ pattern of resource use, a result somewhat 
different than ours (at least under the base-case and less favorable scenarios). Three 
characteristics of our study design may help explain this discrepancy. First, our control group 
received the ARSUIC intervention, an emergency department-scheduled outpatient follow-up 
visit within the first week following hospital discharge. Unlike their control intervention, a 
single suicide risk assessment, ARSUIC has been found to be effective at lowering the risk of 
subsequent suicide attempting by previous research (Martínez-Alés et al., 2019f). Second, we 
only recorded each participant’s first relapse over a 12-month follow-up, while Park et al. 
included all subsequent suicide attempts, including those carried out by heavy attempters. Third, 
our models only considered costs that could be directly attributed to the first re-attempt, while 
they computed all medical costs incurred during the follow-up period. These characteristics 
probably limited our ability to detect differences between the study groups: compared to Park 
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et al.’s study, we estimated a lower relapse rate among controls (11.4 per 100 participants) and 
a more modest mean of costs incurred over the follow-up (EUR 7,020 per relapse).  
Our cost estimates are in line with previous research: a retrospective analysis conducted by 
Tsiachristas and colleagues based on data collected in 2014 in the United Kingdom estimated 
an overall mean direct medical cost per suicide attempt of GBP 809 (approximately EUR 1,056 
in CPI-adjusted 2017 currency) (2017) and a report commissioned in 2005 by the government 
of New Zealand calculated a loss of NZD 6,350 per attempted suicide in indirect costs 
(approximately EUR 5,699 in CPI-adjusted 2017 currency) (O’Dea et al., 2005). Taken together 
with the fact that our data comes an unselected population from the real clinical practice, this 
suggests that our results can be viewed as conservative cost-effectiveness estimates of high 
external validity that are readily applicable for decision makers from comparable healthcare 
systems (Sherman et al., 2016). 
Our study is subject to several limitations. First, our comparative effectiveness estimates were 
derived from an observational study conducted in three real clinical settings. Although we 
adjusted all models by baseline confounders, it is possible that some residual confounding 
remained uncontrolled due to unmeasured variables. However, substantial bias due to residual 
confounding is unlikely, as our data comes from three highly comparable catchment areas of 
the same city, and the original effectiveness study included sensitivity analyses sugges ting 
robust estimates (Martínez-Alés et al., 2019). Second, our study only detected suicide re-
attempts at the emergency department level. It seems eminently plausible that we failed to 
capture a proportion of relapses not receiving hospital treatment and, more importantly, deaths 
by suicide occurring outside of the hospital. As a result, we probably underestimated the actual 
amount of costs per re-attempt. Of note, we have no reason to believe that this limitation varied 
by intervention, as we used a similar method for follow-up and detection across all centers. 
Hence, this limitation probably biased our results towards the null hypothesis, further reducing 
between-group differences. Third, we did not include data on the costs of training providers 
who deliver the interventions under study. Given that only the psychotherapeutic program 
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would plausibly entail additional, specific costs associated to training, it seems likely that 
including such data in our calculations would have yielded results differentially more positive 
for Enhanced Contact. Lastly, not all EHRs contained the full information regarding the 
probability of extra-hospitalary care, hospital admission, death and sick leave. As a result, we 
had to adopt the untestable assumption that all potential outcomes distribute similarly across all 
study centers.  
In conclusion, our study suggests that two post-discharge prevention strategies (an augmented 
contact intervention and an individual psychotherapy program) performed similarly, both 
outperforming treatment as usual, with high probability, in terms of cost-effectiveness; and that 
augmenting contacts between individuals and providers may prove slightly more advantageous, 
in terms of cost minimization, than providing individualized psychotherapy. These results 
contribute to expand the scarce knowledge regarding the cost-effectiveness of secondary 
prevention strategies for suicide attempters by providing the first comparative cost -
effectiveness estimates based on a head to head comparison between psychotherapy and contact 
maintenance.  
Future steps should include studying the economic impact of applying psychotherapeutic 
interventions to specific subsamples of the population, given that recent research has 
highlighted important phenotypic variation across suicidal patients – suggesting two different 
patterns: stress-responsive and non-stress-responsive suicide attempters (Bernanke et al., 2017). 
It seems plausible that the latter subgroup, whose attempts are often planned over longer time 
spans and usually in the context of a major depressive disorder, may benefit more from a 
psychotherapeutic approach than the former, more impulsive subgroup. Also, further research 
is warranted in order to explore the transportability of our results to different settings and 
additional sources of indirect costs (such as other family members’ loss of productivity) should 





1. The period of time immediately following a suicide attempt implies a high risk of re-
attempt. Evaluating individual-level prevention strategies specifically designed for this 
period, in terms of real-world implementation, effectiveness, and cost-effectiveness is a 
priority to guide decision-making. 
2. The Autonomous Community of Madrid has introduced the Suicide Risk Attention Program 
(ARSUIC is its Spanish acronym), whose main intervention is a priority appointment 
following discharge after every suicide attempt to enhance adherence to outpatient mental 
healthcare. 
3. Implementing ARSUIC lowered the median time between discharge and the first outpatient 
visit from 8.5 to 6 days, indicating a substantial uptake of the intervention in the real world.  
4. The proportion of suicide attempters with no outpatient visit within 7 days decreased from 
68% to 50% after program deployment. Despite the substantial uptake of the program, half 
of the patients did not attend the priority appointment within the target time frame.  
5. Following program implementation in 2012, both the rate of suicide attempt per person and 
year, and the proportion of attempts corresponding to re-attempts were reduced 
progressively over the following years. 
6. Compared to the prior treatment as usual, individuals receiving the ARSUIC intervention 
had a 24% lower risk of suicide re-attempt over a three-year follow-up. These results 
suggest that the intervention was effective at lowering relapse risk after a suicide attempt.  
7. Two catchment áreas of the Community of Madrid deployed additional augmentation 
strategies based on enhancing ARSUIC with additional telephone and in-person contacts or 
with psychotherapy. 
8. Augmentation strategies Enhanced Contact and Psychotherapy entailed a 40% additional 
reduction of suicide risk over a one-year follow-up. The difference in effectiveness between 
the two augmentation strategies was practically indetectable. 
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9. Compared to ARSUIC, both Enhanced Contact and Psychotherapy incurred additional costs 
that fall within reasonable thresholds of willingness to pay per suicide attempt averted. 
10. Given that Enhanced Contact incurred lower costs and similar effectiveness, it resulted 
slightly cost minimizing in comparison to Psychotherapy. 
11. As a general approach to non-selected suicide attempters, increasing the rate of contact with 
mental healthcare providers is, probably, the most cost-effective augmentation strategy. 
12. To guide the decision of which intervention is more adequate to each patient, future research 
should identify individual-level predictors of a good clinical response to each treatment and 














1. El periodo de tiempo que sigue inmediatamente a un intento de suicidio implica un riesgo 
muy elevado de reintento. Evaluar las estrategias de prevención individual diseñadas 
específicamente para ese periodo en términos de implementación, efectividad y coste-
efectividad en el mundo real es prioritario para guiar la toma de decisiones.  
2. La Comunidad Autónoma de Madrid ha introducido de manera generalizada un Programa 
de Atención al Riesgo Suicida (ARSUIC) cuya principal intervención es una cita prioritaria 
después de cada intento de suicidio para favorecer la adherencia al seguimiento ambulatorio. 
3. La implementación de ARSUIC redujo el tiempo mediano entre alta y primera consulta 
ambulatoria de 8,5 a 6 días, lo que indica una aceptación sustancial de la intervención en la 
práctica clínica real.  
4. La proporción de pacientes con intento de suicidio que no tuvo una cita ambulatoria en 7 
días se redujo del 68% al 50% después de la introducción de ARSUIC. Pese a la aceptación 
sustancial del programa, la mitad de pacientes no accedieron a la cita prioritaria antes del 
límite temporal objetivo. 
5. Después de instaurar este programa en 2012, tanto la tasa de intento de suicidio por persona-
año como la proporción de intentos que correspondían a reintentos se redujeron de manera 
progresiva en los años posteriores. 
6. En comparación con el anterior tratamiento habitual, los individuos que recibieron la 
intervención ARSUIC tuvieron un 24% menos de riesgo de reintento en un seguimiento de 
tres años. Estos resultados sugieren que la intervención fue efectiva, reduciendo el riesgo 
de suicido tras un intento. 
7. En dos áreas sanitarias de la Comunidad de Madrid se implementaron estrategias de 
intensificación basadas en complementar ARSUIC con contactos adicionales telefónicos y 
en persona o con psicoterapia. 
8. Las intervenciones de intensificación Contacto Aumentado y Psicoterapia conllevaron una 
reducción adicional del riesgo de suicidio del 40% en un seguimiento de un año. La 
84 
 
diferencia de efectividad entre estas dos estrategias de intensificación resultó prácticamente 
indetectable. 
9. En comparación con ARSUIC, tanto Contacto Aumentado como Psicoterapia incurrieron 
en costes adicionales que no superan los límites razonables de disposición a pagar por 
intento de suicidio evitado. 
10. Dado que Contacto Aumentado supuso un coste menor y una efectividad similar, minimizó 
ligeramente los costes en comparación con Psicoterapia.  
11. Como aproximación general a una población no seleccionada de personas que han intentado 
suicidarse, aumentar la tasa de contacto con los profesionales de servicios de salud mental 
es, probablemente, la estrategia de intensificación más coste-efectiva. 
12. Para guiar la decisión de qué intervención es más adecuada para cada paciente, quedan 
pendientes la identificación de predictores individuales de buena respuesta clínica a cada 












8. Tables and figures 
Table 1. Demographic characteristics and distribution of cases of suicide attempt per study year 
Year N Age in years:  P50 (DS)  Male N(%) Female N(%) 
2012 199 42,66 (14,59) 53 (26,6%) 146 (73,4%) 
2013 242  42,85 (17,46) 82 (33,9%) 160 (66,1%) 
2014 265  39,08 (15,89) 76 (28,7%) 189 (71,3%) 
2015 180  39,86 (15,93) 71 (39,4%) 109 (60,6%) 
2012-15 886  282 (31,8%) 604 (68,2%) 
 
Table 2. Percentage of suicide attempts with time to first outpatient visit following discharge ≤ or 
> 7 days (p=0.002) and percentage of cases with no outpatient follow-up (p<0.001). 
Year Total Follow-up ≤7 days Follow-up >7 days No follow-up 
2012 197 63 (32%)  134 (68%)  1% 
2013 231 112 (48,5%)  119 (51,5%)  4,5% 
2014 242 110 (45,5%)  132 (54,5%)  8,7% 
2015 160 77 (48,1%)  83 (51,9%)  11,1% 
2012-15 830 362 (43,6%) 468 (56,4%)  
 
Table 3. Baseline clinical and sociodemographic covariates of the 2,347 episodes attempted by the 
1,775 study subjects, globally and divided by period of treatment. P-values are obtained from 
Student’s T test for the quantitative covariates and Pearson’s Chi-square test for the qualitative ones. 
(ED = Emergency Department, ICD-10 = International Classification of Diseases 10th revision, 
F10-19= Mental and behavioral disorders due to psychoactive substance use, F20-29 = 
Schizophrenia, schizotypal and delusional disorders, F30-39 = Mood (affective) disorders, F40-48 
= Neurotic, stress-related and somatoform disorders, F50-59 = Behavioral syndromes associated 
with physiological disturbances and physical factors, F60-69 = Disorders of adult personality and 
behavior.) 
  Total  Control period 
Intervention 
period P 
Total study subjects N (%) 1,775 875 (49.3) 900 (50.7)  
Total suicide attempts N (%) 2,347 1,176 (50.1) 1,171 (49.9)  
Age in years Mean (SD) 40.5 (16.7) 40.2 (16.3) 40.8 (17.0) 0.36 
Female N (%) 1602 (68.3) 814 (69.2) 788 (67.3) 0.32 
Personal history of a psychiatric 
disorder N (%) 1735 (73.9) 883 (75.1) 852 (72.7) 0.00 
ICD-10 F10-19 N (%) 880 (37.5) 412 (35.5) 468 (40.0)  
ICD-10 F20-29 N (%) 162 (6.9) 98 (8.3) 64 (5.4)  
ICD-10 F30-39 N (%) 925 (39.4) 441 (37.5) 484 (41.0)  
ICD-10 F40-49 N (%) 880 (37.5) 416 (35.4) 464 (39.6)  
ICD-10 F50-59 N (%) 145 (6.2) 65 (5.5) 80 (6.8)  
ICD-10 F60-69 N (%) 401 (17.1) 194 (16.5) 207 (17.7)  
Personal history of suicide attempts N (%) 1137 (48.4) 571 (48.6) 566 (48.3) 0.07 
Concurrent alcohol/ drug abuse N (%) 945 (40.3) 460 (39.1) 485 (41.4) 0.00 
Family support N (%) 1604 (68.3) 732 (62.3) 872 (74.5) 0.00 




Table 4. Risk of relapse during the follow-up, derived from a Cox proportional hazard model 
including time to relapse as the outcome and the clinical and sociodemographic covariates as 
predictors. Control period is the reference. Multivariate model A retained those covariates 
associated to the p≤0.05 significant level. Model B included additional covariates, relevant 
according to the proposed causal frame. 
 Relapsed during 
follow-up N (%) 
Unadjusted HR Adjusted HR (95% CI) 
 (95% CI) Model A Model B 
Control period (REF) 283 (24.1) 1 1 1 
Intervention period 214 (18.3) 0.72 (0.60-0.82) 0.76 (0.62-0.93) 0.69 (0.54-0.87) 
Female 609 (38.0) 1.17 (0.96-1.42) 1.30 (1.03-1.68) 1.30 (1.02-1.65) 
Personal history of psychiatric disorder 757 (43.6) 3.21 (2.30-4.47) 1.99 (1.33-2.99) 2.03 (1.30-3.18) 
Personal history of suicide attempts 627 (55.2) 2.71 (2.20-3.34) 2.29 (1.77-2.96) 2.32 (1.75-3.06) 
Concurrent alcohol/ drug abuse 468 (49.5) 1.77 (1.46-2.15) 1.55 (1.25-1.90) 1.58 (1.26-1.98) 
Family support 640 (39.9) 0.64 (0.49-0.83) 0.74 (0.56-0.99) 0.66 (0.49-0.89) 
Number of relapses - 1.39 (1.36-1.42) 1.35 (1.31-1.39) 1.33 (1.29-1.37) 
Admitted after ED discharge 248 (47.0) 1.14 (0.93-1.40) - 1.20 (0.94-1.53) 




Table 5. Baseline clinical and sociodemographic covariates of the 1,492 study subjects, globally and divided by interventions. P-values are obtained 
from Pearson’s Chi-square test or Fisher’s exact test for qualitative covariates and Wilcoxon’s sign test for quantitative ones. (ICD-10 = International 
Classification of Diseases 10th revision, F00-F09 = Organic, including symptomatic, mental disorders, F10-19 = Mental and behavioral disorders 
due to psychoactive substance use, F20-29 = Schizophrenia, schizotypal and delusional disorders, F30-39 = Mood (affective) disorders, F40-48 = 
Neurotic, stress-related and somatoform disorders, F50-59 = Behavioral syndromes associated with physiological disturbances and physical factors, 
F60-69 = Disorders of adult personality and behavior.) 
 Total N (%) TAU Psychotherapy 
Enhanced 
Contact X2/F P 
Total suicide attempters 1,492 788 (52.8) 523 (35.1) 181 (12.1)   
Age in years (Mean±SD) 40.9 (17.1) 41.0 (18.0) 40.3 (16.6) 42.6 (14.5) 1.25 0.29 
Female 1,040 (69.7) 540 (68.5) 360 (68.8) 140 (77.4) 5.77 0.06 
Personal history of a psychiatric disorder 976 (65.4) 554 (70.3) 255 (48.8) 166 (91.7) 0.00 0.000 
Main diagnosis at discharge       
No diagnosis 190 (12.7) 110 (13.9) 74 (14.15) 6 (3.3) 404.41 0.000 
Organic, including symptomatic, mental disorders 11 (0.8) 6 (0.9) 5 (0.9) 0 (0.0)   
Mental and behavioral disorders due to psychoactive substance use 172 (12.5) 94 (13.8) 68 (13.0) 10 (5.7)   
Schizophrenia, schizotypal and delusional disorders 28 (2.0) 15 (2.2) 12 (2.3) 1 (0.6)   
Mood (affective) disorders 406 (29.4) 304 (44.7) 66 (12.6) 36 (20.3)   
Neurotic, stress-related and somatoform disorders 429 (31.1) 150 (22.1) 208 (39.8) 71 (40.1)   
Behavioral syndromes associated with physiological disturbances and physical factors 37 (2.7) 14 (2.1) 22 (4.2) 1 (0.6)   
Disorders of adult personality and behavior 219 (15.9) 95 (14.0) 68 (13.00) 56 (31.6)   
Personal history of suicide attempts 583 (39.1) 272 (34.5) 145 (27.7) 85 (47.0) 246.21 0.00 
Concurrent alcohol/ drug abuse 446 (29.9) 281 (35.7) 80 (15.3) 85 (47.0) 91.19 0.00 
Cohabitation 1,250 (83.7) 639 (81.1) 458 (87.4) 153 (84.5) 9.30 0.01 
Immigrant 483 (32.4) 132 (16.8) 200 (38.2) 151 (83.4) 322.47 0.00 




Table 6. Risk of relapse during the follow-up, derived from a Cox proportional hazard model including time to relapse as the outcome and the clinical 
and sociodemographic covariates as predictors. Treatment as usual (TAU) is the reference. The multivariate model is age and gender-adjusted and 
includes variables significant to the p≤0.05 level following a non-automatic adjustment method. (ICD-10 = International Classification of Diseases 
10th revision, F10-19= Mental and behavioral disorders due to psychoactive substance use, F20-29 = Schizophrenia, schizotypal and delusional 
disorders, F30-39 = Mood (affective) disorders, F40-48 = Neurotic, stress-related and somatoform disorders, F50-59 = Behavioral syndromes 




 Relapsed during 
follow-up  N (%) 
Unadjusted HR 
(95% CI) 
Adjusted HR  
(95% CI)  
TAU 90 (11.4) 1 1 
Psychotherapy 29 (5.5) 0.47 (0.31-0.72) ** 0.62 (0.40-0.97) * 
Enhanced Contact 14 (7.7) 0.66 (0.38-1.16)  0.56 (0.32-1-00) * 
Age in years  0.99 (0.98-1.00) 0.99 (0.98-1.00) 
Female gender  1.27 (0.86-1.87) 1.32 (0.88-1.98) 
Immigrant  0.68 (0.46-1.00) * - 
Cohabitation  1.10 (0.68-1.77) - 
Personal history of a psychiatric disorder  1.86 (1.24-2.80) ** - 
Diagnosis at discharge    
No diagnosis  0.67 (0.37-1.21) - 
Mental and behavioral disorders due to psychoactive substance use  1.38 (0.86-2.22) - 
Mood (affective) disorders  1.70 (1.20-2.42) ** 1.60 (1.10-2.32) ** 
Neurotic, stress-related and somatoform disorders  0.35 (0.21-0.58) ** - 
Disorders of adult personality and behavior  1.52 (1.00-2.32) * 1.82 (1.14-2.91)** 
Personal history of suicide attempts  1.89 (1.34-2.65) ** 1.63 (1.15-2.31) ** 
Concurrent alcohol/ drug abuse  1.77 (1.35-2.67) ** 1.64 (1.13-2.38) ** 
Comorbid medical condition  1.73 (1.23-2.43) ** - 
 
 
Table 7: Risk of relapse during the follow-up, derived from a Cox proportional hazard model including 
time to relapse as the outcome and the clinical and sociodemographic covariates as predictors. Treatment 
as usual (TAU) is the reference. This alternative multivariate model is age and gender-adjusted and includes 














Table 8. Risk of relapse during the follow-up, stratified into 3 patient groups: male, female≤35 years of age 
and female >35 years of age. The multivariate model is derived from an age and gender-adjusted Cox 
proportional hazard multivariate model, with time to relapse as the outcome and treatment as usual (TAU) 
as the reference and includes the same covariates as the multivariate model in table 2. (ICD-10 = 
International Classification of Diseases 10th revision, F30-39 = Mood (affective) disorders, F50-59 = 
Behavioral syndromes associated with physiological disturbances and physical factors, F60-69 = Disorders 
of adult personality and behavior.) (* p≤0.05; ** p≤0.01) 
 Unadjusted HR (95% CI)  Adjusted HR (95% CI) 
TAU 1  1 
Psychotherapy 0.47 (0.31-0.72) **  0.56 (0.37-0.87)** 
Enhanced Contact 0.66 (0.38-1.16)   0.56 (0.31-0.98)* 
Age in years 0.99 (0.98-1.00)  0.99 (0.98-1.00) 
Female gender 1.27 (0.86-1.87)  1.35 (0.90-2.01) 
Immigrant 0.68 (0.46-1.00) *  - 
Cohabitation 1.10 (0.68-1.77)  - 
Personal history of a psychiatric disorder 1.86 (1.24-2.80) **  1.42 (0.92-2.19) 
Personal history of suicide attempts 1.89 (1.34-2.65) **  1.56 (1.09-2.23)** 
Concurrent alcohol/ drug abuse 1.77 (1.35-2.67) **  1.54 (1.06-2.22)* 
Comorbid medical condition 1.73 (1.23-2.43) **  - 
 Male  Female ≤35 y Female >35 y 
TAU 1 1 1 
Psychotherapy 0.62 (0.37-1.04) 0.57 (0.27-1.20) 0.65 (0.32-1.34)  
Enhanced Contact 0.57 (0.31-1.08) 0.66 (0.22-1.96) 0.54 (0.25-1-19)  
ICD-10 F30-39 1.54 (0.96-2.32) 1.61 (0.75-3.43) 1.54 (0.83-2.85)  
ICD-10 F60-69 2.09 (1.25-3.51) 1.91 (0.75-3.43) 2.29 (1.11-4.70)* 
Personal history of suicide attempts 1.73 (1.16-2.59)** 1.48 (0.79-2.77) 1.93 (1.13-3.29) * 
Concurrent alcohol/ drug abuse 1.73 (0.98-2.32) 1.96 (0.45-2.02) 1.64 (1.14-3.35) * 
N (%) 452 (30.3%) 452 (30.3%) 588 (39.4%) 
 
 
Table 9. Comparative effectiveness estimates  
 Relapsed during 





Inferior limit of 
the 95% CI 
Superior limit of 
the 95% CI 
TAU  90 (11.4) 1 (Ref.) 11.4  10.2 12.6 
Enhanced Contact 29 (5.5) 0.56 (0.31-0.98)  6.4 3.5 11.2 
Psychotherapy 14 (7.7) 0.56 (0.37-0.87) 6.4 4.2 9.9 
TAU = Treatment as Usual.  
Adjusted Hazard Ratio (HR) values were derived from a multivariable Cox proportional hazards model where time 
to relapse was the outcome, intervention group was the independent variable and age, sex, history of a psychiatric 
disorder, history of suicide attempts and concurrent alcohol or drug abuse were covariates. 
 
 
Table 10. Cost-effectiveness model input data 
Parameter Base 
case  
Sensitivity analyses value distribution Source 
Deterministic Sensitivity Analysis Probabilistic sensitivity 






     
TAU 0.114 0.102 0.126 β (α = 0.28, β = 2.14) Martínez-
Alés et 
al., 2019 
Enhanced Contact 0.064 0.035 0.112 β (α = 0.28, β = 2.14) * 0.56 
β (α = 0.28, β = 2.14) * 0.56 Psychotherapy 0.064 0.042 0.099 
Intervention costs      
TAUa € 311 € 264 € 358 € 311 EHR 
Enhanced Contactb € 779 € 662 € 896 € 779 Protocol 
Psychotherapyc € 975 € 829 € 1121 € 975 
Relapse costs      
ED visit € 190 € 162 € 219 All prorated direct costs: 
Normal, mean (SD): 




Ambulance  € 452 € 384 € 520 
In-patient hospitalizationd € 3973 € 3377 € 4569 
Deathe € 631680 € 536928 € 726432 € 631680 * 0.006 
Sick leavef € 9363 € 7956 € 10767 Normal, mean (SD): 
€ 9363 (3122) * 0.23 * 0.994 
All economic amounts come from official costs of the Community of Madrid (BOCM) except for average wages, 
retrieved from the National Institute of Statistics (INE).  
a 1st outpatient visit (€ 91) + 4 follow-ups (€ 220) 
b TAU + 3 specialized visits (€ 438) + 3 telephone calls (€ 30) 
c TAU + 8 psychotherapy sessions (€ 664) 
d The proportion of admissions was: 73% psychiatric ward, 20% medical ward, 7% intensive care unit 
e For deceased participants, average years of life lost (65-37) * Average annual wage (€ 22,560) 
f For participants undergoing sick leave, average duration in days (155.6) * Average daily wage (€ 60.2) 
 
Table 11. Incremental Cost-effectiveness Ratios (ICERs) estimates per re-attempt avoided, calculated 
from a societal perspective 
ICER Base case scenario Most favorable scenario Least favorable scenario 
Enhanced Contact vs. TAU € 2340 € -27 € 30356 








Figure 1: Directed Acyclic Graph representing the causal framework under which models where conducted. 
 
Figure 2: Time between discharge and first outpatient visit, within a maximum 1-month follow-up, per 
study year. Results in medianstandard deviation are P50SD 2012: 8,57,57; 2013: 67,31; 2014: 7 





Figure 3: Percentage of suicide attempts that correspond to a reattempt per study year. P=0.002 
 
 
Figure 4: Suicide attempt rate per person-year. The difference between the logarithms of the rates 2012-





























































































Figure 5: Time between hospital discharge following a suicide attempt and a subsequent suicide attempt, 
within a maximum 1-year follow-up, per study year. P=0.01 
 



















Figure 7. Kaplan-Meier survival function estimates. (A) Shows the graphic representation of time to 
relapse estimate including every suicide attempt recorded between 2010 and 2015. (B) Shows the graphic 
representation of time to relapse estimates divided by treatment period. Differences are significant with a 







Figure 8. Graphically represents Kaplan-Meier survival function estimates by intervention. (A)  
Differences between Treatment as Usual (TAU) and Psychotherapy are significant with a log-rank test’s 
P<0.01. (B) After adjustment by sex, gender, concurrent alcohol or drug abuse, personal history of 
suicide attempts, presence of a mood disorder diagnosis and presence of a personality disorder diagnosis, 
differences between Treatment as Usual (TAU) and both Enhanced Contact and Psychotherapy are 




























Figure 9. Decision tree structure for each strategy. Intermediate nodes include the probability of each 










 Figure 10. Results from the probabilistic sensitivity analysis, indicating the results of 10,000 
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Implementation of a suicide risk 
prevention program in the 
Autonomous Community of Madrid. 
The ARSUIC experience
Introduction. This study evaluates the degree of com-
pliance and effectiveness of the ARSUIC Suicide Risk Care 
Program. ARSUIC seeks to reduce the relapse risk that fol-
lows a suicide attempt by scheduling a high priority outpa-
tient visit following hospital discharge.
Method. Hospital-based retrospective study conducted 
between years 2012 and 2015. We included every suicide 
attempt treated at the La Paz University Hospital’s mental 
healthcare resources network. We estimated the time be-
tween hospital discharge and the first outpatient visit; the 
proportion of visits that fulfill the program’s objective – a 
follow-up within a maximum of 7 days; the suicide attempt 
rate; and the percentage of attempts corresponding to re-
lapses, by study year.
Results. After program deployment, median time be-
tween discharge and the first visit decreased from 8.5 to 6 
days, and the percentage of visits that fulfill the program’s 
objective increased from 32 to 48.5%. Between years 2012 
and 2015, the suicide attempt rate per person and year de-
creased from 1.20 to 1.08 and the proportion of attempts 
corresponding to relapses from 26.6% to 12.8%.
Conclusion. Implementing the ARSUIC Program low-
ered the time between discharge and the first outpatient 
visit following a suicide attempt. The proportion of suicide 
attempts due to relapses and the suicide attempt rate per 
person decreased progressively. The program fulfilment pro-
portion was under 50%, suggesting between-user differenc-
es regarding their effective access to the program.
Key words: Suicide, Mental health, Program evaluation, Implementation
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Implementación de un programa de prevención 
del riesgo de suicidio en la Comunidad Autónoma 
de Madrid. La experiencia ARSUIC
Introducción. Este estudio evalúa el grado de cumpli-
miento y efectividad del programa ARSUIC de Atención al 
Riesgo Suicida, cuyo objetivo es reducir el riesgo posterior al 
intento de suicidio facilitando una cita ambulatoria de alta 
prioridad después del alta hospitalaria.
Metodología. Estudio retrospectivo de base hospitalaria 
conducido, entre 2012 y 2015, en todos los casos de intento 
de suicidio atendidos en la red de recursos de psiquiatría 
del Hospital Universitario La Paz. Se obtienen estimadores 
del tiempo hasta la primera consulta después del alta, de la 
proporción de citas que cumple el objetivo del programa de 
ser atendidos en un máximo de 7 días, de la tasa de intento 
de suicidio y del porcentaje de intentos que corresponde con 
un reintento, en cada year de estudio.
Resultados. Después de la implementación del progra-
ma, la mediana de tiempo entre el alta y la primera consulta 
baja de 8,5 a 6 días y el porcentaje de citas que cumplen 
el objetivo aumenta de 32 a 48,5%. Entre 2012 y 2015, la 
tasa de intentos de suicidio por paciente y year se reduce de 
1,20 a 1,08, y el porcentaje de intentos que corresponde con 
reintentos de 26,6 a 12,8%.
Conclusión. La implementación del Programa ARSUIC 
ha reducido el tiempo entre el alta después de un intento 
de suicidio y la primera cita ambulatoria. Han disminuido los 
intentos de suicidio debidos a reintentos y la tasa de inten-
tos por paciente y year. El porcentaje de cumplimiento me-
nor al 50% sugiere diferencias interindividuales en el acceso 
efectivo al programa.
Palabras clave: Suicidio, Salud mental, Evaluación de programas, Implementación
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INTRODUCTION
Almost 1 million people die by suicide every year1, and it 
is the second most frequent cause of death among youth2. In 
Spain, suicide is the most frequent external cause of death, 
with an annual incidence rate ranging between 11.88 per 
100,000 men and 4.05 per 100,000 women3. Suicide risk fac-
tors interact in complex hierarchical networks4,5. Among 
them, a personal history of suicide attempting stands out as 
the main clinical predictor of subsequent reattempt and 
death by suicide6. It is estimated that having attempted sui-
cide increases lifetime risk of death by suicide by 30 times, 
and antecedes 1 in 2 deaths by suicide7-9. In addition, suicide 
attempt, an entity up to 30 times more frequent than death 
by suicide10, constitutes itself an identifiably clinical chal-
lenge, with remarkable direct and indirect costs and an in-
creasing incidence across the globe11,12.
Suicide prevention can be exercised at different inter-
vention levels13. At the population-level, several measures 
have proved protective: in general terms, these strategies 
seek to limit the access to potentially lethal methods. Exam-
ples include limiting the content in the packaging of drugs 
commonly used in overdose, such as acetaminophen or ben-
zodiacepines14, or limiting the access to suicide by jumping 
hotspots15. Individual-level prevention is exercised through 
clinical interventions directed towards individuals at high 
risk of suicide. The healthcare setting is considered adequate 
for risk detection, since up to 45% who die by suicide have 
been seen by a physician during the previous month16. 
Among high-risk patients, those with a prior suicide attempt 
stand out17, in particular immediately after hospital dis-
charge, a period that entails an extraordinary reattempt 
risk11. Best available evidence corresponds to contact main-
tenance with high-risk individuals, usually using “gatekeep-
ers” – people who can be accessed during suicidal crises18. A 
recent meta-analysis of randomized controlled trials found 
that WHO-BIC (Brief Intervention and Contact), a program 
aimed at enhancing contacts between practitioners and sui-
cidal clients, is effective at lowering suicide reattempts and 
death by suicide19. The same meta-analysis found psycho-
therapeutic interventions not effective. The ED-SAFE ran-
domized trial, conducted in the United States, concluded 
that an Emergency Department-initiated intervention that 
clarified potential resources for suicidal crises effectively re-
duced new attempts and deaths20.
In the Autonomous Community of Madrid, the 2010-
2014 Strategic Mental Health Plan highlighted suicide as a 
fundamental line of work, and selected the following related 
objectives: establishing an epidemiologic surveillance sys-
tem of suicide, developing a clinical gold-standard for peo-
ple at high risk, and enhancing research on suicidal behav-
iors21. The Suicide Risk Care Program (ARSUIC for its Spanish 
acronym) was specifically deployed to prioritize the care of 
suicidal attempters, in order to reduce their reattempt risk. 
Although the ARSUIC program is active in all hospitals in the 
Autonomous Community of Madrid, results have not been 
reported yet. The objective of this study is to evaluate the 
program by estimating the degree of implementation, ful-
fillment and effectiveness. 
METHODS
Study design, context and subjects
Observational, retrospective, hospital-based study. La 
Paz University Hospital serves a catchment area of 525,501 
people in the North of Madrid. The mental healthcare sys-
tem includes a variety of outpatient and inpatient resources, 
such as the Emergency Department (ED), the psychiatric in-
patient unit, and several Community Mental Healthcare 
Centers (CMHC). Between Jan 1st 2012 and Dec 31st 2015, 
1,633 patients received medical and mental healthcare at 
the ED due to a suicidal attempt. Patients admitted to the 
ED following a suicide attempt can be either discharged 
from the ED or admitted to the hospital. If the attempt leads 
to relevant medical damage, the patient will require admis-
sion to a medical ward, where an interconsultation-liaison 
psychiatrist will provide psychiatric care after somatic stabi-
lization. If suicide risk remains substantially high after ED/ 
medical ward discharge, the patient can be admitted to the 
psychiatric inpatient unit. This study featured all suicide at-
tempters discharged from the ED, a medical ward or the psy-
chiatric inpatient unit. In the context of psychiatric emer-
gency care, any self-harm with at least some intention to die 
as a result is considered a suicide attempt. Hence, we ex-
cluded all patients with suicidal ideation who had not com-
mitted self-harm. Also, and given the study aim of evaluat-
ing the degree of program fulfillment within a specific 
catchment area, we excluded all subjects seen in our ED who 
pertained to different areas – these patients are usually re-
ferred to their correspondent ED for clinical management 
before discharge or admission to an inpatient ward. In addi-
tion, we excluded patients who officially pertained to the 
studied area but received treatment at external mental 
healthcare resources, such as those admitted to a different 
psychiatric inpatient unit due to a shortage of beds in the 
studied area’s unit or to their personal preference. The study 
complied with the Declaration of Helsinki and was autho-
rized by La Paz University Hospital’s Clinical Research Ethical 
Committee.
The ARSUIC Suicide Risk Attention Program
ARSUIC ensures priority specialized mental healthcare 
for subjects who have suffered a suicide attempt, by en-
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hancing contact with mental healthcare providers during 
the days following the attempt. The program was imple-
mented during the last trimester of year 2012, when priority 
specialized medical appointments took a mean 19 days in 
the Autonomous Community of Madrid22. ARSUIC’s main 
measure consists on scheduling all suicide attempters to see 
an outpatient psychiatrist, who does not have specific sui-
cide prevention training, within a maximum of 7 days fol-
lowing discharge. After the appointment, patients go on to 
their usual periodic appointments. Hence, ARSUIC does not 
feature further additional follow-ups, or specific psycho-
therapeutic/pharmacologic treatments. The key outpatient 
visit is scheduled before hospital discharge, and the attend-
ing physician details the location and date of the visit in the 
discharge report.
Study variables
Information regarding dates of admission and dis-
charge was obtained from the hospital’s electronic health-
care records (EHR). These records are filed as a requirement 
before any discharge, and they also include sociodemo-
graphic variables: (gender, age), and whether the suicide 
attempt was an index attempt or a reattempt. Information 
regarding the first outpatient visit following discharge, 
and whether the patient complied with it, was retrieved 
from each CMHC’s EHR. To evaluate the degree of imple-
mentation, we computed the time between hospital dis-
charge and the first CMHC outpatient visit within the first 
30 days. By doing so, we prevented other visits, most likely 
unrelated to the suicide attempt, from biasing our esti-
mates. This bias would have favored most recently regis-
tered cases, because their follow-up periods encompass 
shorter time windows. We studied time-to-first outpatient 
visit as a continuous variable, as well as an implementation 
dichotomous variable (proportion of patients actually seen 
within a maximum 7 days). In addition, we computed the 
proportion of subjects who did not had an outpatient visit 
after the attempt. Using the dates of hospital admission 
and discharge, we were able to calculate the interval of 
time between attempts in those patients who had more 
than a suicide attempt during the study period. Then, to 
estimate the effectiveness of the program, we obtained the 
time between attempts within the first follow-up year af-
ter each attempt, and the suicide attempt rate per per-
son-year in each of the study years.
Statistical analyses
We obtained descriptive statistics of the study popula-
tion’s sociodemographic variables. They were summarized as 
percentages in categorical variables, and as the median±−
standard deviation in continuous ones. Then, we calculated: 
time between discharge and the first outpatient visit; time 
between different attempts; and suicide attempt rate per 
person-year. We tested that continuous variables were fol-
lowed a parametric distribution using Kolmogorov-Smirn-
off’s test, we studied temporal trends using Pearson’s R co-
efficients, and we tested before-after implementation 
differences using Student’s t-test for repeated measures. 
Last, we studied time trends in suicide attempt rates per per-
son-year by fitting a generalized linear model (GLM). In-
ter-annual rate logarithm comparisons were adjusted for 
multiple comparisons using Bonferroni’s method. We con-
ducted all analyses using SPSS v.22 for Windows23, with the 
collaboration of La Paz University Hospital’s Biostatistical 
consultants. Graphics were programmed using Stata v. 13 
for Mac24. 
RESULTS
During the study period, a total 886 suicide attempts 
fulfilling inclusion criteria received medical assistance at La 
Paz University Hospital. The majority of them corresponded 
with females (68.2%). Table 1 summarizes the demographic 
characteristics of the study population, divided by study 
year.
Time between discharge and the first outpatient 
visit
Studying the distribution of the intervals of time be-
tween hospital discharge and first outpatient visit within 30 
days, we found that year 2012’s median±standard deviation 
8.5±7.6 days were reduced, after the implementation of the 
program, to 6±7.3 in 2013 (p=0.03). We found an inverse 
correlation between study year and time between discharge 
Table 1 Demographic characteristics and 







2012 199 42.66 (14.59) 53 (26.6%) 146 (73.4%)
2013 242 42.85 (17.46) 82 (33.9%) 160 (66.1%)
2014 265 39.08 (15.89) 76 (28.7%) 189 (71.3%)
2015 180 39.86 (15.93) 71 (39.4%) 109 (60.6%)
2012-15 886 282 (31.8%) 604 (68.2%)
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and first visit, indicating a progressive increase in the pro-
gram’s real uptake (R=-0.11; p<0.001). Figure 1 represents 
this association. Table 2 displays the percentage of cases 
who were compliant with the program’s main goal – having 
a consultation within 7 days, per study year. It also features 
the proportion of cases with no outpatient consultation. 
Given that a longer follow-up period increases the odds of 
having at least one visit after the index suicide attempt, this 
variable increased slightly as the study advanced.
Proportion of suicide reattempts, attempt rate 
per person-year and time between attempts
The distribution of suicide attempts per year was as fol-
lows: 199 cases in 2012, 242 cases in 2013, 265 cases in 
2014, and 180 cases in 2015. Figure 2 shows the evolution in 
the proportion of attempts that corresponds to reattempts, 
a figure that decreased every study year. Figure 3 represents 
the evolution of the attempt rate per person-year through-
out the study period. The rate decreased from 1.20 attempts 
in 2012 to 1.08 attempts in 2015 (p=0.01). Figure 4 shows 
the distribution of the intervals of time to reattempt, within 
Figure 1 Time between discharge and first 
outpatient visit, within a maximum 
1-month follow-up, per study year. 
Results in median±standard deviation 
are P50±SD 2012: 8.5±7.57; 2013: 
6±7.31; 2014: 7±6.91; 2015: 7±6.54; 
p=0.03
Figure 2 Percentage of suicide attempts that 
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Table 2 Percentage of suicide attempts with 
time to first outpatient visit following 
discharge ≤ or > 7 days (p=0.002) 
and percentage of cases with no 
outpatient follow-up (p<0.001)





2012 197 63 (32%) 134 (68%) 1%
2013 231 112 (48.5%) 119 (51.5%) 4.5%
2014 242 110 (45.5%) 132 (54.5%) 8.7%
2015 160 77 (48.1%) 83 (51.9%) 11.1%













a maximum 1-year follow-up, per study year: time between 
attempts progressively increased as the study advanced.
DISCUSSION
This retrospective study analyzed the degree of imple-
mentation and fulfillment of the ARSUIC Suicide Risk Care 
Program, as well as its effectiveness. Our results show that, 
after ARSUIC was implanted, the median time wait be-
tween a suicide attempt and the first outpatient follow-up 
was reduced from 8.5 to 6 days, and then it stabilized in 7 
year
year
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Figure 3 Suicide attempt rate per person-year. 
The difference between the logarithms 
of the rates 2012-2015 is statistically 
significant at an adjusted p-value 
level=0.017
Figure 4 Time between hospital discharge 
following a suicide attempt and a 
subsequent suicide attempt, within a 



























days – the exact maximum that the program allows for. 
Moreover, the proportion of suicide attempts seen at the 
ED that correspond to reattempts decreased, and time be-
tween attempts in patients with multiple attempts in-
creased. This is the first study to evaluate this program, 
adopted in all hospitals across the Autonomous Communi-
ty of Madrid since 2013. 
Since the establishment of the program, a number of 
voices have rightfully pointed out the need for an evalua-
tion of its results25. In fact, implementing suicide prevention 
programs that are innovative and effective, and evaluating 
such programs with observational designs in real-world set-
tings, are two global priorities26. According to our results, 
median time to follow-up, considering only the first 30 days 
after discharge, has decreased until becoming compliant 
with the study’s objectives. In addition, our study shows high 
adherence to follow-ups after suicide attempting – over 
88% patients were seen at a CMHC at some point, following 
discharge. Notwithstanding, there is a marked proportion of 
patients who do not turn up to these outpatient visits with-
in the maximum 7 days established in the program. During 
the study period, this proportion has lowered from 68% to 
roughly 50%. The figure is in keeping with a study from Bar-
celona, where up to 50% did not comply with a suicide risk 
reduction protocol based on telephone calls27. Hence, while 
central tendency indicators suggest that ARSUIC’s goals 
have been fulfilled, there seem to exist substantial be-
tween-subject differences in effective access to care. The 
marked increase of absolute suicide attempts we observed 
between 2012 and 2014 is in line with trends reported else-
where12. Our ecological assessment of the program’s effec-
tiveness is promising: the proportion of attempts corre-
sponding to reattempts and the suicide attempt rate per 
person-year have decreased every year since the program 
was implemented.  
Our study includes several limitations that may some-
what affect its validity, and the applicability of our results. 
First, a proportion of all patients seen at the ED was under 
long-term treatment in a different catchment area, indicat-
ing the possibility that some suicide attempts pertaining to 
our studied area were, in turn, seen at other EDs, and are not 
included among our study population. Other authors, from 
comparable healthcare settings28, maintain that, in Spain, 
most attempts are derived to the correspondent catchment 
area’s ED. Overall, Madrid’s healthcare planning has not suf-
fered major changes during the study period, and we con-
sider unlikely the possibility that this limitation affects be-
tween-study year differences. Thus, we believe that our 
findings are valid. Second, due to technical and ethical lim-
itations, our effectiveness assessment is based on suicide 
reattempt, rather than death by suicide, as the measure of 
effect. Most authors agree that suicide attempt, as a rela-
tively frequent event that can be registered in the clinical 
setting, is a useful proxy for death by suicide, an infrequent 
and difficult-to-detect outcome7-9,29. Notwithstanding, oth-
er studies have reported profile differences between people 
who attempt suicide and those who die by suicide30, and we 
consider that including suicide as an outcome should be a 
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priority in future assessments of the program. Last, our study 
uses an ecological and historical design to evaluate the pro-
gram’s effectiveness, two characteristics that limit our abil-
ity to draw causal inferences. The retrospective design in-
creases the possibility of a potential undetected historical 
artifact affecting our results. For example, some authors 
have reported an association between the 2000s decade’s 
economic downturn and suicide rates in Europe31. The eco-
logical approach somewhat limits our study’s applicability to 
the clinical practice, in terms of individual-level deci-
sion-making.
Our study’s main strength is its naturalistic character that 
allows for the assessment of a recently implemented inter-
vention in unselected patients. There is a growing demand for 
pragmatic intervention studies for comparative effectiveness 
research that favor the generation of external rather than 
internal validity and expedite the implementation of evi-
dence-based programs32. The age and gender distribution of 
our study population are in line with those observed in com-
parable settings27. We believe that our implementation esti-
mates can be generalized to the rest of the Autonomous 
Community of Madrid, and that the effectiveness estimates 
are valid for other universal coverage healthcare systems. In 
addition, evidence suggests that, just as other subpopulations 
of patients under mental healthcare, people who attempt sui-
cide have lower rates of adherence to outpatient care, as well 
as other inequities in access to care, than the general popula-
tion20,33. Hence, hospital contexts such as the ED are an oppor-
tunity to enhance their access to effective interventions20,33. 
Our study contributes with novel information to the field of 
hospital-initiated interventions for suicide prevention in 
high-risk individuals. Last, the ecological approach to estimat-
ing the program’s effectiveness makes our results especially 
useful for decision-making at the healthcare policy and man-
agement level. Although most clinical studies opt for an indi-
vidual-level approach, it should be noted that suicide is, by 
definition, a complex problem that requires the assessment of 
ecological-level factors and how these interact with individu-
al-level ones12,34. 
Further research is needed for a deeper understanding 
of the ARSUIC Suicide Risk Care Program. Clarification of 
the barriers and facilitators that suicidal individuals face in 
the process of accessing the program is a priority, in order to 
reduce access inequality. Also, building on other authors’ 
findings that similar, early contact enhancement programs 
might not be effective in the long-run35, future repetitions 
of this evaluation will be required. Last, Lopez-Castroman 
and colleagues have pointed out that most suicides take 
place in low and middle income countries, while research in 
mainly conducted in high income countries36. Direct com-
parisons to programs deployed in the same and other con-
texts will allow for the identification of common compo-
nents, to estimate is the program is adaptable and scalable37.
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Implementación de un programa de 
prevención del riesgo de suicidio en la 
Comunidad Autónoma de Madrid. La 
experiencia ARSUIC
Introducción. Este estudio evalúa el grado de cumpli-
miento y efectividad del programa ARSUIC de Atención al 
Riesgo Suicida, cuyo objetivo es reducir el riesgo posterior al 
intento de suicidio facilitando una cita ambulatoria de alta 
prioridad después del alta hospitalaria.
Metodología. Estudio retrospectivo de base hospitalaria 
conducido, entre 2012 y 2015, en todos los casos de intento 
de suicidio atendidos en la red de recursos de psiquiatría 
del Hospital Universitario La Paz. Se obtienen estimadores 
del tiempo hasta la primera consulta después del alta, de la 
proporción de citas que cumple el objetivo del programa de 
ser atendidos en un máximo de 7 días, de la tasa de intento 
de suicidio y del porcentaje de intentos que corresponde con 
un reintento, en cada año de estudio.
Resultados. Después de la implementación del progra-
ma, la mediana de tiempo entre el alta y la primera consulta 
baja de 8,5 a 6 días y el porcentaje de citas que cumplen el 
objetivo aumenta de 32 a 48,5%. Entre 2012 y 2015, la tasa 
de intentos de suicidio por paciente y año se reduce de 1,20 
a 1,08, y el porcentaje de intentos que corresponde con re-
intentos de 26,6 a 12,8%.
Conclusión. La implementación del Programa ARSUIC 
ha reducido el tiempo entre el alta después de un intento 
de suicidio y la primera cita ambulatoria. Han disminuido los 
intentos de suicidio debidos a reintentos y la tasa de inten-
tos por paciente y año. El porcentaje de cumplimiento me-
nor al 50% sugiere diferencias interindividuales en el acceso 
efectivo al programa.
Palabras clave: Suicidio, Salud mental, Evaluación de programas, Implementación
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Implementation of a suicide risk prevention 
program in the Autonomous Community of 
Madrid. The ARSUIC experience
Introduction. This study evaluates the degree of com-
pliance and effectiveness of the ARSUIC Suicide Risk Care 
Program. ARSUIC seeks to reduce the relapse risk that fol-
lows a suicide attempt by scheduling a high priority outpa-
tient visit following hospital discharge.
Method. Hospital-based retrospective study conducted 
between years 2012 and 2015. We included every suicide 
attempt treated at the La Paz University Hospital’s mental 
healthcare resources network. We estimated the time be-
tween hospital discharge and the first outpatient visit; the 
proportion of visits that fulfill the program’s objective – a 
follow-up within a maximum of 7 days; the suicide attempt 
rate; and the percentage of attempts corresponding to re-
lapses, by study year.
Results. After program deployment, median time be-
tween discharge and the first visit decreased from 8.5 to 6 
days, and the percentage of visits that fulfill the program’s 
objective increased from 32 to 48.5%. Between years 2012 
and 2015, the suicide attempt rate per person and year de-
creased from 1.20 to 1.08 and the proportion of attempts 
corresponding to relapses from 26.6% to 12.8%.
Conclusion. Implementing the ARSUIC Program low-
ered the time between discharge and the first outpatient 
visit following a suicide attempt. The proportion of suicide 
attempts due to relapses and the suicide attempt rate per 
person decreased progressively. The program fulfilment pro-
portion was under 50%, suggesting between-user differenc-
es regarding their effective access to the program.
Key words: Suicide, Mental health, Program evaluation, Implementation
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INTRODUCCIÓN
Casi un millón de personas mueren anualmente por sui-
cidio1, la segunda causa de muerte más frecuente entre los 
jóvenes2. En España, supone la primera causa de muerte ex-
terna, con una tasa anual que varía entre 11,88 suicidios por 
100.000 personas en hombres y 4,05 en mujeres3. Los facto-
res de riesgo del suicidio consumado interactúan en comple-
jas redes jerárquicas4,5. Entre ellos, el antecedente personal 
de intento de suicidio destaca como principal marcador clí-
nico de riesgo de reintento y de suicidio consumado6. Se es-
tima que un intento previo aumenta el riesgo de muerte por 
suicidio 30 veces, y lo antecede en la mitad de los casos7-9. 
Además, el intento de suicidio, una entidad hasta 30 veces 
más frecuente que el suicidio consumado10, constituye un 
problema clínico en sí mismo, con enormes costes directos e 
indirectos asociados y una incidencia en progresivo aumento 
en todo el mundo11,12.
La prevención del suicidio se puede ejercer en diferentes 
niveles de intervención13. En el poblacional, varias medidas 
se han mostrado protectoras: en general, están orientadas 
a limitar el acceso a métodos potencialmente mortales. Al-
gunos ejemplos incluyen reducir el contenido de las cajas 
de fármacos utilizados en sobredosis, como paracetamol o 
benzodiacepinas14, o dificultar el paso a “puntos calientes” 
de suicidio por precipitación15. La prevención individual del 
suicidio se ejerce a través de intervenciones clínicas para las 
personas con riesgo elevado. Se considera que el medio sani-
tario es adecuado para la detección del riesgo porque hasta 
el 45% de los sujetos que consuman el suicidio ha acudido 
a una consulta médica durante el mes previo16. Entre los pa-
cientes con riesgo, destacan los que han tenido un intento 
de suicidio17, en especial durante el periodo inmediatamente 
posterior al alta, que asocia una extraordinaria vulnerabi-
lidad al reintento11. La mejor evidencia científica corres-
ponde a estrategias de mantenimiento de contacto con el 
individuo en alto riesgo de suicidio a través de los llamados 
“gatekeepers”, personas accesibles en momentos de crisis18. 
Un reciente metaanálisis de ensayos clínicos encontró que 
el WHO-BIC (Brief Intervention and Contact), un programa 
que potencia el contacto entre el personal clínico y el sujeto, 
es efectivo a la hora de reducir la tasa de repetición del in-
tento de suicidio y el suicidio consumado19. En el mismo me-
taanálisis, las intervenciones psicoterapéuticas regladas no 
mostraron resultados positivos. El ensayo clínico pragmático 
ED-SAFE, conducido en Estados Unidos, concluyó que una 
intervención iniciada a nivel de urgencias hospitalarias, di-
rigida a clarificar los recursos en caso de crisis, era efectiva 
en la reducción de nuevos intentos y suicidios consumados20. 
En la Comunidad Autónoma de Madrid, el Plan Estra-
tégico de Salud Mental para 2010-2014 señaló el riesgo de 
suicidio como una línea de trabajo fundamental, y marcó 
como objetivos la vigilancia epidemiológica del suicidio, el 
desarrollo de un abordaje clínico normalizado para su pre-
vención y el fomento de la investigación sobre las conduc-
tas suicidas21. Específicamente, se desarrolló el programa de 
Atención al Riesgo Suicida (ARSUIC), por el que se prioriza la 
atención a sujetos que han sufrido intentos de suicidio, con 
el objetivo de reducir el riesgo de nuevos intentos y del sui-
cidio consumado. Aunque está implantado de forma general 
en la Comunidad Autónoma de Madrid desde 2013, no se 
han publicado sus resultados. El objetivo de este estudio es 
evaluar el programa ARSUIC con estimadores de implemen-
tación, cumplimiento y efectividad. 
METODOLOGÍA
Diseño del estudio, contexto y sujetos
Estudio observacional retrospectivo de base hospita-
laria. El Hospital Universitario La Paz (HULP) atiende a un 
área sanitaria de 525.501 personas en el norte de Madrid. 
La atención a los pacientes con necesidades psiquiátricas 
se realiza de manera articulada entre una variedad de re-
cursos intra y extrahospitalarios, entre los que destacan el 
Servicio de Urgencias (SU), la Unidad de Hospitalización 
Breve Psiquiátrica (UHB) y los Centros de Salud Mental Co-
munitaria (CSM).  Entre el 1 de enero de 2012 y el 31 de 
diciembre de 2015, se atendieron 1.633 urgencias hospita-
larias debidas a intento de suicidio. Todos ellos recibieron 
valoración psiquiátrica antes del alta hospitalaria. Los pa-
cientes atendidos en el SU pueden recibir el alta hospita-
laria en la propia sala de urgencias. En caso de que el daño 
requiera ingreso para tratamiento médico, un psiquiatra 
(de Interconsulta y Enlace) evaluará al paciente una vez 
estabilizado. Por último, si el psiquiatra responsable consi-
dera que el riesgo de suicidio sigue siendo elevado, se pue-
de realizar un ingreso en la UHB. Incluimos en el estudio 
a todos los sujetos que hubieran realizado un intento de 
suicidio, independientemente del dispositivo hospitalario 
desde el que hubiera sido dado de alta. En el contexto de 
la urgencia hospitalaria, se considera intento de suicidio 
cualquier acto autolesivo con al menos alguna intención 
de morir como resultado. Por lo tanto, no se incluyeron pa-
cientes con ideación de suicidio que no hubiesen cometido 
ningún acto. Asimismo, y debido al objetivo del estudio de 
valorar el grado de cumplimiento del programa al alta en 
el propio área sanitaria, se excluyeron de la muestra los su-
jetos pertenecientes a otros áreas sanitarias, generalmente 
derivados a su correspondiente SU, cuyo seguimiento al 
alta e ingreso se realizarían en centros no pertenecientes 
a la red del HULP, así como aquellos que, perteneciendo 
al área sanitaria estudiado, ingresaron en otras UHB de-
bido a falta de disponibilidad de camas o a su preferencia 
personal. El estudio cumple con la declaración de Helsinki 
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y cuenta con la autorización del Comité Ético de Investiga-
ción Clínica (CEIC) del HULP.
El programa de Atención al Riesgo Suicida 
(ARSUIC)
ARSUIC trata de asegurar una atención especializada 
prioritaria para los sujetos que han sufrido un intento de sui-
cidio, potenciando el contacto con los profesionales de salud 
mental a lo largo de los primeros días posteriores al intento. 
Se implementó durante el último trimestre del año 2012. En el 
mismo periodo, las citas médicas preferentes en la Comunidad 
de Madrid tardaban en torno a los 19 días22. La principal me-
dida de ARSUIC se basa en citar a todos los sujetos incluidos, 
con un psiquiatra ambulatorio sin especial entrenamiento en 
la prevención del suicidio, en un máximo de 7 días después 
del alta hospitalaria. Posteriormente, cada paciente continúa 
el tratamiento habitual con citas periódicas. Por lo tanto, no 
incluye más mantenimiento de contacto o intervención far-
macológica o terapéutica más allá de la reducción del tiempo 
hasta la primera cita. La cita se organiza desde el propio hos-
pital (SU, Interconsulta o UHB), y el psiquiatra responsable del 
alta hospitalaria la especifica en el informe. 
Variables estudiadas
La información relativa a las fechas de ingreso y alta se 
obtuvo de los registros informatizados hospitalarios que se 
rellenan previamente a cualquier alta hospitalaria (SU, In-
terconsulta, UHB). Los mismos registros contienen algunas 
variables sociodemográficas complementarias: (sexo, edad) 
y si el intento de suicidio es el primero o un reintento. La 
información relativa a la primera cita ambulatoria poste-
rior al alta, y de la asistencia de cada paciente a la misma, 
se obtuvo de los registros informatizados de los CSM. Para 
valorar la implementación del programa estudiado, se con-
sideraron los tiempos entre el alta hospitalaria y la primera 
cita en CSM durante los 30 días siguientes. De esta forma, 
evitamos que otras citas más alejadas, sin relación con el 
alta hospitalaria, sesguen los resultados a favor de los últi-
mos casos registrados, que tienen menos tiempo de segui-
miento. Se estudió el tiempo hasta la consulta como varia-
ble continua y, asimismo, como una variable dicotómica de 
implementación del programa (porcentaje de sujetos que 
acuden a consulta en un máximo de 7 días). Además, se 
computó el porcentaje de sujetos que no llegó a consultar 
después del intento de suicidio. A partir de las fechas de 
ingreso y alta hospitalarios recogidas, en los sujetos que 
sufrieron más de un intento de suicidio durante el tiempo 
de estudio, se calculó el tiempo entre intentos. Para valorar 
la efectividad del programa, se obtuvieron estimadores del 
tiempo entre intentos con un máximo de seguimiento de 
un año, así como de la tasa de intento por persona-año en 
cada año de estudio. 
Análisis estadístico
Se calcularon estadísticos descriptivos de las variables 
sociodemográficas, que se expresan en forma de porcentaje 
(cualitativas) y mediana±desviación estándar (cuantitativas). 
A continuación, se obtuvieron los estimadores del tiempo 
hasta la primera consulta, el tiempo entre diferentes inten-
tos de suicidio y la tasa de intento por persona-año. Com-
probamos que las variables cuantitativas son paramétricas 
con el test de Kolmogorov-Smirnoff, valoramos la tendencia 
temporal de las mismas a través de coeficientes R de Pearson 
y contrastamos las diferencias entre antes y después de la 
implementación del programa con test T de Student para 
muestras apareadas. Por último, estudiamos las tendencias 
temporales en la tasa de intento de suicidio por persona-
año, empleando un modelo de regresión lineal generalizado 
(GLM). Las comparaciones interanuales de logaritmos de ta-
sas se ajustaron por el método de Bonferroni para compa-
raciones múltiples. Los análisis se realizaron con el paquete 
estadístico SPSS v.22 para Windows23 y con la colaboración 
del Equipo de Bioestadística del HULP; los gráficos se pro-
gramaron en el paquete Stata v.13 para Mac24.
RESULTADOS
En el periodo de tiempo de estudio, un total de 886 ca-
sos de intento de suicidio que cumplían con los criterios de 
inclusión fueron atendidos en HULP. La mayor parte de in-
tentos de suicidio se correspondió con mujeres (68,2%). La 
tabla 1 resume las características demográficas de los casos, 
divididas por año de estudio.
Tabla 1 Características demográficas y 








2012 199 42,66 (14,59) 53 (26,6%) 146 (73,4%)
2013 242 42,85 (17,46) 82 (33,9%) 160 (66,1%)
2014 265 39,08 (15,89) 76 (28,7%) 189 (71,3%)
2015 180 39,86 (15,93) 71 (39,4%) 109 (60,6%)
2012-15 886 282 (31,8%) 604 (68,2%)
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Tiempo entre el alta y la consulta ambulatoria 
más cercana
Estudiando la distribución del tiempo hasta la primera 
consulta dentro de los 30 días posteriores al alta, obtuvimos 
que de una mediana±desviación estándar de 8,5±7,6 días en 
2012, se pasó a 6±7,3 después de implementar el programa, 
en 2013 (p=0,03). La correlación entre los sucesivos años de 
estudio y el tiempo hasta la primera consulta fue inversa, 
indicando un aumento progresivo en la implementación real 
del programa (R=-0,11; p<0,001). La figura 1 representa la 
distribución del tiempo hasta la consulta por año de estudio. 
La tabla 2 muestra el porcentaje de casos que cumplieron 
con el objetivo de acudir a consulta en un tiempo menor o 
igual a 7 días por año de estudio. También incluye la propor-
ción de casos que no llegaron a consultar ambulatoriamen-
te. Como un seguimiento más largo aumenta la probabilidad 
de tener alguna consulta, esta variable aumentó conforme 
avanzaba el estudio.
Porcentaje de reintentos de suicidio, tasa de 
intentos por persona-año y tiempo entre intentos
La distribución de intentos de suicidio atendidos fue la 
siguiente: 199 casos en 2012, 242 casos en 2013, 265 casos 
Figura 1 Distribución del tiempo entre el alta 
hospitalaria y la primera consulta 
ambulatoria, durante un máximo de 
1 mes de seguimiento, por año de 
estudio. Los resultados en mediana de 
días ±desviación estándar son P50±SD 
2012: 8,5±7,57; 2013: 6±7,31; 2014: 7± 
6,91; 2015: 7±6,54; p=0,03.
Figura 2 Porcentaje de intentos de suicidio que 


















2012 2013 2014 2015
Tabla 2 Porcentaje de casos de intento de 
suicidio con tiempo hasta la consulta 
posterior al alta hospitalaria ≤ o > 
a 7 días (p=0,002) y porcentaje de 
casos que no se siguen de consulta 
ambulatoria (p<0,001)





2012 197 63 (32%) 134 (68%) 1%
2013 231 112 (48,5%) 119 (51,5%) 4,5%
2014 242 110 (45,5%) 132 (54,5%) 8,7%
2015 160 77 (48,1%) 83 (51,9%) 11,1%













en 2014 y 180 casos en 2015. La figura 2 muestra la evo-
lución del porcentaje de intentos de suicidio que se debe a 
reintentos. Cada año de estudio, este porcentaje se redujo. 
La figura 3 representa la evolución de la tasa de intento de 
suicidio por paciente-año a lo largo del estudio. La tasa se 
redujo desde 1,20 intentos en 2012 a 1,08 en 2015 (p=0,01). 
La figura 4 muestra la distribución del tiempo hasta el rein-
tento, durante un seguimiento máximo de un año, por año 
de estudio. Se puede apreciar un aumento del tiempo entre 
intentos conforme el estudio avanza.
año
año
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Figura 3 Tasa de intento de suicidio por 
persona-año. Diferencia entre los 
logaritmos de las tasas de 2012 y 2015 
significativa, p ajustada=0,017
Figura 4 Distribución del tiempo entre el alta 
hospitalaria y la siguiente atención por 
un reintento de suicidio durante un 
tiempo máximo de seguimiento de un 



























En este estudio retrospectivo se analizaron el grado de 
implementación y cumplimiento de objetivos y la efectivi-
dad del programa ARSUIC de Atención al Riesgo Suicida. Los 
resultados muestran que el tiempo mediano entre el alta 
hospitalaria después de un intento de suicidio y la primera 
consulta ambulatoria se ha reducido, con la introducción 
de ARSUIC, de 8,5 a 6 días, para pasar a estabilizarse en los 
7 días máximos que el programa establece como objetivo. 
Asimismo, el porcentaje de intentos de suicidio atendidos en 
urgencias que se corresponden con reintentos ha descendido 
y el tiempo entre diferentes intentos de un mismo pacien-
te ha aumentado. Se trata del primer estudio que evalúa 
este programa, adoptado de forma generalizada en todos 
los hospitales de la Comunidad Autónoma de Madrid desde 
2013.
Desde la puesta en marcha del programa ARSUIC, al-
gunas voces han señalado la necesidad de valorar sus resul-
tados25. De hecho, programas de prevención del riesgo de 
suicidio efectivos e innovadores, y evaluar dichos progra-
mas con diseños observacionales en población real han sido 
identificados como prioridad a nivel global26. De acuerdo 
con nuestros resultados, el tiempo mediano hasta la primera 
consulta, después del alta hospitalaria, y tomando única-
mente los primeros 30 días de seguimiento, se ha reducido 
hasta cumplir con el objetivo del programa. Asimismo, nues-
tro estudio muestra un elevado porcentaje de seguimien-
to posterior al intento de suicidio cuando se consideran las 
citas sin límite de tiempo, con una adherencia por encima 
del 88%. No obstante, existe un llamativo porcentaje de 
pacientes que no acuden a la consulta ambulatoria en el 
tiempo marcado por el programa, si bien se ha reducido de 
un 68 a un 50% aproximadamente. Un estudio conducido en 
Barcelona mostró resultados comparables, con un 50% de 
pacientes que no cumplían con un protocolo de reducción 
del riesgo de suicidio basado en llamadas telefónicas27. Por 
lo tanto, si bien en términos de medidas de tendencia central 
el objetivo del programa se ha cumplido, parece que existen 
diferencias interindividuales en el acceso efectivo al mismo. 
El marcado aumento progresivo de los intentos de suicidio, 
en términos absolutos, observado en nuestro estudio entre 
2012 y 2014, se asimila a las tendencias observadas en otros 
centros en el mundo12. La valoración ecológica de la efectivi-
dad muestra resultados alentadores: el porcentaje de inten-
tos de suicidio que se deben a reintentos y la tasa de intento 
de suicidio por paciente-año han ido reduciéndose cada año 
desde la implementación del programa. 
Nuestro estudio incluye algunas limitaciones que mo-
dulan la validez y aplicabilidad de sus resultados. En primer 
lugar, un porcentaje de los sujetos atendidos en urgencias 
hacía su seguimiento en otro centro sanitario, lo que sugiere 
la posibilidad de que algunos intentos de suicidio que co-
rresponden con el área estudiada, pero fueran atendidos en 
otros hospitales, no estén incluidos en nuestros resultados. 
Otros autores de áreas sanitarias comparables28 sostienen 
que, en España, la mayor parte de intentos de suicidio son 
derivados a sus centros de referencia. No obstante, y dado 
que la ordenación de la atención especializada en la Co-
munidad Autónoma de Madrid no ha cambiado durante el 
periodo de estudio, consideramos poco probable que esta li-
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mitación altere diferencialmente los estimadores entre años 
de estudio. Por tanto, consideramos que las diferencias en-
contradas son válidas. En segundo lugar, nuestra valoración 
de la efectividad ha utilizado como medida de resultado el 
reintento de suicidio, y no el suicidio consumado, por razo-
nes técnicas y de protección de datos individuales. La mayor 
parte de autores están de acuerdo en la utilidad del intento 
de suicidio, un evento frecuente, como variable instrumental 
del suicidio consumado, menos frecuente y más difícil de de-
tectar7-9,29. No obstante, se han notificado diferencias entre 
los perfiles de las personas que intentan el suicidio y las que 
lo consuman30, y consideramos que incluir el suicidio consu-
mado será necesario en estudios futuros. Por último, nuestro 
estudio utiliza un diseño histórico y ecológico para valorar 
la efectividad del programa, lo que reduce su capacidad para 
realizar inferencia causal. El planteamiento retrospectivo 
aumenta la posibilidad de un posible artefacto histórico no 
identificado que afecte a las diferencias encontradas. Por 
ejemplo, algunos autores han encontrado asociación entre 
la crisis financiera de la década de los 2000 y la incidencia 
de suicidios31. El abordaje ecológico limita nuestra capacidad 
para dar respuestas válidas para la práctica clínica.
La principal fortaleza de nuestro estudio es su carác-
ter naturalístico, que permite valorar una intervención de 
reciente implementación en pacientes poco seleccionados. 
Existe una creciente demanda de estudios de intervención 
pragmáticos, que favorezcan la generación de validez ex-
terna por encima de la interna, y que aceleren la implemen-
tación de intervenciones basadas en la evidencia32. La edad 
media y el sexo predominantemente femenino de nuestros 
pacientes se asemejan a los observados en otras muestras 
clínicas de ámbitos comparables27. Consideramos que nues-
tros estimadores de implementación son generalizables al 
resto de la Comunidad Autónoma de Madrid, mientras que 
los de efectividad lo son a otros sistemas de atención sani-
taria universales. Además, la evidencia sugiere que, al igual 
que otros pacientes en seguimiento en los servicios de salud 
mental, los sujetos que sufren intentos de suicidio tienen 
menores tasas de adherencia al seguimiento ambulatorio, 
así como otras inequidades en el acceso a los tratamientos 
disponibles20,33. Por lo tanto, contextos hospitalarios como 
el servicio de urgencias son una oportunidad para facilitar 
su acceso a los tratamientos que han demostrado efectivi-
dad20,33. Nuestro estudio contribuye con información no-
vedosa al campo de las intervenciones para la prevención 
indicada de las conductas suicidas iniciadas en el medio hos-
pitalario. Por último, el planteamiento ecológico del estudio 
de la efectividad confiere a nuestros resultados una utilidad 
especial para la toma de decisiones en política sanitaria y 
gestión de centros. Aunque la mayor parte de estudios con 
población clínica se centran en la perspectiva individual, 
conviene recordar que el suicidio es, por definición, un pro-
blema “complejo” que requiere valorar factores ecológicos y 
cómo interactúan con los individuales12,34.
Se requieren más estudios que permitan entender con 
mayor profundidad el programa ARSUIC de Atención al 
Riesgo Suicida. Es prioritario clarificar qué barreras y faci-
litadores individuales determinan el acceso efectivo al pro-
grama, para poder reducir inequidades en el mismo. Además, 
y dado que algunos autores han puesto en duda la efectivi-
dad a largo plazo de programas similares35, serán necesarias 
nuevas evaluaciones futuras. Por último, López-Castromán 
y cols. han señalado que la mayor parte de fallecimientos 
por suicidio tienen lugar en países de pequeño y mediano 
ingreso, mientras que la investigación al respecto se con-
centra en países desarrollados36. La comparación directa con 
programas comparables implementados en el mismo y otros 
contextos permitirá identificar componentes comunes y es-
tudiar su adaptabilidad y escalabilidad37. 
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AnEmergency Department-Initiated
Intervention to Lower Relapse Risk after
Attempted Suicide
GONZALOMARTINEZ-ALES, MD,MSC, EDUARDO JIMENEZ-SOLA, MD,
EVA ROMAN-MAZUECOS, MD,MARIA PILAR SANCHEZ-CASTRO,MD,
CONSUELO DE DIOS, MD, PHD, BEATRIZ RODRIGUEZ-VEGA,MD, PHD, AND
MARIA FE BRAVO-ORTIZ, MD, PHD
Objective: According to randomized trials, contact after a suicide attempt lowers
relapse risk. However, effectiveness studies based on real clinical data can provide
additional external validity.
Method: We conducted an observational study to determine if an emergency
department (ED)-initiated intervention for suicide attempt risk reduction,
consisting on scheduling a single added appointment within 7 days after discharge
following a suicide attempt, can reduce the risk of relapse. The study included
1,775 patients who had been treated at a general hospital ED due to a suicide
attempt. The principal outcome measure was ED return after a new attempt. We
obtained Kaplan-Meier survival functions and used Cox proportional hazard
regression models to estimate unadjusted and adjusted risks of relapse by treatment
phase. Covariates included: age, gender, history of suicide attempts, history of
psychiatric disorders, concurrent alcohol/drug abuse, number of attempts during
follow-up, admission as an inpatient and family support.
Results: A total of 497 (22.5%) attempts were followed by a relapse. Subjects
exposed to the studied intervention had a lower risk of relapse after a suicide
attempt, with a 24% adjusted risk reduction estimate.
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Conclusion: Our real-world results suggest that an additional early appointment,
scheduled before discharging suicide attempters, reduces suicide reattempt risk.
Suicide is considered the second most fre-
quent cause of death between 15 and 29 years
of age and accounts for over 800,000 annual
deaths worldwide (WHO, 2018). In Spain,
annual incidence varies between 11.7 suicides
per 100,000 people in men and 3.8 in women
(INE, 2017). Main risk factors for accom-
plished suicide interact in complex hierarchi-
cal networks (O’Connor & Nock, 2014; Van
Heeringen & Mann, 2014). Mental disorders
are considered among the strongest predictors
(Holmstrand, Bogren, Mattison, & Bradvik,
2015). For instance, suicide is 20 times more
likely if a previous diagnosis of major depres-
sion is present. Suicide is also associated with
bipolar disorder, drug and alcohol addiction
disorders, and psychoses, as well as to a broad
variety of social stressors, such as socioeco-
nomic disadvantage and the lack of social sup-
port (Bertolote, Fleischmann, De Leo, &
Wasserman, 2002). However, nonlethal suici-
dal behaviors are considered the most specific
risk marker (Arias et al., 2016; Turecki &
Brent, 2015). Some researchers find that these
behaviors may involve almost 30 times more
incidence of accomplished suicide (Finkel-
stein et al., 2015). Addressing suicidal behav-
ior, therefore, offers a great opportunity to
prevent future suicide attempts. Moreover,
suicidal behaviors drive high direct medical
costs (Czernin et al., 2012) and entail over
$93 billion in total burden per year, only in
the United States (Shepard, Gurewich, Lwin,
Reed, & Silverman, 2016).
Several prevention programs, aimed at
different levels, have been established in order
to reduce suicide and suicidal behaviors
(Mann et al., 2005). At the individual level,
the referral of high-risk individuals to general
mental health services (Van der Feltz-Corne-
lis et al., 2011) and, more specifically, to pro-
grams directly addressing suicidal behaviors
(Meerwijk et al., 2016) is effective. The first
weeks following an attempted suicide entail
an exceptionally high reattempt risk (Owens,
Horrocks, &House, 2002; Parra-Uribe et al.,
2017). Accordingly, some high-risk case-
management programs focus on enhancing
patient engagement, favoring access to
medical resources after discharge through
strategies such as telephone calls or emer-
gency-contact cards (Mann et al., 2005;
McMain, Guimond, Barnhart, Habinski, &
Streiner, 2017). Emergency departments
(ED) can play a key role in such strategies:
Suicide attempters treated at the ED fre-
quently repeat self-harm during the following
year (Olfson, Wall, et al., 2017), and a single
ED visit for self-harm increases future suicide
risk nearly sixfold (Owens et al., 2002). In
addition, suicidal ED patients have low rates
of outpatient treatment engagement (Lizardi
& Stanley, 2010; Shand et al., 2017). Hence,
there is a growing interest in brief interven-
tions initiated at the ED that can enhance
retention and prevent suicidal crises (Arias
et al., 2016). Results from a randomized trial
(RCT) showed a 30% decrease in subsequent
suicide attempts after an ED-based interven-
tion consisting on a combination of suicide
risk screening, discharge resources, and tele-
phone calls (Miller et al., 2017). In clinical
research, however, comparative effectiveness
studies based on data from the real clinical
practice can add external validity to the evi-
dence provided by RCTs (Sherman et al.,
2016).
In Spain, suicide rates have steadily
increased throughout the last two decades
(INE, 2017; Ruiz-Perez & Olry de Labry-
Lima, 2006). The Community of Madrid’s
Regional Office of Mental Health established
suicidal behavior prevention as a priority in
its 2010–2014 Mental Health Strategy. This
implied to launch the Suicide Risk Attention
Program. Its main purpose is to offer priority
specialized care to those patients who have
attempted suicide, in order to prevent poten-
tial relapses. The present study evaluates its
clinical effectiveness at reducing the risk of
relapse among patients discharged from the
ED after a suicide attempt.
2 RESULTS FROM A REAL-WORLD EFFECTIVENESS STUDY
METHODS
Study Setting
The Spanish tax-funded National
Health Service (NHS) provides universal
access to medical care. The Community of
Madrid’s Health Council organizes its psy-
chiatric care in 25 community-based catch-
ment areas. Each area includes a general
hospital and a network of in- and outpatient
psychiatric care and rehabilitation resources.
Most of the patients with psychiatric needs
use this network, and they usually come from
primary care. We conducted our study in a
northern catchment area, with a total popula-
tion of 525,500 persons by the beginning of
the study.
Study Design and Subjects
We conducted an observational study.
Between January 1, 2010, and December 31,
2015, every suicide attempt receiving medi-
cal and psychiatric attention at the ED
entered the study, regardless of whether
admission to a medical or psychiatric ward
was indicated following ED discharge. In
this particular ED, every subject in an emer-
gency psychiatric need first undergoes gen-
eral medical assessment and treatment and
then receives psychiatric care. In addition,
anybody presenting with suicide ideation or
a suicide attempt has to be seen by a psychia-
try consultant before hospital discharge. If
medical damage due to the suicide attempt
requires admission in a medical ward, a psy-
chiatrist evaluates the patient once stabi-
lized. If the psychiatrist considers that the
relapse risk remains excessively high, volun-
tary or involuntary psychiatric admission can
be indicated. We defined suicide attempt as
any self-injurious act committed with at least
some intent to die as a result. Therefore, we
excluded patients exhibiting suicide ideation
without suicidal behavior. Otherwise, every
suicide attempt was admitted to the study
and included in the analyses. We considered
each attempt a unit of analysis given that the
intervention was widely administered at
discharge, regardless of whether it was a first
suicide attempt or a relapse. The study pro-
tocol complies with the Declaration of Hel-
sinki for Human Rights and has the approval
of the La Paz general hospital’s Ethical and
Clinical Research Committee. Data were
anonymized before extracting sociodemo-
graphic and clinical information from
patient records.
Intervention
The Suicide Risk Attention Program
(ARSUIC, by its Spanish acronym) seeks to
ensure a prioritized and specialized care for
those individuals who have attempted suicide,
fostering potential contacts with mental
health workers during the more dangerous
first days after the attempt. It was imple-
mented across the Community of Madrid
during the last trimester of 2012. Previously,
priority specialized appointments could take
up to 19 days (Madrid’s Health Results
Observatory, 2017). The program considers
that every suicide attempter must have an
appointment with a general psychiatrist with
no specific suicide prevention training within
the first 7 days after hospital discharge.
Hence, it does not imply any specific contact
maintenance strategy or therapeutic interven-
tion other than scheduling a priority outpa-
tient visit in the next 7 days. The date and
time of the appointment are explained to the
patient and indicated in the hospital discharge
report by the ED psychiatrist or, if the patient
has been admitted to the hospital, by the
treating psychiatrist. Following the priority
appointment, the patient continues the usual
psychiatric care; no further follow-up con-
tacts are used, and no specific materials are
shared. No new staff has been hired to con-
duct the program; instead, every community
psychiatrist should devote a number of weekly
consultation hours to the program.
Variables and Outcomes
Information of prognostic interest was
selected according to prior existing knowl-
edge (Arias et al., 2016; Turecki & Brent,
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2015). By protocol, an individual semi-struc-
tured interview is performed prior to hospital
discharge and stored in computer databases
for clinical purposes. In addition, we reviewed
each subject’s historical medical records to
identify previous attempts and psychiatric
diagnoses. Clinical variables included the fol-
lowing: personal history of psychiatric disor-
der, previous suicide attempts, concurrent
alcohol or abuse drugs use, and hospital
admission after the attempt. Sociodemo-
graphics considered age (continuous vari-
able), and gender and family support after
discharge (dichotomous variables). Addi-
tional dichotomous variables regarding psy-
chiatric diagnoses in medical records were
included, according to the presence or
absence of ICD-10, chapter V, F10-69 diag-
nostic groups (mental and behavioral disor-
ders due to psychoactive substance use;
schizophrenia, schizotypal and delusional dis-
orders; mood disorders; neurotic, stress-
related and somatoform disorders; behavioral
syndromes associated with physiological dis-
turbances and physical factors; and disorders
of adult personality and behavior) (ICD,
1992).
We defined the outcome of interest as
being admitted to the emergency department
due to a new suicide attempt (any self-injur-
ious act committed with at least some intent
to die) during the follow-up after a previous
suicide attempt. If a recurrence happened
during follow-up time, it was considered a
relapse, and the time between attempts was
measured. Time to the event of inter-
est was obtained from hospital’s records.
Every attempt, and its follow-up time, was
considered.
Data Analyses
Suicide attempts were divided accord-
ing to whether they had happened in the
3 years prior to the program implementation,
the “control period” (2010–2012), or the
three-ones during the “intervention period”
(2013–2015). Initially, we compared baseline
clinical and sociodemographic correlates in
both periods, using Student’s t test for
differences in continuous variables and Pear-
son’s chi-square test for those in categorical
ones.
Then, we conducted a survival analysis.
We censored those subjects who had not
suffered the outcome of interest by the end
of each period’s follow-up. We obtained
Kaplan–Meier estimates of the survival func-
tion, both for the whole study time and by
periods. We tested the difference between
periods using log-rank test. In order to esti-
mate the intervention’s influence in the risk
of relapse, we conducted Cox proportional
hazard regressions, obtaining crude and
adjusted risk estimates (hazard ratio, HR). For
the multivariate models, we retained those
covariates remaining significant to the p < .10
level, utilizing a nonautomatic method for
their introduction, as well as those variables
considered to be clinically relevant according
to prior knowledge. Number of relapses dur-
ing the follow-up was included as a continuous
variable, in order to control its possible role as
a source of confounding. Then, we estimated
the number needed to treat (NNT) and its
95% CI from the multivariate model B, fol-
lowing widely accepted methods (Altman &
Andersen, 1999). The fulfillment of propor-
tional hazards assumption requirements was
ascertained both through graphicmethods and
using Schoenfeld’s test. Analyses were carried
on Stata v13 software for Mac (StataCorp,
2013. College Station, TX, USA).
RESULTS
Clinical and Demographic Characteristics
We included data from 2,347 suicide
attempts treated at the ED by a psychiatrist,
between January 1, 2010, and December 31,
2015. “Control period” comprised 1,176
attempts, while “intervention period”
included 1,171. Globally, 1,775 subjects
attempted suicide. Figure 1 illustrates the
attempt–reattempt distribution across the
study subjects. Thirty-nine subjects were
excluded due to computer-related data mis-
takes. The two major repeaters suffered 14
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suicide attempts during the time of study.
Table 1 shows baseline characteristics of the
included cases, both for the whole study per-
iod and by treatment groups. In most cases,
the subject was female (68.3%) and the mean
age in years was 40.5. As for the most relevant
risk factors, 73.9% had a personal history of
at least one psychiatric disorder, 40.3% had a
substance abuse disorder, and 48.4% had pre-
viously attempted suicide at least once. Most
frequent psychiatric diagnoses were as fol-
lows: “Mental and behavioral disorders due
to psychoactive substance use” (37.5%),
“Neurotic, stress-related and somatoform
disorders” (37.5%) and “Mood (affective) dis-
orders” (39.4%). Comparing both groups
showed that control period had a lower preva-
lence of family support (62.3% vs. 74.5%), a
lower presence of concurrent alcohol/drug
abuse (39.1% vs. 41.4%), and a higher per-
centage of inpatient admission after the sui-
cide attempt (24.5% vs. 20.5%).
Follow-up and Relapse
A total 497 (21.2%) cases relapsed dur-
ing follow-up. The intervention group had a
lower incidence of relapse during follow-up
(18.3% vs. 24.1%; p < .01). Curves obtained
from Kaplan–Meier survival probability and
multivariate-adjusted survivor functions are
shown in Figure 2. Median follow-up was
434 days for the whole study, 394 for the con-
trol group, and 468 for the intervention
group. Differences between control and
intervention group’s survival probability esti-
mates are statistically significant (log-rank
test p < .01). Table 2 displays results from
the adjusted and unadjusted Cox proportional
hazard models. Univariate models showed an
association between a higher risk of relapse
and the following risk factors: personal his-
tory of psychiatric disorders, personal history
of suicide attempts, and concurrent alcohol or
drug abuse. The presence of social support
was a protective factor. For the multivariate
models, we retained those variables that were
significant at the p < .05 level (multivariate
model A), as well as those variables consid-
ered clinically relevant (multivariate model
B). Results show that attempts followed by a
scheduled priority appointment had a lower
risk of relapse, with little difference between
estimates from the unadjusted model, HR
(95% CI) = 0.72(0.60–0.82), and the multi-
variate models, A, HR (95% CI) = 0.76
(0.62–0.93), and B, HR (95% CI) = 0.69
(0.54–0.87). The proportional hazards
assumption was fulfilled (Schoenfeld’s residu-
als test p = .30; p = .15 and p = .14 for the
univariate and multivariate models A and B,
respectively). The NNT (95% CI) estimate
obtained from the multivariate model B was
7.7 (4.5–20.0).
DISCUSSION
In this observational study, scheduling
a priority outpatient psychiatry appointment
lowered the risk of relapse among suicide
attempters by up to 25% over a three-year


























Figure 1. Distribution of repeated suicide attempts
among subjects across study periods.
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the effectiveness of the ARSUIC Suicide Risk
Attention Program, a contact enhancement
intervention, currently in use throughout the
Community of Madrid, Spain. Because we
stuck to a strictly naturalistic design and
included data from the real clinical practice,
recruiting all suicide attempt patients treated
at the ED level with no exclusion criteria, the
results likely capture the implemented pro-
gram’s true effectiveness. The effect estimates
are consistent with those of other interven-
tions aimed at contact maintenance (Zalsman
et al., 2016), including studies conducted in
other European countries (Cebria et al.,
2013; Reijas, Ferrer, Gonzalez, & Iglesias,
2013), the United States (Miller et al., 2017),
and several low- and middle-income coun-
tries (LMIC) (Riblet, Shiner, Young-Xu, &
Watts, 2017). In keeping with the literature,
risk factors for reattempts included a personal
history of previous suicide attempts, the pres-
ence of a diagnosed psychiatric disorder,
female gender, and concurrent alcohol or
drug abuse, while family support was a pro-
tective factor.
Emergencies because of attempted sui-
cide have steadily increased throughout the
last decades worldwide (Ting, Sullivan, Bou-
dreaux, Miller, & Camargo, 2012; Zalsman
et al., 2016), and their frequency typically
peaks among the younger age groups (Can-
ner, Giuliano, Selvarajah, Hammond, & Sch-
neider, 2015). Our results contribute with
relevant information regarding the effective-
ness of ED-initiated outpatient preventive
programs directed toward attempters, consid-
ered exceptionally high-risk individuals.
Given that discharge after a suicide attempt
entails a remarkably high risk of relapse, a
majority of prevention strategies have focused
TABLE 1
Baseline Clinical and Sociodemographic Covariates of the 2,347 Episodes attempted by the 1,775 Study




Total study subjects N (%) 1,775 875 (49.3) 900 (50.7)
Total suicide attempts N (%) 2,347 1,176 (50.1) 1,171 (49.9)
Age in years Mean (SD) 40.5 (16.7) 40.2 (16.3) 40.8 (17.0) 0.36
Female N (%) 1,602 (68.3) 814 (69.2) 788 (67.3) 0.32
Personal history of a
psychiatric disorder
N (%) 1,735 (73.9) 883 (75.1) 852 (72.7) 0.00
ICD-10 F10-19 N (%) 880 (37.5) 412 (35.5) 468 (40.0)
ICD-10 F20-29 N (%) 162 (6.9) 98 (8.3) 64 (5.4)
ICD-10 F30-39 N (%) 925 (39.4) 441 (37.5) 484 (41.0)
ICD-10 F40-49 N (%) 880 (37.5) 416 (35.4) 464 (39.6)
ICD-10 F50-59 N (%) 145 (6.2) 65 (5.5) 80 (6.8)
ICD-10 F60-69 N (%) 401 (17.1) 194 (16.5) 207 (17.7)
Personal history of suicide attempts N (%) 1137 (48.4) 571 (48.6) 566 (48.3) 0.07
Concurrent alcohol/drug abuse N (%) 945 (40.3) 460 (39.1) 485 (41.4) 0.00
Family support N (%) 1,604 (68.3) 732 (62.3) 872 (74.5) 0.00
Admitted after ED discharge N (%) 528 (22.5) 288 (24.5) 240 (20.5) 0.00
p-Values are obtained from Student’s t test for the quantitative covariates and Pearson’s chi-square
test for the qualitative ones.
ED, emergency department; ICD-10, International Classification of Diseases 10th Revision; F10-
19, mental and behavioral disorders due to psychoactive substance use; F20-29, schizophrenia, schizotypal
and delusional disorders; F30-39, mood (affective) disorders; F40-48, neurotic, stress-related and somato-
form disorders; F50-59, behavioral syndromes associated with physiological disturbances and physical fac-
tors; F60-69, disorders of adult personality and behavior.




Figure 2. Kaplan–Meier survival function estimates. (A) Shows the graphic representation of time to relapse estimate
including every suicide attempt recorded between 2010 and 2015. (B) Shows the graphic representation of time to relapse
estimates divided by treatment period. (C) Adjusted survivor functions, following multivariate model (A). Differences
shown are significant with a log-rank test’s p < 0.001.
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in this period (Meerwijk et al., 2016; Milner,
Carter, Pirkis, Robinson, & Spittal, 2015).
Contact-enhancing programs, specifically
directed at establishing brief contacts and
maximizing access to clinical and social
resources, are considered effective: Accord-
ingly, a range of evidence-based contact
maintenance programs including the use of
letters, telephone calls,messages, or caseman-
agement have been successfully developed,
deployed, and scaled-up (Berrouiguet et al.,
2014; Dekker, Vergouwen, Buster, & Honig,
2017; Vaiva et al., 2011). Recently, theWHO
Brief Intervention and Contact (WHO BIC),
a strategy searching to enhance contact after a
suicide attempt, was the only intervention to
significantly lower the risk of suicide in a
recent meta-analysis of randomized control
trials (RCT) including other therapeutic and
pharmacologic strategies and a variety of dif-
ferent locales (Riblet et al., 2017). In the ED-
Safe study, an RCT conducted in North
American subjects, a brief ED-based inter-
vention, consisting on postdischarge
resources and telephone calls, significantly
decreased reattempts, with an incidence rate
ratio (95% CI) of 0.72 (0.52–1.00) (Miller
et al., 2017). However, studying suicide
behaviors using experimental designs can be
technically and ethically challenging, and a
call has been made to conduct effectiveness
and implementation studies on naturalistic
settings, in order to obtain externally valid
real-world data that can inform decision-
makers (Sherman et al., 2016). Along
these lines, an observational study conducted
among suicidal ED patients from Veterans
Health Administration hospitals found that a
brief structured intervention, including an
outpatient appointment and telephone calls,
increased engagement and reduced suicidal
behaviors after discharge (Stanley et al.,
2018). Building on the tradition of suicide
prevention among high-risk individuals, our
study contributes with data from the clinical
practice suggesting that contact maintenance,
by scheduling a single priority appointment
before discharging suicide attempters from
the ED, can lower the risk of suicide attempt
relapse.
TABLE 2
Risk of relapse during the follow-up, derived from a Cox proportional hazard model including time to




N (%) (95%CI) Model A Model B
Control period (REF) 283 (24.1) 1 1 1
Intervention period 214 (18.3) 0.72 (0.60–0.82) 0.76 (0.62–0.93) 0.69 (0.54–0.87)
Female 609 (38.0) 1.17 (0.96–1.42) 1.30 (1.03–1.68) 1.30 (1.02–1.65)
Personal history of
psychiatric disorder
757 (43.6) 3.21 (2.30–4.47) 1.99 (1.33–2.99) 2.03 (1.30–3.18)
Personal history of
suicide attempts
627 (55.2) 2.71 (2.20–3.34) 2.29 (1.77–2.96) 2.32 (1.75–3.06)
Concurrent
alcohol/drug abuse
468 (49.5) 1.77 (1.46–2.15) 1.55 (1.25–1.90) 1.58 (1.26–1.98)
Family support 640 (39.9) 0.64 (0.49–0.83) 0.74 (0.56–0.99) 0.66 (0.49–0.89)
Number of relapses – 1.39 (1.36–1.42) 1.35 (1.31–1.39) 1.33 (1.29–1.37)
Admitted after
ED discharge
248 (47.0) 1.14 (0.93–1.40) – 1.20 (0.94–1.53)
Age in years – 1.00 (0.99–1.00) – 0.99 (0.99–1.00)
Control period is the reference. Multivariate model A retained those covariates associated with the
p ≤ 0.05 significant level. Model B included additional covariates, relevant according to the proposed cau-
sal frame.
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Suicide, a global public health con-
cern, is the second cause of death among
the Spanish youth (INE, 2017). In the Uni-
ted States, it is the only one, among the 10
leading causes of death, with an increasing
rate over the last decade (Swanson, Bonnie,
& Appelbaum, 2015). Suicide attempts are
considered the most accurate markers for
completed suicide: Attempters from a mul-
ticenter controlled study in England had a
43 times higher risk of suicide (Hawton
et al., 2015). However, suicide attempts
demand further attention beyond their pre-
dicting role. Not only they are an opportu-
nity for prevention but also a frequent
clinical entity by themselves (for example,
around 10% of Spanish citizens have
attempted suicide at least once) (Gabilondo
et al., 2007), with an important associated
burden of economic and emotional costs
and a tendency to relapse. In fact, the pres-
ence of previous suicide attempts stood out
as the major risk factor, with a HR of 2.32
in our adjusted models. In our study, more
than 1 out of 5 attempts subsequently
relapsed, and most reattempts took place
during the first months of follow-up. This
figure is consistent with that of a prospec-
tive study conducted in 150 Spanish sub-
jects after hospital discharge (Tejedor,
Dıaz, Castillon, & Pericay, 1999), while a
Danish cohort including 3,690 attempts
exhibited an even higher risk, around 28%
(Christiansen & Jensen, 2007).
As an addition, our study offers
updated information on several clinical and
sociodemographical risk factors for suicide
and suicide attempts. As previously published
in studies from a variety of international loca-
tions, female gender, previously diagnosed
psychiatric disorders, and drug or alcohol
abuse carried higher risk (Beghi, Rosenbaum,
Cerri, & Cornaggia, 2013; Christiansen &
Jensen, 2007; Holmstrand et al., 2015). A
recent cohort study, conducted in Barcelona,
Spain, found an increased risk in younger
groups (Parra-Uribe et al., 2017), a finding
that was absent in our study. However, differ-
ences could be explained because we consid-
ered age in years a continuous variable,
whereas the aforementioned study used age
groups, established >60-year-old as the refer-
ence group and found an almost constant risk
increase across the rest of age groups.
Our main strength is an easy-to-
implement, well-defined intervention—an
outpatient appointment with a psychiatrist
within 7 days after the ED discharge. In the
studied catchment area, ordinary consulta-
tions with specialists usually have waiting
times over 19 days (Madrid’s Health Results
Observatory, 2017). We have found that
median time to the first consultation after a
hospital discharge, after a suicide attempt,
decreased to 7 days after ARSUIC program
was implemented, over 50% of the subjects
were seen in the desired time window, and
compliance with the program is above 88%
(E. Jimenez, G. Martınez-Ales, E. Roman,
M. P. Sanchez, B. De Dios C, Rodrıguez-
Vega et al., Under Review). Previous
authors have emphasized the necessity to
focus on suicide prevention at the ED, where
most of the highest risk patients seek help,
including those with a low adherence to con-
ventional outpatient treatment (Larkin &
Beautrais, 2010). In order to evaluate the
program from a pragmatic point of view, we
did not exclude any of the 2,347 suicide
attempts treated during the study period,
regardless of clinical profiles or inpatient
admissions. As a consequence, our real-
world results, obtained from a naturalistic
setting, may provide critical evidence for
decision makers. The effect estimates
remained almost unchanged across the dif-
ferent univariate and multivariate models,
suggesting an elevated robustness. The stud-
ied location, a catchment area with universal
health coverage, combines different city dis-
tricts and rural areas, including a wide range
of ages, nationalities, and socioeconomical
contexts (Hortas & Onrubia, 2017). In addi-
tion to the mentioned coincidence with pre-
vious results from other places and health
systems, the heterogeneity of patient profiles
and social contexts included provides
grounds for our results to be considered
widely generalizable, especially to settings
with universal medical coverage.
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Our study includes several limita-
tions. First, we lack information regarding
completed suicide among the study partici-
pants. As we have mentioned, suicide
attempt and death by suicide are closely
associated (Olfson, Wall, et al., 2017). Sui-
cide is a less frequent phenomenon, and
using reattempt as the main outcome
allowed us to detect differences between
groups. Nevertheless, certain authors have
found differences between the profiles of
suicide attempters and achievers (Parra-
Uribe et al., 2013). Hence, further research
should be conducted to ascertain to which
level this program also reduces suicide risk.
Secondly, it is possible that certain subjects
relapsed and were evaluated at a different
hospital during follow-up. However, we
consider this possibility unlikely: As previ-
ously published, in our setting, treated sui-
cide attempts are systematically referred to
the catchment area’s general hospital ED
(Parra-Uribe et al., 2017). In addition,
Madrid has high residential stability: For
example, during 2017, only 2.88% of the
studied area’s population moved to a differ-
ent catchment area (Ayuntamiento de
Madrid). Besides, even though our reduced
sensitivity to deaths and relapses evaluated
elsewhere could lead to an underestimation
of the incidence of relapse, this limitation
would equally affect both treatment phases
and thus not imply systematic error at the
comparison level. Finally, the observational
nature of our study makes it vulnerable to
unascertained sources of bias. In particular,
because we used a historical control group,
we cannot rule out a potential sentinel or
historical artifact. Notwithstanding, we con-
sider this possibility unlikely because there
is no evidence of a contemporary decrease in
suicidal behaviors either in Madrid or else-
where in Spain. On the contrary, data from
outpatient and inpatient facilities suggest a
general increase in such behaviors, in line
with what has been observed in several sam-
ples from the United States (Olfson, Blanco,
et al., 2017; Wester, Trepal, & King, 2017).
A study conducted in Andalusia, Spain,
analyzed data on suicide attempts using tele-
phone call records from the public emer-
gency health care system: They found that
the number and rate of attempts increased
annually between 2010 and 2013, the last
year of study (Mejıas-Martın et al., 2017).
Furthermore, data from nationwide elec-
tronic registries indicate that the number of
hospital discharges including any form of
suicide attempt as a diagnosis also increased
annually, both in Madrid (1.747 registries in
2010 and 2,418 in 2015) and in Spain
(11,476 registries in 2010 and 15.857 in
2015) (Ministerio de Sanidad, Consumo y
Bienestar Social, 2018).
Further studies should include evalua-
tions considering a longer follow-up, as previ-
ous research has called into question the
long-term effectiveness of brief contact pro-
grams (Cebria et al., 2015). Head-to-head
comparisons with more complex interven-
tions implemented in other catchment areas
of the same location will help clarify the
differential suicide risk reduction potential
of their respective components (Lopez-
Castroman, Blasco-Fontecilla, Courtet,
Baca-Garcıa, & Oquendo, 2015). Implemen-
tation studies in different locations, especially
from LMIC, will define our findings’ implica-
tions for Global Mental Health. As Lopez-
Castroman, Mendez-Bustos, et al., 2015 have
pointed out, most of completed suicides take
place in LMIC, while most suicide prevention
research is conducted elsewhere. In addition,
comparison studies across countries can yield
findings concerning supra-individual deter-
minants of interest (Susser & Martınez-Ales,
2018). For example, recent ecological studies
suggest that the late 2000s financial recession
had an increased impact on suicides in Spain
(Fernandez-Navarro et al., 2016) and that the
substantial variation in national suicide rates
can be partially explained by ecological vari-
ables (Schomerus et al., 2015). Suicide is, by
definition, a “complex problem” that requires
a careful assessment of the interactions
between risk factors and multi-level preven-
tive interventions (Hawton & Pirkis, 2017;
Hegerl &Kohl, 2016).
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ABSTRACT
Objective: To determine the comparative effectiveness of 3 real-
practice preventive programs aimed at lowering the relapse risk 
following a suicide attempt: a single priority appointment with 
an outpatient psychiatrist, an enhanced contact intervention, 
and an individual psychotherapy program.
Methods: This observational study was conducted in a sample 
of 1,492 suicide attempters from 3 catchment areas in Madrid, 
Spain, between 2013 and 2017. Relapse was defined as an 
emergency department return after a new attempt within a 
1-year follow-up. Kaplan-Meier survival functions were obtained 
by intervention, and Cox proportional hazard regression models 
were used to estimate unadjusted and adjusted risks of relapse 
by intervention. Sex- and age-stratified analyses were also 
conducted. Covariates were age, sex, history of suicide attempts, 
history of psychiatric disorders, main ICD-10 psychiatric 
diagnostic groups, medical comorbidities, and family support.
Results: A total of 133 subjects (8.9%) relapsed. The 
psychotherapy group had a lower presence of known risk 
factors for suicide attempt. Individual psychotherapy and 
enhanced contact were more effective than a single priority 
appointment at reducing suicide reattempt, with a 40% lower 
relapse risk in adjusted models. Results did not differ after sex 
and age stratification.
Conclusions: In a naturalistic clinical setting, patients exposed to 
individual psychotherapy or an enhanced contact intervention 
had a similar, lower relapse risk than the single priority 
appointment group.
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Suicide, a global public health concern,1 is the second leading cause of death among youth worldwide.2 
Attempted suicide, a much more frequent phenomenon 
with a rising incidence,3 is considered the most faithful risk 
marker of future suicide, with an associated 25-fold risk 
increase compared to the general population.4 Furthermore, 
self-inflicted harm itself entails relevant clinical and economic 
costs5 and represents 1.5% of all loss of disability-adjusted 
life-years according to Global Burden of Disease 2000.6 An 
attempted suicide entails a 5-year follow-up risk of relapse 
up to 35%, with most reattempts taking place during the first 
month after discharge.7,8
Prevention of suicidal behaviors can be exercised at 
several levels of intervention.9 A number of population-
level strategies, such as structurally limiting the access to 
suicide-by-jumping hotspots10 or legally restricting the 
size of acetaminophen packs,11 can reduce the incidence of 
suicide attempts. At the individual level, enhancing contact 
between high-risk subjects and mental health providers 
can reduce attempted and completed suicide.12–14 As 
noted, discharge after an attempted suicide offers a critical 
opportunity for indicated tertiary prevention. Accordingly, 
postdischarge contact maintenance programs lower relapse 
risk.15–19 Manualized psychotherapies, including problem-
solving,20 cognitive-behavioral,21 dialectical behavior,22,23 
or psychodynamic therapy,24 are also seemingly effective. 
However, psychotherapy for suicidal behaviors has been 
called into question when compared to more feasible 
programs aimed at simply favoring continuation of care 
after discharge.25 In a recent meta-analysis of randomized 
controlled trials (RCTs), the World Health Organization 
(WHO) Brief Intervention and Contact (BIC), a program of 
9 follow-up contacts, significantly lowered the odds of suicide 
after an attempt by 80%, whereas cognitive-behavioral therapy 
(CBT) was not significantly protective.26 Thus, although 
contact-enhancing and psychotherapeutic approaches seem 
promising, the adequate components and recommended 
length of interventions for recurring suicide attempt risk 
remain unclear. Most evidence concerning suicide prevention 
strategies comes from either non-experimental epidemiologic 
designs or RCTs. In clinical research, however, there is a 
growing call for comparative effectiveness studies including 
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This study compares 3 different interventions for suicide 
reattempt prevention in real-world settings. Compared 
programs following a suicide attempt include a single priority 
medical appointment within 7 days after discharge, a series 
of repeated in-person and telephone follow-up contacts, and 
an individual problem-solving psychotherapy intervention.
METHODS
Study Settings
In Spain, a National Health Service (NHS) funded by taxes 
provides universal access to medical care. The Community 
of Madrid’s Health Council coordinates 25 health care 
catchment areas. Each area features a general hospital and 
includes a psychiatry department offering a range of inpatient 
and outpatient care resources to which general practitioners 
and other specialists refer patients with psychiatric needs.
Although enhancing the general population’s access to 
proper longitudinal, articulated psychiatric care decreases 
suicidal behaviors, directly addressing suicide offers an 
additional protective effect.28 Madrid’s Mental Health Strategy 
2010–2014 deployed the Suicide Risk Attention Program 
(ARSUIC, by its Spanish acronym) as an addition to its 
community-based mental health care service. This program 
prioritizes psychiatric attention to suicide attempters. Every 
hospital in Madrid adopted this program in 2012. Its basic 
measure, a scheduled meeting with an outpatient psychiatrist 
within the first 7 days after every suicide attempt, lowered 
the risk of reattempt by 25%.29 Some hospitals have added 
complementary features to their particular suicide prevention 
programs. In general terms, the additional measures seek 
to either foster further contact maintenance with mental 
health practitioners via programmed telephone calls during 
the follow-up or provide patients with specific individual or 
group psychotherapy. In this study, we examine 3 different 
prevention strategies corresponding to 3 general hospitals 
covering 3 catchment areas located in the south, north, and 
west of Madrid, respectively.
Study Design and Subjects
We conducted an observational study. We included all 
suicide attempters who, after discharge, had entered each 
center’s suicide prevention program between January 1, 
2013, and December 31, 2016, and followed them for 1 
year. We considered a suicide attempt any self-injurious act 
committed with at least some intent to die as a result of the 
act. Thus, we excluded individuals with suicidal ideation but 
without suicidal behavior. The study protocol complies with 
the Declaration of Helsinki for Human Rights. Approval was 
obtained from the corresponding ethics committees in each 
catchment area. Data from patient records were anonymized 
before extraction of sociodemographic and clinical details.
Interventions
Participants from the northern catchment area received 
the strict ARSUIC intervention, a scheduled appointment 
with an ordinary psychiatrist at the corresponding 
Community Mental Healthcare Center (CMHC) within 
the first 7 days after hospital discharge. Thereafter, this 
intervention did not include further add-ons, nor did it 
have exclusion or inclusion criteria for participants, other 
than having been treated at the General Hospital due to an 
attempted suicide. As this program is widely implemented in 
Madrid, we considered it treatment as usual (TAU).
Participants from the southern catchment area received 
a modified ARSUIC intervention, adding individual 
psychotherapy. Inclusion criteria were to have attempted 
suicide, to be aged 18 years or older and not to have a 
concurrent ongoing therapeutic treatment at an outpatient 
clinic. The psychotherapy was administered at the general 
hospital. It included 2 months of weekly 30-minute individual, 
non–suicide-specific therapy sessions focused on problem-
solving, stress reduction, and cognitive reformulation. 
Therapy sessions were conducted by trained clinical 
psychologists, under a general psychiatrist’s supervision. 
Then, the patient was referred to a general practitioner or a 
CMHC. In case the participant failed to attend the sessions, 
reminder telephone calls were made from the hospital.
Participants from the western catchment area received an 
enhanced contact maintenance intervention framed within 
the greater “Código 100” (Code 100) Suicide Prevention 
Program, a strategy delivered in collaboration with Madrid’s 
out-of-hospital emergency service to guarantee an appropriate 
continuity of care.30 Inclusion criteria to Código 100 were to 
have attempted suicide, to be 18 years of age or older, and 
to sign an informed consent form. The intervention started 
with an appointment 3 days after discharge, followed by 
6–12 months of an intensified frequency of outpatient visits 
depending upon the patient’s severity and his or her personal 
preference, with a specifically devoted psychiatrist trained 
in suicide prevention. In addition, every patient received 
telephone calls from the hospital at follow-up months 1, 
6, and 12. The content of these calls was explanatory and 
supportive, seeking to reassure patients, clarify their doubts 
regarding treatment, enhance their adherence to follow-up 
visits, and remind them of the available emergency treatment 
options in case of a new crisis. The intervention did not 
include a specific psychotherapeutic approach. Then, the 
patient continued usual treatment at a CMHC.
Measures
Our primary outcome was relapse after a suicide attempt, 
which we defined as being treated again at the reference 
hospital due to another suicide attempt after hospital 
Clinical Points
 ■ Brief contact maintenance lowers the risk of relapse after 
a suicide attempt, but whether longer interventions, 
including telephone calls or psychotherapy, yield 
additional protective effects has heretofore been unclear.
 ■ After a suicide attempt, prolonging contact maintenance 
and enhancing it with telephone calls or psychotherapy 
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Effectiveness of 3 Suicide Prevention Programs
Table 1. Baseline Clinical and Sociodemographic Covariates of the 1,492 Study Subjects, Overall and by Intervention
Variable Overall TAU Psychotherapy
Enhanced 
Contact χ2/F Pa
Total suicide attempters, n 1,492 788 (52.8% 
of overall)




Age, mean (SD), y 40.9 (17.1) 41.0 (18.0) 40.3 (16.6) 42.6 (14.5) 1.25 .29
Female 1,040 (69.7) 540 (68.5) 360 (68.8) 140 (77.4) 5.77 .06
Personal history of a psychiatric disorder 976 (65.4) 554 (70.3) 255 (48.8) 166 (91.7) 0.00 .000
Main diagnosis at discharge
No diagnosis 190 (12.7) 110 (14.0) 74 (14.2) 6 (3.3) 404.41 .000
Organic, including symptomatic, mental disordersb 11 (0.7) 6 (0.8) 5 (0.9) 0 (0.0)
Mental and behavioral disorders due to psychoactive substance usec 172 (11.5) 94 (11.9) 68 (13.0) 10 (5.5)
Schizophrenia, schizotypal, and delusional disordersd 28 (1.9) 15 (1.9) 12 (2.3) 1 (0.6)
Mood (affective) disorderse 406 (27.2) 304 (38.6) 66 (12.6) 36 (19.9)
Neurotic, stress-related, and somatoform disordersf 429 (28.8) 150 (19.0) 208 (39.8) 71 (39.2)
Behavioral syndromes associated with physiologic disturbances and 
physical factorsg
37 (2.5) 14 (1.8) 22 (4.2) 1 (0.6)
Disorders of adult personality and behaviorh 219 (14.7) 95 (12.1) 68 (13.0) 56 (30.9)
Personal history of suicide attempts 583 (39.1) 272 (34.5) 145 (27.7) 85 (47.0) 246.21 .00
Concurrent alcohol or drug abuse 446 (29.9) 281 (35.7) 80 (15.3) 85 (47.0) 91.19 .00
Cohabiting 1,250 (83.7) 639 (81.1) 458 (87.4) 153 (84.5) 9.30 .01
Immigrant 483 (32.4) 132 (16.8) 200 (38.2) 151 (83.4) 322.47 .00
Comorbid medical conditions 551 (36.9) 481 (61.0) 39 (7.4) 31 (17.1) 422.87 .00
aP values are obtained from Pearson χ2 test or Fisher exact test for qualitative covariates and Wilcoxon signed-rank test for quantitative covariates.
bICD-10 F00–F09.   cICD-10 F10–F19.   dICD-10 F20–F29.   eICD-10 F30–F39.   fICD-10 F40–F48.   gICD-10 F50–F59.   hICD-10 F60–F69.
Abbreviation: TAU = treatment as usual.
discharge and during a 1-year follow-up. Time to relapse 
was obtained from the hospital’s records. For subjects 
experiencing multiple relapses, we retained only the first 
one after entrance into the study.
Data on clinical and sociodemographic variables of 
prognostic interest were obtained from predischarge 
semistructured interviews, regularly performed by 
psychiatrists and stored in computer databases for clinical 
purposes. We selected the following sociodemographic 
variables: age (continuous variable), sex, immigrant status, 
and cohabitation status (binary variables). Clinical variables 
recorded as dichotomous included personal history of a 
diagnosed psychiatric disorder, personal history of suicide 
attempts, concurrent alcohol or drug consumption at the 
moment of the attempt, presence of comorbid medical 
conditions, and main diagnosis at discharge, encoded 
according to ICD-10, chapter V, F10–F69 diagnostic groups 
(mental and behavioral disorders due to psychoactive 
substance use; schizophrenia, schizotypal and delusional 
disorders; mood disorders; neurotic, stress-related, and 
somatoform disorders; behavioral syndromes associated 
with physiologic disturbances and physical factors; and 
disorders of adult personality and behavior).31
Data Analyses
Continuous variables were reported as mean 
(standard deviation) and categorical variables as 
proportions. To analyze baseline differences in clinical 
and sociodemographic variables between the intervention 
groups, we used Wilcoxon signed-rank, Pearson χ2, and 
Fisher exact tests.
We then conducted a survival analysis. Subjects who had 
not relapsed within 1 year of follow-up were censored. We 
obtained Kaplan-Meier estimates of the survival function 
by treatment group. We tested the difference using log rank 
tests. To control for potential confounders, we conducted 
Cox proportional hazards regressions and obtained crude 
and adjusted risk estimates (hazard ratios [HRs]) for the 
different groups. For the multivariate model, we retained 
those covariates remaining significant to the P < .10 level, 
utilizing a non-automatic method for their introduction, as 
well as those variables considered to be clinically relevant 
according to prior knowledge. We followed widely accepted 
schemes for the adjustments.32 Proportional hazards 
assumption fulfillment was ascertained both through 
graphic methods and using the Schoenfeld test. Finally, we 
obtained number needed to treat (NNT) estimates for both 
interventions compared to TAU using an accepted method 
for studies in which the outcome of interest is the time to 
an event.33
Sex and age-group differences exist in suicide and 
self-harm rates, and recent research shows that the young 
women stratum is becoming increasingly more affected.34,35 
Accordingly, we conducted sex- and age group–stratified 
Cox proportional hazards regressions seeking for differences 
between programs across subgroups. We defined 3 different 
subgroups: female and ≤ 35 years old, female and > 35 years 
old, and male. To keep reasonable statistical power for 
comparisons, we did not differentiate age groups within 
males. Analyses were carried on Stata v13 software.36
RESULTS
Clinical and Demographic Characteristics
We included data from 1,492 patients who had attempted 
suicide and subsequently entered the suicide prevention 
program at 1 of the 3 hospitals between January 1, 2013, 
and December 31, 2016. Table 1 summarizes baseline 
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aAdjusted by sex, concurrent alcohol or drug abuse, personal history of suicide attempts, presence of a mood disorder diagnosis, and presence of a 
personality disorder diagnosis
*P < .05 (log rank test) vs TAU.
**P < .01 (log rank test) vs TAU.
Abbreviation: TAU = treatment as usual.
Figure 1. Kaplan-Meier Survival Function Estimates by Intervention
A. Unadjusted B. After Adjustmenta
Intervention Group Baseline Differences
Baseline covariates showed comparable intergroup 
age distribution and a higher percentage of females in the 
enhanced contact group, along with several differences 
regarding clinical and social covariables. Subjects receiving 
TAU (the majority of the study participants) had proportions 
of psychiatric history (70.3%), previous suicide attempts 
(34.5%), and concurrent alcohol or drug abuse (35.7%) that 
fall roughly halfway between that of the other two treatment 
groups, suggesting that this cohort had an intermediate level 
of clinical severity. As for social correlates, subjects receiving 
TAU had the lowest levels of both immigration and household 
cohabitation. The sample receiving psychotherapy, formed 
by one-third of the subjects, had the lowest prevalence of 
the aforementioned clinical covariables, intermediate levels 
of immigration, and relatively high levels of cohabitation. 
Participants receiving enhanced contact, the smallest group, 
had the highest prevalence of previous psychiatric conditions, 
immigration, and previous suicide attempts and drug or 
alcohol abuse. Regarding main diagnoses at discharge, the 
psychotherapy and enhanced contact groups had similar 
rates of neurotic, stress-related, and somatoform disorders, 
and the latter also showed a high presence of disorders of 
adult personality and behavior, while TAU participants were 
more frequently diagnosed as having mood disorders. These 
findings, suggesting the psychotherapy group included a less 
severely ill sample, make sense as this intervention included 
only subjects who did not have an ongoing outpatient 
therapeutic treatment.
Follow-Up and Relapse
A total of 133 subjects (8.9%) experienced a relapse 
during follow-up. TAU had twice the crude incidence of the 
psychotherapy group, while the enhanced contact group had 
an intermediate figure. Mean (95% CI) days of follow-up 
were TAU: 335.8 (329.7–341.9), enhanced contact: 347.4 
(337.2–357.6), and psychotherapy: 349.6 (343.8–355.3) for 
global: 342.0 (338.0–346.1).
Curves obtained from Kaplan-Meier survival probability 
function estimates per intervention group and multivariate 
adjusted survivor functions are presented in Figure 1. 
Differences between TAU and both psychotherapy and 
enhanced contact groups in Kaplan-Meier estimates are 
statistically significant (log rank test P = .001).
Table 2 displays results arising from Cox proportional 
hazards models, including unadjusted and adjusted 
estimates. Univariate regressions showed an association 
between a higher risk of relapse and several measured risk 
factors: a personal history of suicide attempts, concurrent 
alcohol or drug abuse, and a comorbid condition. Among 
psychiatric conditions diagnosed, mood and personality 
disorders stood out as risk factors, and adjustment and 
stress disorders behaved as protective factors. Immigration 
also showed a protective effect. On the other hand, female 
sex did not achieve statistical significance and neither 
did cohabitation or age in years. We fitted a subsequent 
multivariate regression by following a non-automatic method 
and delivered an adjusted model. We controlled for age, sex, 
previous suicide attempts, alcohol or drug abuse, and mood 
(affective) and personality disorders. The fulfillment of the 
proportional hazards assumption was checked: Schoenfeld 
residuals test P values of .26 and .13 were found for the 
univariate and multivariate models, respectively. Using the 
adjusted regression, we estimated the NNT (95% CI) for each 
intervention compared to TAU, resulting in 6.7 (3.3–100.0) 
for psychotherapy and 5.3 (2.6–1,000.0) for enhanced 
contact. An alternative multivariate model including the 
more general personal history of a psychiatric disorder 
instead of specific diagnoses resulted in similar estimates 
and served as a sensitivity analysis (Supplementary Table 1).
We obtained age- and sex-stratified multivariate estimates 
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Table 3. Risk of Relapse During the Follow-Up by Patient Sex and Age Groupsa
Variable
Male  
(n = 452, 30.3%  
of Overall)
Female ≤ 35 y  
(n = 452, 30.3% 
of Overall)
Female > 35 y  
(n = 588, 39.4%  
of Overall)
Intervention
TAU 1 1 1
Psychotherapy 0.62 (0.37–1.04) 0.57 (0.27–1.20) 0.65 (0.32–1.34)
Enhanced contact 0.57 (0.31–1.08) 0.66 (0.22–1.96) 0.54 (0.25–1-19)
Mood (affective) disordersb 1.54 (0.96–2.32) 1.61 (0.75–3.43) 1.54 (0.83–2.85)
Disorders of adult personality and 
behaviorc
2.09 (1.25–3.51) 1.91 (0.75–3.43) 2.29 (1.11–4.70)*
Personal history of suicide attempts 1.73 (1.16–2.59)** 1.48 (0.79–2.77) 1.93 (1.13–3.29)*
Concurrent alcohol or drug abuse 1.73 (0.98–2.32) 1.96 (0.45–2.02) 1.64 (1.14–3.35)*
aValues are shown as hazard ratio (95% CI). The multivariate model is derived from an age- and sex-
adjusted Cox proportional hazard multivariate model, with time to relapse as the outcome and 
treatment as usual (TAU) as the reference, and includes the same covariates as the multivariate 












TAU: n=90 (11.4) 1 1
Psychotherapy: n=29 (5.5) 0.47 (0.31–0.72)** 0.62 (0.40–0.97)*
Enhanced contact: n=14 (7.7) 0.66 (0.38–1.16) 0.56 (0.32–1-00)*
Age 0.99 (0.98–1.00) 0.99 (0.98–1.00)
Female 1.27 (0.86–1.87) 1.32 (0.88–1.98)
Immigrant 0.68 (0.46–1.00)* …
Cohabiting 1.10 (0.68–1.77) …
Personal history of a psychiatric disorder 1.86 (1.24–2.80)** …
Diagnosis at discharge
No diagnosis 0.67 (0.37–1.21) …
Mental and behavioral disorders due to psychoactive substance useb 1.38 (0.86–2.22) …
Mood (affective) disordersc 1.70 (1.20–2.42)** 1.60 (1.10–2.32)**
Neurotic, stress-related, and somatoform disordersd 0.35 (0.21–0.58)** …
Disorders of adult personality and behaviore 1.52 (1.00–2.32)* 1.82 (1.14–2.91)**
Personal history of suicide attempts 1.89 (1.34–2.65)** 1.63 (1.15–2.31)**
Concurrent alcohol or drug abuse 1.77 (1.35–2.67)** 1.64 (1.13–2.38)**
Comorbid medical condition 1.73 (1.23–2.43)** …
aHazard ratio (HR) values were derived from a Cox proportional hazards model that included time to relapse as the 
outcome and the clinical and sociodemographic covariates as predictors. Treatment as usual (TAU) is the reference. 
The multivariate model is age- and sex-adjusted and includes variables significant at the P ≤ .05 level following a 
non-automatic adjustment method.
bICD-10 F10–F19.   cICD-10 F30–F39.   dICD-10 F40–F48.   eICD-10 F60–F69.   
*P ≤ .05.   **P ≤ .01.
per stratum made the confidence intervals wider, the effect 
estimates of both interventions were not altered across 
sex groups or between younger and older females. Mood 
(affective) and personality disorders, previous suicide 
attempts, and concurrent alcohol or drug abuse also had 
comparable effect sizes with wider confidence intervals 
across groups.
DISCUSSION
In this observational study, 2 programs—a 2-month 
weekly problem-solving psychotherapy intervention 
followed by scheduled telephone calls (psychotherapy) and 
an early appointment followed by a 6- to 12-month schedule 
of in-person visits and telephone calls (enhanced contact)—
lowered the risk of relapse after an attempted suicide by 38% 
and 44% during a 1-year follow-up, respectively, compared 
to a single priority outpatient psychiatry appointment within 
7 days (TAU). The NNT estimates were 6.7 (psychotherapy) 
and 5.3 (enhanced contact). Building on the tradition of 
natural experiments including real-world clinical settings,27 
our study contributes to the identified need of head-to-
head comparative effectiveness studies between detailed 
suicide prevention programs to develop a means for a better 
understanding of the underlying mechanisms of different 
interventions.37
The period following discharge after a suicide attempt is 
a time of extremely high relapse risk.38 In this cohort, 8.9% 
of the subjects relapsed during a 12-month follow-up, a 
somewhat lower figure than reported during longer follow-
ups in comparable settings.39 This difference is probably 
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can reduce repetition of suicidal behaviors.37 Our control 
intervention, an early follow-up after self-harm, has shown 
effectiveness in reducing recurrence both in our setting27 
and in others.40 Also, we did not include subsequent relapses, 
hence excluding attempts conducted by heavy repeaters.
In keeping with the literature,16,41,42 our results suggest 
that repeated scheduled telephone calls lower postdischarge 
relapse risk. Some psychotherapeutic approaches have 
proved useful in lowering suicide risk among certain 
subtypes of patients.21–23 However, in our study, the group 
receiving individual problem-solving psychotherapy did 
not significantly differ from those only receiving intensive 
contact maintenance. This finding is unsurprising: RCTs 
and systematic reviews have found no benefits in adding 
psychotherapy to conventional treatments for unselected 
suicidal subjects.25,43,44
Our study has limitations we would be remiss not to report. 
To have enough power to detect differences between groups, 
we chose suicide reattempt as our outcome of interest and 
did not include information concerning death by suicide, an 
important but infrequent event. As we have mentioned, there 
is a close association between suicide attempt and death by 
suicide.4,45 For example, Finkelstein et al46 reported that 
first-time self-poisoning survivors had a completed suicide 
HR of 41.96 when compared to controls. Nonetheless, 
differences between suicide attempters and completers have 
been reported elsewhere.38,47 Thus, we can focus only on 
the programs’ protective role against attempted suicide. As 
this was a real-world study, we did not randomly assign the 
interventions. Instead, each center had different criteria 
for inclusion. As a matter of fact, baseline characteristics 
showed differences across groups. Accordingly, we fitted 2 
different multivariate models and obtained similar estimates 
across models, suggesting robust results. Nevertheless, we 
cannot rule out residual confounding or selection bias due 
to unmeasured correlates such as lethality, suicide attempt 
method, or family history of suicide, and therefore the effect 
estimates should be carefully considered. A comparison 
with historical controls from each catchment area might 
provide useful additional effect estimates. Also, there is a 
possibility that certain relapses were evaluated at a different 
hospital during follow-up. In our context, this possibility 
is unlikely. First, as other authors from comparable areas 
of the same health care system have previously published, 
treated suicide attempters are systematically referred to the 
subject’s catchment area’s general hospital.8 Second, Madrid’s 
population shows high residential stability through time: per 
official data from 2017,48 only 3.49% of the people living 
in 1 of the 3 studied catchment areas moved to a different 
district. All in all, this possibility does not differentially 
affect our studied catchment areas; thus, we consider 
our comparative effectiveness estimates internally valid. 
Lastly, it has been suggested that, just as in most complex 
phenomena, risk factors for suicide and suicidal behaviors 
act not only at the individual level but also at overarching 
ecological levels.9,45,49,50 For example, the frequency of 
suicide ideation and attempts shows remarkable differences 
across countries.50 However, the 3 intervention groups are 
contemporary and belong to comparable catchment areas 
of the same city, so we consider differences in such factors 
unlikely.
The strictly naturalistic enrollment of the study yields 
results that can be considered directly applicable. Most 
clinical guidelines prioritize evidence arising from RCTs. 
However, although strict inclusion criteria, randomization, 
and close follow-up provide highly internally valid efficacy 
estimates, their ability to also produce clinically generalizable 
effectiveness estimates has been called into question.27 In 
line with this similarity, effectiveness estimates from clinical 
settings are progressively becoming a valuable source, 
sought after by decision makers.51 This real-world approach 
most likely captures an intervention’s actual impact in the 
management of most psychiatric conditions, deeply shaped 
by interactions with the environment (such as suicide risk 
or schizophrenia).52 As previously mentioned, the results are 
in line with most published research on suicide attempters 
regarding both the sample’s characteristics (a mean age of 
around 40 years, a higher percentage of females, frequent 
co-occurrence of alcohol or drug consumption, and 
main diagnoses of mood, adjustment, and personality 
disorders8,12,53) and the effect estimates of the implemented 
measures. Hence, we consider these estimates as widely 
generalizable, especially to contexts where, as in ours, a 
catchment area–based public system provides universal 
coverage to the population. Besides, patients were enrolled 
right before discharge from the general hospital, mostly at 
the emergency department. Our study therefore supports 
recent studies’ recommendation of a focus toward suicide 
prevention at such settings because of the concentration 
of subjects with high suicide risk and low adherence to 
outpatient resources.54
Suicide behaviors are a growing, critical public health 
issue: in the United States, 1.1 million persons attempt suicide 
every year.55 Even though several preventive strategies 
have proved useful at lowering such behaviors, selecting 
and promoting measures that entail an additional staff 
burden require both political will and adequate evidence. 
Because RCTs of interventions designed to prevent suicide 
attempts often have ethical limitations,56 pragmatic designs 
using real-world data offer an advantageous approach. 
Nonetheless, the question of if psychotherapy adds value 
to contact maintenance for suicidal behavior prevention 
remains partially unanswered.
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Supplementary Table 1: Risk of relapse during the follow-up, derived from a Cox proportional 
hazard model including time to relapse as the outcome and the clinical and sociodemographic 
covariates as predictors. Treatment as usual (TAU) is the reference. This alternative multivariate 
model is age and gender-adjusted and includes personal history of a psychiatric disorder, instead 






(95% CI)  
Adjusted HR 
(95% CI) 
     
TAU  1  1 
Psychotherapy  0.47 (0.31-0.72) **  0.56 (0.37-0.87)** 
Enhanced Contact  0.66 (0.38-1.16)   0.56 (0.31-0.98)* 
Age in years  0.99 (0.98-1.00)  0.99 (0.98-1.00) 
Female   1.27 (0.86-1.87)  1.35 (0.90-2.01) 
Immigrant  0.68 (0.46-1.00) *  - 
Cohabitation  1.10 (0.68-1.77)  - 
Personal history of a psychiatric disorder  1.86 (1.24-2.80) **  1.42 (0.92-2.19) 
Personal history of suicide attempts  1.89 (1.34-2.65) **  1.56 (1.09-2.23)** 
Concurrent alcohol/ drug abuse  1.77 (1.35-2.67) **  1.54 (1.06-2.22)* 
Comorbid medical condition  1.73 (1.23-2.43) **  - 
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Putting Psychosis Into Sociocultural Context
An International Study in 17 Locations
Ezra Susser, MD, DrPH; Gonzalo Martínez-Alés, MD, MSc
It seems eminently plausible that there should be variation in
the incidence of psychoses across the globe. Nonetheless, we
know little about the nature and scope of such variation,
and what we do know is often misunderstood. The landmark
World Health Organization
Ten Country Study,1 pub-
lished in 1992, pioneered a
strategy for comparing the in-
cidence of treated cases of psychoses across multiple settings
in different countries. It obtained incidence rates for schizo-
phrenic disorders from 8 diverse settings, including rural and
urban Chandigarh, India; Nagasaki, Japan; European loca-
tions; and North American settings. The authors described the
rates of schizophrenic disorders as “surprisingly similar”1(p90)
and further remarked that this finding would “not easily lend
itself to an interpretation.”1(p91) They did not claim that schizo-
phrenia has the same incidence across the globe, a common
misunderstanding of the study. (Indeed, Chandigarh was the
only site in a low-income country that yielded any incidence
rates1; in later analyses, a distinctive psychotic disorder sub-
type was found to be more common there.2) A subsequent com-
prehensive review3 of a large number of studies concluded that
the incidence of schizophrenia shows substantial variation by
place. A specific example was higher incidence rates in more
urban locales. However, to our knowledge, there has not been
another attempt to date to demonstrate variation in psycho-
sis incidence within a single study of multiple locations in sev-
eral countries using comparable methods in each place.
In this issue of JAMA Psychiatry, Jongsma et al4 publish
an extraordinary study designed to compare incidence rates
of all psychotic disorders in 17 settings in 6 countries. The study
included 2774 people with psychotic disorders detected at the
time that the patients presented for treatment at mental health
services. This study differs in important ways from the Ten
Country Study.1 The settings are less diverse, with all but 1 lo-
cated in western Europe and more than half located in either
Spain (n = 6) or Italy (n = 3). This reduces sociocultural con-
trasts but made the study more tractable for examining mea-
sured dimensions of social context that might explain varia-
tion across settings. Recent developments in theory and
empirical research facilitated the choice of contextual
measures.5 Moreover, the study is an integral part of a broader
scientific initiative focused on gene-environment interac-
tions, the European Network of National Schizophrenia Net-
works Studying Gene-Environment Interactions. The study also
reports on individual characteristics (age, sex, and racial/
ethnic minority status), but the comparisons across settings
in different countries were the most novel contribution.
The initial results are intriguing and somewhat surpris-
ing. Jongsma et al4 report a striking 10-fold variation across
study settings, from 6.3 to 61.4 cases per 100 000 person-
years in the crude incidence of all psychotic disorders for people
aged 18 to 64 years. This was reduced to approximately 8-fold
variation after accounting for age, sex, and (at least crudely)
racial/ethnic minority status. Results were not entirely con-
sistent at the setting level across 3 interrelated measures of so-
cial context. A strong and important result was that some of
the variation was explained by the association of a higher pro-
portion of owner-occupied homes, a proxy for social stability
and cohesion, with lower incidence of psychosis. In unad-
justed analyses, a higher proportion of single-person house-
holds, a proxy for social fragmentation, was associated with
higher psychosis incidence, but this characteristic did not have
a detectable effect on incidence after adjustment for home
ownership. Additional unadjusted analyses showed that higher
unemployment, a proxy for social deprivation, was unexpect-
edly associated with lower incidence of psychotic disorders,
but this also had no detectable effect after adjustment for home
ownership. Another unexpected result was that higher popu-
lation density was not associated with higher psychosis inci-
dence in Spain, Italy, or all settings combined; however, popu-
lation density was associated with psychotic disorder incidence
in England and the Netherlands, which is consistent with pre-
vious studies.3
These results4 should generate vigorous debate and fur-
ther analysis as we seek to explain them. One possibility might
be that the sociocultural contexts of Spain and Italy are dis-
tinctive in ways that were not captured by measurements at
the level of individual settings or catchment areas. A related
point is that the relationships between the measures chosen
might vary across levels of analysis. For example, Spain has
relatively high levels of home ownership and unemploy-
ment, and these 2 variables are generally correlated with one
another at the country level in western Europe.6 This might
partly explain why unemployment was related to lower inci-
dence across settings from various countries before adjust-
ment for home ownership. There might also be interactions be-
tween individual-level and setting-level characteristics that
could not be captured in the analysis; for example, living in a
single-person household might have a different meaning when
it is more or less common within a setting.5 Finally, setting-
level measures might not capture the substantial heteroge-
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neity of local contexts within a study setting, nor the relation
of individuals to those contexts.7
We would be remiss if we did not comment on some of the
potential sources of artifactual variation, which will surely be
hotly debated. Most are addressed by the authors, but we wish
to emphasize 3 that might require further attention. One con-
cern is that the generally low incidence rates in Italy and Spain
(range, 6.3-21.5 cases per 100 000 person-years) are underes-
timated. Previous, partially overlapping studies from Italy have
reported similar findings.8 However, in Spain questions might
be raised about the outlier finding of very low incidence in
Santiago (6.1 cases per 100,000 person-years). Also, in the
metropolitan area of Madrid, patients are not necessarily re-
stricted to the use of mental health services within a specific
catchment area.9 In addition, the remarkably low median du-
ration of untreated psychosis in Madrid (2.5 weeks) is puz-
zling, as it is lower than all other sites, which had a median du-
ration of untreated psychosis of 8 weeks. A second concern is
that key setting-level variables were derived from data at the
provincial level, a broader region than the catchment area. A
third concern is that the authors4 modified the approach of the
World Health Organization Ten Country Study, which had
aimed to identify the first treatment contact that patients had
made in any kind of health care service; Jongsma et al4 in-
stead covered only contacts with mental health services. It can
be challenging to identify all incident treated psychoses, even
with a broader approach to data collection.10 It is therefore
possible that this study underestimates incidence to variable
extents in different settings.
Despite these and other concerns, it seems likely that much
of the unexplained variation reported here is real. It also seems
likely that part of it is explained by as-yet unidentified socio-
cultural differences between settings.
There is a long history of research on the social determi-
nants of psychoses. Building primarily on the tradition of so-
cial ecologic research,11 this study shows how far this field has
advanced and how far it has yet to go. We now have strong evi-
dence that social experiences influence individual brain
development12 and some evidence about the kinds of social
context that may play a role in the trajectory toward psycho-
sis onset.5 Our understanding of how the effect of individual
experiences interact with or reflect the broader social con-
text at multiple levels is ever advancing but quite incomplete.7
These results of the study by Jongsma et al4 underscore the
need to continue to refine both theories and measurements of
the relationships between sociocultural environmental fac-
tors and psychoses,5 to seize opportunities to examine inter-
actions at multiple, strategically chosen levels via strong study
designs,and to use new opportunities to extend these studies
across the globe. That is no small task, but it is not inherently
more difficult than making advances in other crucial areas, such
as neurodevelopmental neuroscience. Finally, these results re-
inforce the importance of integrating developmental neuro-
science and genomics with sociocultural research; the loca-
tion of this study within a broader initiative, the European
Network of National Schizophrenia Networks Studying Gene-
Environment Interactions, represents a step toward that goal.
Like the World Health Organization Ten Country Study,1 this
study4 raises more questions than it answers, demonstrating
how much we can still learn. We hope that it will spur further
international efforts to explore how variation in sociocultural
environments might be associated with psychosis incidence.
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Suicide: Contexts and persons
Suicidio: contextos y personas
Dear  Editor,
Suicide  is  a  public  health  problem  of  the  highest  magni-
tude.  Of  the  10  most  common  causes  of  death  worldwide,
suicide  alone  is  the  only  one  which  has  not  decreased
during  the  last  decade,  despite  the  enormous  scientific
accomplishments  relating  to  it.1 Despite  the  huge  invest-
ment  in  research  projects  and  increasing  implementation
of  specific  programmes,  the  prevention  of  suicide  is  a  yet
‘‘unresolved  clinical  requirement’’.2 In  their  editorial,  Bar-
rigón  and  Baca-García  proposed  that  some  of  the  bases  upon
which  the  field  of  investigation  into  the  prevention  of  suicide
has  been  constructed  over  the  last  few  decades  should  be
reformulated.3 They  suggested  that  the  general  framework
of  clinical  research  be  based  on  individuals,  and  recom-
mended  evolving  from  the  isolated  study  of  risk  factors  to
the  definition  of  their  algorithms,  based  on  data  processing
with  automatic  learning  techniques  and  personalised  moni-
toring  supported  by  new  technologies.
We  believe  that  the  study  and  prevention  of  suicide
should  necessarily  include  a  populational  standpoint  to
understand  and  reduce  their  risk  factors  on  an  individual
level.  Since  the  publication  of  the  Durheim  sociological
studies  it  has  been  accepted  that  suicide  is  a  phenomenon
where  the  rate  at  least  partially  responds  to  certain
supraindividuals.4 Some  examples  support  this  idea:  several
countries,  such  as  Lithuania  have  standardised  rates  of  sui-
cide  5  times  higher  than  other  countries,  like  for  example,
Greece.5 In  U.S.A.  the  suicide  rates  in  rural  areas  are  double
those  of  urban  areas.6 Indeed,  within  the  same  city,  London,
 Please cite this article as: Martínez-Alés G, Mascayano F, Bravo-
Ortiz MF. Suicidio: contextos y personas. Rev Psiquiatr Salud Ment
(Barc). 2019;12:253--254.
areas  with  higher  ecological  rates  of  social  deprivation  are
associated  with  higher  suicide  rates.7
Modern  epidemiology  attempts  to  define  what  elements
have  a  causal  relationship  with  the  presentation  of  diseases
in  populations.  Development  has  led  to  paradigms  which
have  determined  the  research  questions  and  consequently
the  response  obtained.8 The  initial  idea  was  eminently
ecological:  it  is  believed  that  modern  epidemiology  emerged
with  John  Snow  and  spatial  distribution  of  epidemics  of
cholera  in  19th  century  London.  After  this,  the  discovery
of  the  tubercle  bacillus  and  other  infectious  agents  paved
the  way  for  the  molecular  era.  Lastly,  as  a  result  of  the  sec-
ond  world  war,  epidemiology  of  chronic  non-transmissible
diseases  appeared.  These  are  centred  upon  the  subject,
their  behaviour  and  individual  risk  factors  such  as  a  tobacco
habit  or  high  blood  pressure.  Characteristically,  each  era  of
epidemiology  has  focused  on  a  single  level  of  study  (ecolog-
ical,  molecular,  individual),  negating  all  others  to  a  greater
or  lesser  degree.8 Epidemiology  of  risk  factors  has  there-
fore  produced  a  sizable  body  of  eminently  individual  causal
knowledge.  At  present,  however,  we  are  witnessing  the
growth  of  an  integral  approach  to  epidemiology  which  some
people  have  called  multilevel  epidemiology,  and  which  pro-
poses  that  disease  phenomena  respond  to  causal  patterns
with  rationale  that  act  at  different  molecular,  individual
and  populational  levels  which  interact  on  complex  hierarchi-
cal  networks.9 From  this  outlook,  information  collected  by
ecological  variables,  far  from  being  considered  an  exchange-
able  estimator  with  data  collected  on  an  individual  level,
enjoy  their  own  relevance  for  proper  understanding  of  the
sociological  motives  of  the  disease.10
One  initiative  stands  out  as  an  optimisation  opportu-
nity  when  giving  ecological  causal  factors  the  place  they
have  earned:  overall  mental  health  collaborations.  By  defini-
tion,  an  epidemiological  study  is  able  to  analyse  potentially
causal  relationships  when  a  control  exists  with  which  to
generate  comparison.  Through  the  inclusion  of  different
research  contexts  using  ecological  measurements  to  pin-
point  the  differences  between  contexts,  we  may  calculate
the  role  played  by  supraindividual  variables  on  suicide  rates.
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The  study  of  all  disease  phenomena  may  benefit  from  a
multilevel  approach.  In  a  recent  example,  the  EU-FEI  inter-
national  consortium  published  enormous  differences  in  the
rate  of  psychosis  between  different  European  regions.11
Their  results  also  suggested  that  one  of  the  best  established
risk  factors  for  psychosis,  the  urban  environment,  probably
does  not  have  the  same  impact  in  Northern  compared  with
Southern  Europe.
Populational  and  individual  outlooks  will  need  to  be
included  to  understand  the  enormous  variability  in  suicide
rates  and  to  improve  our  ability  to  prevent  it.  Ecological
variables  provide  irreplaceable  information  for  decision-
making  by  clinicians,  managers  and  politicians.
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El suicidio  es  un  problema  de  salud  pública  de  primera  mag-
nitud.  Destaca  por  ser  la  única,  entre  las  10  causas  de
muerte  más  frecuentes  a  nivel  mundial,  cuya  incidencia  no
ha  descendido  en  la  última  década,  pese  a  la  enorme  pro-
ducción  científica  relacionada1.  Se  considera  que,  pese  a  la
gran  inversión  en  proyectos  de  investigación  y  la  creciente
implementación  de  programas  específicos,  la  prevención  del
suicidio  es  una  «necesidad  clínica  no  resuelta»2.  En  su  ar-
tículo  editorial,  Barrigón  y  Baca-García  proponen  reformu-
lar  algunas  de  las  bases  sobre  las  que  se  ha  construido  el
campo  de  investigación  sobre  la  prevención  de  suicidio  a
lo  largo  de  las  últimas  décadas3.  Sugiriendo  como  marco
general  la  investigación  clínica  basada  en  individuos,  reco-
miendan  evolucionar  desde  el  estudio  aislado  de  factores
de  riesgo  a  la  definición  de  algoritmos  de  los  mismos,  basa-
dos  en  el  tratamiento  de  datos  con  técnicas  de  aprendizaje
automático  y  en  el  seguimiento  personalizado  apoyado  en
nuevas  tecnologías.
Consideramos  que  es  necesario  incluir,  en  el  estudio  y
prevención  del  suicidio,  una  perspectiva  poblacional  para
comprender  y  reducir  sus  factores  de  riesgo  a  nivel  indi-
vidual.  Desde  la  publicación  de  los  estudios  sociológicos  de
Durkheim  se  acepta  que  el  suicidio  es  un  fenómeno  cuya  inci-
dencia  responde,  al  menos  parcialmente,  a  determinantes
supraindividuales4.  Ciertos  ejemplos  apoyan  este  plantea-
miento:  algunos  países,  como  Lituania,  tienen  incidencias
estandarizadas  de  suicidio  5  veces  superiores  a  la  de  otros,
como  Grecia5.  En  EE.UU.,  las  tasas  de  suicidio  en  áreas
rurales  duplican  las  urbanas6.  Incluso  dentro  de  una  misma
ciudad,  Londres,  las  zonas  con  mayores  índices  ecológicos
de  privación  social  asocian  las  mayores  tasas  de  suicidio7.
La  epidemiología  moderna  trata  de  definir  qué  elementos
tienen  una  relación  causal  con  la  aparición  de  las  enferme-
dades  en  las  poblaciones.  En  su  desarrollo  se  han  sucedido
paradigmas  que  han  determinado  las  preguntas  de  investiga-
ción  y,  con  ello,  las  respuestas  obtenidas8.  El  planteamiento
inicial  fue  eminentemente  ecológico:  se  considera  que  la
epidemiología  moderna  nació  con  John  Snow  y  la  distri-
bución  espacial  de  las  epidemias  de  cólera  en  el  Londres
del  siglo  XIX.  Posteriormente,  el  descubrimiento  del  bacilo
tuberculoso  y  otros  agentes  infecciosos  dio  paso  a  la  era
molecular.  Por  último,  a  raíz  de  la  segunda  guerra  mundial,
apareció  la  epidemiología  de  las  enfermedades  crónicas  o  no
transmisibles,  centrada  en  el  sujeto,  su  conducta  y  los  facto-
res  de  riesgo  individuales,  como  el  tabaquismo  o  la  hiperten-
sión  arterial.  Característicamente,  cada  era  de  la  epidemio-
logía  se  ha  centrado  en  un  solo  nivel  de  estudio  (ecológico,
molecular,  individual),  negando  los  demás  en  mayor  o  menor
medida8. Así,  la  epidemiología  de  los  factores  de  riesgo
ha  producido  un  gran  cuerpo  de  conocimiento  causal  emi-
nentemente  individual.  En  este  momento,  no  obstante,
atendemos  al  crecimiento  de  una  concepción  integradora
de  la  epidemiología,  que  algunos  han  llamado  epidemiología
multinivel,  y  que  considera  que  los  fenómenos  de  enferme-
dad  responden  a esquemas  causales  con  determinantes  que
actúan  a  diferentes  niveles,  molecular,  individual  y  poblacio-
nal,  interactuando  en  complejas  redes  jerárquicas9.  En  este
planteamiento,  la  información  recogida  por  variables  ecoló-
gicas,  lejos  de  ser  considerada  un  estimador  intercambiable
con  datos  recogidos  al  nivel  individual,  goza  de  su  propia
relevancia  para  el  correcto  entendimiento  de  los  determi-
nantes  sociológicos  de  la  enfermedad10.
Una  iniciativa  destaca  como  oportunidad  de  mejora  a
la  hora  de  colocar  a  los  factores  causales  ecológicos  en  el
espacio  que  les  corresponde:  las  colaboraciones  de  salud
mental  global.  Por  definición,  un  estudio  epidemiológico
es  capaz  de  analizar  relaciones  potencialmente  causales
cuando  consta  de  un  control  con  el  que  generar  compa-
raciones.  A  través  de  la  inclusión  de  diferentes  contextos
de  investigación,  utilizando  medidas  ecológicas  que  recojan
las  diferencias  entre  contextos,  podremos  estimar  el  papel
que  juegan  las  variables  supraindividuales  en  la  incidencia
del  suicidio.  El  estudio  de  todos  los  fenómenos  de  enfer-
medad  se  puede  beneficiar  de  un  planteamiento  multinivel.
En  un  ejemplo  reciente,  el  consorcio  internacional  EU-GEI
ha  publicado  enormes  diferencias  en  la  incidencia  de  psi-
cosis  entre  diferentes  regiones  de  Europa11.  Sus  resultados,
además,  sugieren  que  uno  de  los  factores  de  riesgo  mejor
establecidos  para  la  psicosis,  el  ambiente  urbano,  probable-
mente  no  se  comporte  igual  en  el  norte  y  el  sur  de  Europa.
Será  necesario  incluir  las  perspectivas  poblacional  e
individual  para  comprender  la  enorme  variabilidad  en  las
incidencias  de  suicidio  y  mejorar  nuestra  capacidad  para
prevenirlo.  Las  variables  ecológicas  proporcionan  informa-
ción  irremplazable  para  la  toma  de  decisiones  por  parte  de
clínicos,  gestores  y  políticos.
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Señor Director: El suicidio es un problema de Salud 
Pública de primera magnitud1. En nuestro país, pese 
a la tradicional baja incidencia de suicidio en 
comparación con otros países europeos, supone la 
primera causa de muerte por causa externa2. 
Además, al afectar especialmente a personas 
jóvenes, el suicidio asocia enormes pérdidas 
económicas (se estima que ocasiona el 1,5% de 
todos los años de vida ajustados por calidad 
perdidos a nivel mundial) y un gran impacto 
emocional a nivel sociofamiliar. A lo largo de las 
últimas décadas, la investigación en prevención del 
suicidio se ha centrado en identificar factores de 
riesgo individuales para prevenir el suicidio a nivel 
del sujeto3. Un ejemplo contemporáneo es el 
proyecto Army STARRS, considerado el mayor 
estudio de la historia de salud mental en personal 
militar, que estudia variables predictores del 
suicidio entre excombatientes del ejército de los 
Estados Unidos4. La incidencia de suicidio entre 
militares norteamericanos es muy elevada: provoca 
más muertes que el combate. Fruto del conocimiento 
acumulado, se han implementado programas de 
contacto y psicoterapia orientados a individuos de 
alto riesgo5, 6. Sin embargo, pese a los esfuerzos en 
investigación, la prevención del suicidio sigue 
considerándose una “necesidad clínica no resuelta”7. 
En Estados Unidos es la única, de entre las 
principales causas de muerte, cuya incidencia está 
en aumento8.
Una de las máximas en el estudio de la incidencia 
del suicidio es que se trata de un fenómeno sujeto, 
en cierta medida, a determinantes que intervienen a 
un nivel por encima del individual. La investigación 
de las causas sociológicas del suicidio comenzó 
con la publicación del libro seminal Le suicide, de 
Èmile Durkheim, el primero en relacionar las tasas 
de incidencia con fenómenos como guerras o 
depresiones económicas9. Esta perspectiva ha 
recuperado actualidad, recientemente, con el vivo 
debate acerca de la relación entre la recesión 
económica internacional y un posible aumento de 
casos10. El estudio de los determinantes 
poblacionales de los fenómenos de enfermedad, de 
forma separada de los determinantes individuales, 
tiene siglos de tradición. La epidemiología, la 
ciencia que estudia la distribución de las 
enfermedades y sus causas en la población, tuvo 
originalmente una vocación eminentemente 
ecológica contrapuesta, en muchos casos, a la 
visión individual de la medicina clínica. Tomando 
las palabras de Geoffrey Rose: “¿Por qué algunos 
individuos tienen hipertensión? es una pregunta 
diferente de ¿Por qué algunas poblaciones tienen 
mucha hipertensión? (…) requieren diferentes tipos 
de estudio y tienen diferentes respuestas”11. Sin 
embargo, la epidemiología clínica de los últimos 50 
años se ha centrado en identificar factores 
acumulativos de riesgo individual de las 
enfermedades, excluyendo las causas ecológicas de 
su marco conceptual12. Este escotoma no es un 
fenómeno raro en investigación: de acuerdo con 
Mervyn y Ezra Susser, es característico que la 
mayor parte de producción científica se desarrolle 
dependiendo del modelo causal predominante en 
cada época, y negando en una medida variable los 
planteamientos preexistentes12. Recientemente, el 
progresivo aumento de las colaboraciones de 
investigación multidisciplinares dentro del campo 
de la epidemiología, junto con las novedosas 
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aproximaciones estadísticas multinivel, que 
integran variables de los niveles poblacional, 
individual y molecular (con especial relevancia en 
el desarrollo de las medicinas personalizada y de 
precisión), ha permitido recuperar las variables 
ecológicas y estudiar cómo interactúan entre sí 
estos tres niveles en la inferencia causal de los 
fenómenos de enfermedad13.
Dejando al margen las limitaciones metodológicas 
en la detección de los suicidios consumados, las lla-
mativas diferencias de  tasa de incidencia de suicidio 
entre países (e incluso comunidades autónomas), y 
las fluctuaciones en las tendencias temporales des-
critas desde Durkheim hasta nuestros días, sugieren 
que existe un potencial beneficio en identificar y tra-
tar los factores de riesgo supraindividuales (macro-
económicas, sociales, culturales, etc.) para el suici-
dio14, 15. Consideramos que, con este objetivo, es ne-
cesaria la integración del trabajo de los clínicos con 
el de los investigadores en “ciencias poblacionales”. 
El ejemplo de otros países ofrece pistas para la arti-
culación de potenciales cambios que pueden favore-
cer este trabajo investigador multidisciplinar y mul-
tinivel. La alarma por el aumento de la tasa de suici-
dio y su impacto diferencial en algunos estratos so-
ciales especialmente vulnerables en Estados Unidos 
ha facilitado diferentes iniciativas16. En 2011, se es-
tableció la Estrategia Nacional de Prevención del 
Suicidio, un plan de obligado cumplimiento, entre 
cuyos puntos directrices se encuentra realizar cam-
bios políticos y ambientales para potenciar la articu-
lación entre prevenciones clínica y poblacional17. 
Tanto el National Institute of Mental Health (NIMH), 
la mayor agencia financiadora de investigación en 
psiquiatría, como los Centers for Disease Control 
(CDC), principales agentes federales para el control 
y la prevención de la enfermedad y la discapacidad, 
tienen programas específicos sobre suicidio. 
El estudio de los determinantes ecológicos de la 
enfermedad permite encontrar dianas para la 
intervención preventiva alternativas a las de las 
intervenciones individuales. En Europa, existen 
experiencias exitosas en la prevención del suicidio 
con intervenciones orientadas al nivel poblacional. 
Por ejemplo, la reducción del tamaño de las cajas 
de paracetamol, un medicamento altamente tóxico 
en sobredosis y muy accesible para la población 
general, asoció una menor tasa de incidencia de 
mortalidad por sobreingesta medicamentosa 
voluntaria en el Reino Unido18. Dificultar el acceso 
a las armas de fuego y a los puntos de concentración 
de suicidio por precipitación (puentes, etc.) también 
ha demostrado eficacia al reducir la tasa específica 
de suicidio por estas causas, con datos que además 
sugieren que el exceso de riesgo evitado no se 
transmite a otros puntos de precipitación ni a otros 
métodos de suicidio19. En nuestro país, no tenemos 
grandes ejemplos de prevención de las conductas 
suicidas con medidas orientadas al nivel 
poblacional. Sin embargo, España sí tiene una 
tradición de abordaje de los fenómenos de 
enfermedad a través de intervenciones orientadas 
al nivel poblacional en otros ámbitos. La legislación 
del uso de tabaco en lugares públicos, que regula la 
exposición al humo de fumadores en diferentes 
ámbitos (incluidos los sanitarios y educativos, 
aspectos en los que fue pionera a nivel mundial) ha 
demostrado eficacia al reducir dicha exposición y 
sus enfermedades asociadas20, 21. La mortalidad por 
accidentes de tráfico (antes la primera causa de 
mortalidad por causa externa en nuestro país, 
primer puesto que ahora ocupa el suicidio) se ha 
reducido de 11,6 fallecidos diarios en 2000 a 3,2 en 
2016, una reducción en la que diferentes medidas 
orientadas al nivel poblacional (mejoría de la red 
de carreteras, cambios legislativos) han tenido un 
papel protagonista21. Creemos que nuestro país es 
un entorno privilegiado para la adopción de 
estrategias ecológicas para la prevención del 
suicidio.
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Prior studies have suggested that dementia adversely influences clinical outcomes and
increases resource utilization in patients hospitalized for acute diseases. However, there is
limited population-data information on the impact of dementia among elderly hospitalized
patients with sepsis.
Methods
From the 2009–2011 National Hospital Discharge Database we identified hospitalizations in
adults aged�65 years. Using ICD9-CM codes, we selected sepsis cases, divided them into
two cohorts (with and without dementia) and compared both groups with respect to organ
dysfunction, in-hospital mortality and the use of hospital resources. We estimated the impact
of dementia on these primary endpoints through multivariate regression models.
Results
Of the 148 293 episodes of sepsis identified, 16 829 (11.3%) had diagnoses of dementia.
Compared to their dementia-free counterparts, they were more predominantly female and
older, had a lower burden of comorbidities and were more frequently admitted due to a prin-
cipal diagnosis of sepsis. The dementia cohort showed a lower risk of organ dysfunction
(adjusted OR: 0.84, 95% Confidence Interval [CI]: 0.81, 0.87) but higher in-hospital mortality
(adjusted OR: 1.32, 95% [CI]: 1.27, 1.37). The impact of dementia on mortality was higher in
the cases of younger age, without comorbidities and without organ dysfunction. The cases
with dementia also had a lower length of stay (-3.87 days, 95% [CI]: -4.21, -3.54) and lower
mean hospital costs (-3040€, 95% [CI]: -3279, -2800).
Conclusions
This nationwide population-based study shows that dementia is present in a substantial pro-
portion of adults�65s hospitalized with sepsis, and while the condition does seem to come
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with a lower risk of organ dysfunction, it exerts a negative influence on in-hospital mortality
and acts as an independent mortality predictor. Furthermore, it is significantly associated
with shorter length of stay and lower hospital costs.
Introduction
Dementia is a global public health matter that affects 44 million people worldwide and costs
1% of global GDP [1]. It is estimated that the number affected will double in the next few years
as a result of an ageing population and the lack of effective available options for prevention [2,
3]. Previous studies have shown that the prevalence of dementia among hospitalized patients is
high [4–8], and on the rise [5,6]. In addition, various studies have highlighted that dementia
increases the risk of death in elderly patients hospitalized for acute diseases [5, 6, 9] as well as
hospital stays and costs [4, 6, 7, 10].
A large proportion of hospitalizations of patients with dementia are related with infectious
processes and sepsis [5, 6, 8, 9, 11, 12]. In fact, sepsis is increasing in the elderly [13] and it is
recognised as a global health priority [14] due to its high morbidity, mortality and utilization
of hospital resources, especially when it presents with organ dysfunction [15]. Nevertheless,
there is limited population-data information on the impact of dementia among elderly hospi-
talized patients with sepsis. Recently, a retrospective population-based study carried out in Tai-
wan [16] found that dementia increased the risk of organ failure and therefore mortality in
hospitalized older adults. However, this study did not specifically analyse the characteristics or
outcomes of the patients with sepsis, and for that reason it is difficult to understand the impact
of dementia on the outcomes in elderly hospitalized patients with sepsis.
Spain is one of the countries with the highest prevalence of dementia worldwide [3] and
this study aims to analyse the epidemiological characteristics and the impact of dementia on
organ failure, in-hospital mortality and the utilization of hospital resources by adults aged
�65years with sepsis via the Spanish national database of hospital discharges. Our hypothesis
is that patients with dementia have a higher risk of acute organ dysfunction, greater rates of in-
hospital mortality and use more hospital resources.
Materials and methods
Design and data source
The data used come from the official database (CMBD) of the Spanish National Health System
(Ministry of Health, Social Services and Equality). According to the regulations of the Spanish
National Health System, every health professional should enter–at the moment of each
patient’s hospital discharge–all of the diagnoses and procedures carried out, using the 9th revi-
sion of the International Classification of Diseases (ICD-9-CM) and the associated “diagnosis-
related groups” or DRGs. This information, the completion of which is a legal requirement, is
gathered together in a national database called the “Minimum Basic Data Set” (Conjunto
Mínimo Básico de Datos, CMBD), which includes more than 97% of the hospital discharges
that occur in Spain each year, and is considered representative of the national population [17].
In the CMBD each hospitalization is treated as a specific record, and includes demographic
information, type of admission, dates of admission and discharge, destination on discharge,
primary diagnosis, 13 secondary diagnoses and up to 20 procedures carried out during the
hospitalization [17–18].
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Population studied. Identification of cases and definitions
We included hospitalizations of� 65s with sepsis from January 1st 2009 to 31 December 2011.
In order to identify sepsis, previously used codes to define infection were employed [19–21]:
038 (038.0, streptococcal septicaemia; 038.1, staphylococcal septicaemia; 038.2, pneumococcal
septicaemia; 038.3, septicaemia due to anaerobes; 038.4, septicaemia due to other Gram-nega-
tive organisms; 038.8, other specified septicaemias; 038.9, unspecified septicaemia); 003.1 (Sal-
monella septicaemia); 020.2 (septicaemic plague); 036.2 (meningococcal septicaemia); 036.3
(Waterhouse–Friderichsen syndrome); 054.5 (herpetic septicaemia); 098.89 (gonococcaemia);
112.5 (systemic candidiasis); 112.81 (candida endocarditis); 117.9 (other and unspecified
mycoses); and 790.7 (bacteraemia). The ICD-9-CM code for sepsis, 995.91 (sepsis, systemic
inflammatory response syndrome due to infectious process without organ dysfunction), which
was introduced in Spain in January 2004, was also included [17].
To identify cases with acute organ dysfunction, we used ICD-9-CM code 995.92 (severe
sepsis, sepsis with organ dysfunction)–as well as the codes that specifically define organ dys-
function. These specific codes were [19,20]: respiratory: 518.81 (acute respiratory failure),
518.82 (other pulmonary insufficiency), 518.84 (acute on chronic respiratory failure), 518.85
(acute respiratory distress syndrome after shock or trauma), 786.09 (respiratory distress, insuf-
ficiency), 799.1 (respiratory arrest), 96.7 with all sub-codes (invasive mechanical ventilation);
cardiovascular: 785.5 with all sub-codes (shock without mention of trauma, includes 785.51,
785.52, 785.59), 458 (hypotension, 458.0, 458.8 458.9), 796.3 (nonspecific low blood pressure
reading); renal: 584 with all sub-codes (acute renal failure), 580 (acute glomerulonephritis),
39.95 (haemodialysis); hepatic: 570 (acute and subacute necrosis of liver), 572.2 (hepatic
coma), 573.3 (hepatitis, unspecified); hematologic: 286.6 (defibrination syndrome), 286.9
(other and unspecified coagulation defects), 287.3–5 (secondary thrombocytopenia, unspeci-
fied); neurologic: 293 (Transient organic psychotic conditions), 348.1 (anoxic brain damage),
348.3 (encephalopathy, unspecified), 357.82 (critical illness polyneuropathy), 780.01 (coma),
780.09 (drowsiness, unconsciousness, stupor), 89.14 (electroencephalogram) and metabolic:
276.2 (acidosis, metabolic or lactic).
This combination of codes from the ICD-9CM has shown capable of accurately estimating
the burden of sepsis and organ dysfunction [21], and has been used previously by our research
group [22]. Dementia cases were identified by the presence, in the principal or secondary diag-
noses, of the following ICD-9CM codes: 290 (dementias), 294.1 (dementia in conditions classi-
fied elsewhere), 294.2 (dementia, unspecified), 331.0 (Alzheimer’s disease), 331.1
(frontotemporal dementia), 331.2 (senile degeneration of brain), 331.82 (dementia with Lewy
bodies) [4,7]. The cases with and without dementia were compared in relation to the primary
variables of interest–including the presence of organ failure, in-hospital mortality, and hospital
resource utilization (length-of-stay and cost). These variables were also examined according to
age, given its influence on patients’ outcomes and the use of resources in septic patients [13].
Likewise, we analysed other demographic characteristics, such as sex or institutionalization
status (whether the subject lived in a nursing home before hospitalization), as well as other
covariates of clinical importance like the burden of comorbidities, the potential site of infec-
tion, microbiological data and whether invasive life-support procedures were used. These pro-
cedures were defined as: infusion of vasopressor agent (ICD-9CM code: 00.17); continuous
invasive mechanical ventilation (ICD-9CM code: 96.70, 71 y 72); and haemodialysis (ICD-
9CM: 39.95). In order to explore comorbidity, we used the Charlson Index in the version vali-
dated by Deyo for use on administrative databases [23] and improved for ICD-9CM [24] for
the 14 diagnosis fields. This index includes specific comorbid conditions of known prognostic
value, which are classified using ICD-9 codes from prior outpatient and inpatient codes.
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Previous epidemiological studies have shown its usefulness in assessing risk of death in septic
patients [25]. For the purposes of this study, the presence of dementia in the Charlson Index
was excluded [12, 16]. To be able to identify specific microorganisms, we used code 041,
which, according to the ICD-9-CM coding manual, is used as an additional code to identify
the bacterial agent in diseases classified elsewhere [17].
Ethics
The data are anonymized and, according to Spanish law, are exempt from the necessity for
informed consent [26]. They come from hospital discharge records collected and de-identified
by the Spanish Ministry of Health, Social Services and Equality. The authors requested and
obtained access to the data from the Ministry and, due to a signed confidential agreement
under the project PI09/0597, cannot share these data with third parties. However, these rec-
ords are publicly available for research purposes. Requests of access to the data should be
addressed directly to the Ministry [27].
Analysis of data
We carried out descriptive and comparative analyses of the cases with and without dementia,
including clinical and demographic data, the burden of comorbidities, the presence of organ
failure, in-hospital mortality, length-of-stay and hospital costs. The Charlson Index was calcu-
lated–using the improved version of Stata 14 –and expressed as a continuous variable and, in
addition, as a category in 4 groups (0, 1–2, 3–4, >4) of increasing severity and impact on out-
comes [28]. Case Fatality Rate (CFR) was calculated as the number of deaths divided by the
number of cases and expressed as a percentage. The quantitative variables are presented as
means with standard deviations, and the categories as overall counts and percentages. The
association between qualitative variables was analyzed via the Pearson χ2 test or Fisher’s exact
test. A t-test was used to compare continuous variables.
The specific effect of dementia on the primary endpoints was calculated using multivariate
regression models. In order to evaluate the effect on organ dysfunction we used two different
adjusted logistic regression models: Model 1 included the main baseline characteristics: sex,
age and the burden of comorbidities, whereas Model 2 also included the identification of the
pathogen and the site of infection.
Regarding in-hospital mortality, before carrying out the multivariate analysis, we per-
formed an exploratory analysis, calculating the independent effect of dementia on each of the
principal covariates (sex, age, comorbidities, identification of pathogens, site of infection, and
presence of organ dysfunction). Following this, we used adjusted logistic-regression tech-
niques on three models, which included Models 1 and 2 and an additional third model that
included the presence of organ failure.
For the continuous variables relating to hospital resources (length-of-stay and costs), we
employed multivariate linear-regression models, adjusted by two further models: Model 4,
included baseline characteristics, identification of pathogen and site of infection, and presence
of organ dysfunction; Model 5 added invasive therapeutic measures to the variables in
Model 4.
The results of logistic regression models are presented as odds ratios (ORs) with 95%
confidence intervals (95%CI), and those of the linear regression models as coefficients (β),
also with 95% confidence intervals. The statistical analysis was carried out using STATA
14 (1985–2015 StataCorp LP. TX 77845 USA). Results were considered significant with a
p-value <0.05.
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Results
In the period analyzed, there were 148 293 entries with sepsis in adults aged� 65 years, of
which 16 829 cases (11.3%) had a diagnosis of dementia. Around 45.8% of cases (n = 7712)
were coded as Alzheimer’s disease, 18.5% (n = 3119) as vascular dementia and the remaining
35.6% (n = 5998) was made up of mixed dementias and other types of dementia.
Clinical and demographic characteristics
As shown in Table 1, the cohort with dementia showed a clear predominance of women and a
greater mean age—more than half of the cases were 80 or over, while 54% of the cases without
dementia were under that age. Although in both groups hospital admission was primarily
non-elective through emergency departments, there were differences between groups, and
planned admission was significantly lower in cases with dementia.
Before hospital admission, 11.9% of the cases with dementia were institutionalized com-
pared to 3.1% of those without dementia.
Likewise, while the reasons for admission were primarily medical in both groups, the per-
centage of surgical cases was significantly lower in the cohort with dementia, with 5% of cases.
Sepsis was the cause of admission for 62% of cases with dementia, and 43% of the cohort with-
out dementia; being the differences statistically significant.
In Table 1, the values from the Charlson Index show that the cohort with dementia had a
significantly lower burden of comorbidities than the cohort without dementia. In addition,
except for diabetes and cerebrovascular diseases, the frequency of specific comorbidities was
significantly lower in the cohort with dementia.
The most frequent potential sources of sepsis were genitourinary, being the percentage of
cases significantly greater in the cohort with dementia (40% vs. 29%) and respiratory (18% vs.
17.3%). However, both the identification of pathogens (42.6% vs. 54.1%) and the presence of
bacteraemia (18.2% vs. 29.4%) were significantly lower in the cohort with dementia. In both
cohorts the most frequent pathogen identified was gram-negative bacteria.
Organ dysfunction
As shown in Table 1, almost 40% of cases overall were not suffering from organ dysfunction
with a slightly–but significantly–larger proportion being found in the cohort with dementia.
Furthermore, the percentage of dementia cases who presented with a single dysfunction was
greater (35.5% vs. 30.1%), while this relationship was inverted in those cases with dysfunction
of two or more organs.
Similar differences can be observed in Table 2 for the specific dysfunctions analyzed, and
the cohort with dementia showed a significantly lower frequency for each. In both cohorts
respiratory dysfunction was the most common, followed by kidney dysfunction and then car-
diovascular, whose occurrence was notably different between cohorts.
Table 2 also presents the results of the multivariate analysis in which the impact of dementia
on the presence and type of organ dysfunction was analyzed. The first model was adjusted for
age, sex and points on the Charlson Index; the second, additionally adjusted for the site of
infection and identification of pathogens. After adjustment, in Model 1, dementia was associ-
ated with 7% lower risk of presenting with organ dysfunction than the cohort without demen-
tia. Meanwhile, in Model 2, this difference increased to 16%. In the individual analyses of the
individual types of dysfunction, in all of them and in both models, dementia was associated
with a significantly lower risk.
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Table 1. General characteristics of the population 2009–2011.
With dementia Without dementia p-value
16 829 (11.3) 131 464 (88.7)
Year of Study 0.505
2009 5244 (11.3) 41 360 (88.7)
2010 5551 (11.3) 43 556 (88.7)
2011 6034 (11.5) 46 548 (88.5)
Sex <0.001
Women 9587 (57) 57 708 (43.9)
Age, years <0.001
65–69 379 (2.2) 18 624 (14.2)
70–74 1007 (6.0) 22 205 (16.9)
75–79 2811 (16.7) 30 734 (23.4)
80–84 4860 (28.9) 28 248 (21.5)
85–89 4920 (29.2) 20 592 (15.7)
�90 2852 (17.0) 11 061 (8.4)
Mean±SD # 83.6±6.3 78.7±7.7 <0.001
Type of hospital admission <0.001
Non-elective 16 077 (95.5) 120 026 (91.3)
Institutionalized 1995 (11.9) 4121 (3.1) <0.001
Medical pathology 15 980 (95.0) 103 890 (79.0) <0.001
Sepsis as reason for admission 10 391 (61.7) 56 778 (43.2) <0.001
Charlson Index <0.001
0 points 5991 (35.6) 28 506 (21.7)
1–2 points 8330 (49.5) 61 098 (46.5)
3–4 points 2100 (12.5) 27 986 (21.3)
>4 points 408 (2.4) 13 874 (10.5)
Mean±SD# 1.23±1.34 2.06±1.90 <0.001
Principal comorbidities
Diabetes 4906 (29.2) 35 607 (27.1) <0.001
Cerebrovascular disease 2657 (15.8) 11 739 (8.9) <0.001
Chronic kidney disease 2167 (12.9) 23 121 (17.6) <0.001
Congestive heart failure 1936 (11.5) 23 388 (17.8) <0.001
Chronic obstructive pulmonary disease 1789 (10.6) 23 852 (18.1) <0.001
Cancer 954 (5.7) 27 498 (20.9) <0.001
Peripheral vascular disease 740 (4.4) 8270 (6.3) <0.001
Acute myocardial infarction 471 (2.8) 5834 (4.4) <0.001
Site of infection 11 248 (66.8) 94 362 (71.8)
Genitourinary 6803 (40.4) 38 259 (29.1) <0.001
Respiratory system 3023 (18) 22 761 (17.3) 0.036
Soft tissue 573 (3.4) 4923 (3.7) 0.028
Abdomen 359 (2.1) 9355 (7.1) <0.001
Identification of pathogens 7160 (42.6) 71 081 (54.1) <0.001
Gram-negative bacteria 5159 (72.0) 47 798 (67.2) <0.001
Gram-positive bacteria 2591 (36.2) 28 660 (40.3) <0.001
Number of organ dysfunction�� <0.001
None 6493 (38.6) 48 123 (36.6)
1 5979 (35.5) 39 542 (30.1)
(Continued)
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Among cases who presented with organ dysfunction, 3.6% (n = 376) in the dementia cohort
and 25.5% (n = 21 280) in the without dementia cohort received invasive therapeutic measures
for organ-system support; the difference was statistically significant (p<0.001).
Mortality
The CFR was 43% (n = 7276) in the cohort with dementia and 34% (n = 45 187) in the non-
dementia cases, and these differences were statistically significant.
In both cohorts (see Fig 1), to be a woman, of more advanced age, with a greater burden of
comorbidities, the non-identification of the site of infection or the pathogen, and the presence
of organ dysfunction were all associated with higher mortality. Nevertheless, as it can be seen,
there was a significant difference in mortality between cohorts, with higher values for the
dementia cohort in all of the variables analyzed.
The same chart shows the effect of dementia on mortality, adjusted for each of the variables.
These results indicate that dementia independently augments the mortality risk for each vari-
able analyzed, while the extent of the effect is greater in specific groups, namely: the younger
patients with less comorbidities and organ dysfunction. Thus, adjusting for age, the mortality of
cases with dementia is 26% higher than cases without dementia. For subjects between 65 and 69
years old, the OR of death is 1.51 times higher in the patients with dementia, while it decreases
to 1.12 times for those�90. The same occurs with the Charlson Index, where the impact of
dementia on mortality shows an OR of 1.71 in cases without comorbidity and of 1.42 where
there is a higher burden of comorbidities. Having analyzed organ dysfunction, the results of the
analysis indicate that in cases without organ dysfunction the risk of death is twice as high in
patients with dementia, while said risk is 43% higher in cases with organ dysfunction.
As regards the utilization of therapeutic measures for organ-system support, although they
are used in 86% fewer cases in the cohort with dementia. In those cases where these measures
Table 1. (Continued)
With dementia Without dementia p-value
�2 3391 (20.2) 39 646 (30.2)
Chi-squared Test
# Student’s T-Test; SD: Standard Deviation
��in 3.4% of cases the number of organ failures was not specified.
https://doi.org/10.1371/journal.pone.0212196.t001









Acute organ dysfunction 10 336 (61.4) 83 341 (63.4) 0.93 (0.90, 0.97) 0.84 (0.81, 0.87)
Respiratory 4190 (24.9) 38 362 (29.2) 0.85 (0.82, 0.89) 0.80 (0.77, 0.83)
Cardiovascular 3329 (19.8) 37 089 (28.2) 0.67 (0.64, 0.70) 0.59 (0.57, 0.62)
Renal 3957 (23.5) 39 431 (30.0) 0.75 (0.72, 0.78) 0.71 (0.69, 0.75)
Hepatic 164 (1.0) 3411 (2.6) 0.64 (0.55, 0.76) 0.61 (0.52, 0.72)
Hematological 523 (3.1) 8804 (6.7) 0.48 (0.44, 0.53) 0.46 (0.42, 0.51)
Metabolic 645 (3.8) 7823 (6.0) 0.61 (0.56, 0.66) 0.56 (0.51, 0.61)
Neurological 1033 (6.1) 9137 (7.0) 0.85 (0.80, 0.91) 0.85 (0.79, 0.91)
Model 1: adjusted for sex, age and points on the Charlson Index
Model 2: adjusted for sex, age, points on the Charlson Index, identification of pathogens and site of infection
https://doi.org/10.1371/journal.pone.0212196.t002
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Fig 1. Likelihood of in-hospital mortality from principal covariates in dementia cases compared with non-dementia cases.
https://doi.org/10.1371/journal.pone.0212196.g001
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are employed, we did not observe significant differences in the mortality of the two groups
(OR:0.89, 0.72–1.09).
In Table 3, the results of the multivariate regression analysis show the impact of dementia
on in-hospital mortality. The cohort with dementia presents a risk of death 36% higher than
the cohort without dementia, controlled for baseline covariables (Model 1). Nevertheless, this
risk is reduced to 23% if the detection of pathogens and the potential site of infection are con-
trolled for (Model 2), and to 32% when the presence of organ dysfunction is also controlled
for.
Utilization of resources
Both the average length-of-stay and the mean hospital costs were significantly lower in the
cohort with dementia. The mean stay was 11.3 days for the cohort with dementia and 17.4
days for the without dementia cases. These differences are maintained when analyzing the
cases who died as well as those who survived their stay. For cases who died the mean stay was
8.6 days in the cohort with dementia, against 14.7 days in the cohort without dementia. As
shown in Fig 2, the mean length-of-stay decreases with increased age, but the decline is clearly
less pronounced in the cohort without dementia and the differences between both groups are
much more marked between 65 and 85 years of age.
As regards the costs, Table 4 shows a mean hospitalization cost of €6824 in the cohort with
dementia and €11,230 for cases without dementia. Fig 3 shows the mean costs for both
cohorts, as related to age and status on discharge; in the same figure we can see that–for the
without dementia cases–the mean costs are much greater in cases where the patient died than
in those that survived their hospital stay, and that in both cases the figure falls with increased
age. In cases with dementia the cost is practically stable for both living and dead in the different
age ranges. The curves of both cohorts show a substantial difference between 65 and 80 years
of age, and tend to overlap from 90 onwards.
The results of the multivariate linear regression model employed to evaluate the impact of
dementia on the utilization of hospital resources is shown in Table 4. This analysis, adjusted
for age, sex, points on the Charlson Index and the presence or non-presence of organ dysfunc-
tion, indicates that dementia involves a 3.87-day reduction in length of hospital stay. This dif-
ference is reduced to -2.69 days if adjustment for the use of invasive therapeutic measures is
accounted for. The difference in mean hospital costs per case is €3040 lower (95%CI: -3279,
-2800) in patients with dementia, but this is reduced to -1489 euros (95%CI: -1713, -1266)
when invasive therapeutic measures for life support are incorporated into the model.
Discussion
This nationwide population-based study shows that dementia is present in a substantial pro-
portion of adults�65s hospitalized with sepsis, and while the condition associates with a lower






Model 1 Model 2 Model 3
Mortality 43.2% 34.4% 1.36 (1.32, 1.41) 1.23 (1.19, 1.27) 1.32 (1.27, 1.37)
Model 1: adjusted for sex, age and points on the Charlson Index
Model 2: adjusted for sex, age, points on the Charlson Index, identification of pathogens and site of infection
Model 3: adjusted for sex, age, points on the Charlson Index, identification of pathogens and site of infection and presence of organ dysfunction
https://doi.org/10.1371/journal.pone.0212196.t003
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risk of organ dysfunction, it exerts a negative impact on in-hospital mortality and acts as an
independent mortality predictor. The negative impact of dementia on mortality is greater in
lower age-groups, groups with a lower comorbidity burden and in cases without organ dys-
function. Furthermore, it is significantly associated with shorter length of stay and lower hos-
pital costs.
As far as we know, this is the first population-level study which investigates the epidemiol-
ogy and outcomes of hospitalized patients with sepsis and dementia. Our data shows that
Fig 2. Mean length-of-stay for patients with and without dementia by age and vital status on discharge.
https://doi.org/10.1371/journal.pone.0212196.g002
Table 4. Impact of dementia on utilization of hospital resources.
With dementia Without dementia Adjusted (95%CI)
Hospital Resources Model 4 Model 5
Length-of-stay,
mean number of days
11.3±12.4 17.4±21.4 -3.87 (-4.21,-3.54) -2.69 (-3.02, -2.36)
Costs, € mean 6824±4260 11 230±15 793 -3040 (-3279, -2800) -1489 (-1713, -1266)
Model 4: adjusted for sex, age, Charlson Index, and presence of organ dysfunction
Model 5: adjusted for sex, age, Charlson Index, presence of organ dysfunction, and invasive therapeutic measures
https://doi.org/10.1371/journal.pone.0212196.t004
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dementia is common in the adult population�65 with sepsis–affecting 11.3%, with a distribu-
tion that increases progressively with age and that more than half of the cases are women.
These findings are in line with the literature, although the observed frequency is somewhat
higher than that referred to in studies which analyze its prevalence in the general hospital pop-
ulation [6, 7, 12, 29, 30]. Also, Alzheimer’s disease is common and represents almost half of
the cases with dementia [29, 31–33]. It is important to highlight that in 62% of cases with
dementia, sepsis was the reason for hospital admission. This figure, significantly higher than
that for cases without dementia, suggests a community-acquired origin of sepsis in a large pro-
portion of those patients. In line with literature, the most frequent site of infection was urinary
followed by respiratory [4, 5, 8, 12].
Several studies have demonstrated that mortality from sepsis is associated with greater age,
greater burden of comorbidities and, in particular, with the presence of organ dysfunction [13,
15, 19–22]. The results of our study accord with these previous studies, in addition to showing
that the existence of dementia is an independent factor associated with higher mortality in this
population.
In this study, the cohort with dementia presents a lower burden of comorbidity as evaluated
through the Charlson Index, which does in fact contrast with some previous publications [7,
Fig 3. Mean hospital costs for patients with and without dementia by age and vital status on discharge.
https://doi.org/10.1371/journal.pone.0212196.g003
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12, 34], but agrees with others [6, 30, 33]. Although we cannot discount that patients with
dementia are subject to under-diagnosis of comorbidities, the presence of a profile with higher
diabetes and cerebrovascular-disease prevalence agrees with the results of prior studies [6, 30,
35, 36] and suggests that the coding is not systematically biased.
Moreover, the cases with dementia showed a significantly lower risk of acute organ dys-
function than those without dementia, after adjusting–in the multivariate analysis–for demo-
graphic and clinical characteristics known as predictive factors for outcome such as age, sex,
burden of comorbidity, the identification of a potential site of infection and the responsible
microorganism. Our findings contrast with those described by Shen et al. in Taiwan [16]
where dementia was associated with a higher risk of organ dysfunction. This discrepancy
might be due to methodological and design differences between the two studies, as their popu-
lation consisted of�65years hospitalized for any cause and they did not specifically analyze
cases of sepsis. This great difference and the lack of information about cases with sepsis make
it impossible to adequately compare the results. That said, we have confidence in the results of
our study given that it uses cases identified through well-used and validated strategies for the
epidemiological analysis of sepsis and its outcomes [13,19–22]. In addition, as the study is
based upon population data whose declaration is obligatory and not subject to systematic
selection bias, there is no reason to presume that the registration of organ dysfunctions would
be different between cohorts. By the same token, given the universal character of our national
health system we can assume that coding practices were not due to economic incentives.
Unfortunately, we have not identified any other studies that analyze the outcomes of acute
organ dysfunction in patients with dementia and sepsis with which we might compare our
data.
In relation to age, for patients with dementia and sepsis the increased risk of death with
greater age is clearly lower than in the without dementia cases. In addition, although cases
with dementia are, on average, around five years older than those without dementia, the great-
est differences in mortality between the cohorts are found among lower age ranges. Along sim-
ilar lines, the impact of dementia on mortality has a greater effect on clinically less severe
groups–with fewer comorbidities and without organ dysfunction. Regrettably, the design of
this study does not permit us to identify the causes of these differences, but our results suggest
that dementia is a mortality risk factor whose impact is less perceptible with more advanced
ages and/or greater clinical severity [16, 37].
The presence of dementia has a negative association with indicators of clinical manage-
ment, like the identification of the site of infection, the pathogen responsible for causing the
sepsis or the use of invasive techniques for organ support. The correct identification of the site
of infection and the responsible microorganism are critical for clinical management of sepsis,
as the administration of ineffective antibiotic increases mortality [15, 38, 39]. It must be
acknowledged that the clinical manifestations of sepsis are variable and may be subtle in
elderly patients–and that dementia presents additional challenges due to communication diffi-
culties and poor tolerance for diagnostic procedures and other care activities. Nonetheless, the
implementation of educational programmes for professionals on the diagnosis and early treat-
ment of sepsis has improved patients outcomes and reduced mortality [40, 41]. Along the
same lines, the results of this study suggest that it is necessary to undertake greater diagnostic
efforts in these patients–once the identification of the potential site of infection and pathogen
responsible is accomplished, the impact of dementia on in-hospital mortality should shrink
markedly.
It is also important to mention that the use of withdrawing or withholding invasive life sup-
port measures may provide a partial explanation to some of our findings. The use of invasive
therapeutic measures in patients with dementia is under debate–as the appropriateness of their
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use and their results are far from clear [42–44] and, as stated by Richardson [42], acute care
patients with dementia are treated substantially less aggressively than patients without demen-
tia. Conversely, a recent study by Lagu in the US, however, shows that between 2001 and 2011
the utilization of invasive mechanical ventilation increased four times more in patients with
dementia than in those without dementia [45]. In our study these measures were used in a
small percentage of cases with dementia, but in those cases where they were used we did not
observe significant differences in mortality between the two groups. This suggests that the
selection criteria for the use of these measures were evaluated from the perspective of appro-
priate care and concurs with the findings of recent publications [16, 43, 46]. Unfortunately,
our study design rendered it impossible to assess cases in which there have been decisions to
forgo life-sustaining measures and we are unaware of the influence of patients’ advanced direc-
tives in our study population. Further, studies investigating the frequency and quality of pallia-
tive care in critically ill patients with dementia are scarce [47]. However, the results of previous
studies in which we participated show that, in our country, these decisions are taken by profes-
sionals on the basis of biomedical reasons of therapeutic futility or ineffectiveness, that their
attitude tends to be conservative and less pro-active than in other countries, and that such
decisions are taken in approximately 6.6%-9.8% of patients admitted to the Intensive Care
Unit [48,49]. Furthermore, besides age and acute and chronic diagnoses, quality of life and
functional status have the greatest impact on decisions to limit life support [48]. Accordingly,
it seems eminently plausible that the presence and severity of dementia may determine less
aggressive clinical management decisions and patients with dementia and sepsis may be less
likely to be treated with invasive measures.
Previous studies have noted that dementia increased the mean length-of-stay and the costs
of hospitalization for elderly patients diagnosed with acute conditions [5, 10]. However, our
study provides contrasting results: length-of-stay and hospital costs were significantly lower
for patients with dementia, both overall and when examining the cases who died or survived
their hospital stay. Overall, the adjusted differences observed in our study go up to almost four
days hospital stay and more than €3000 mean hospitalization costs. The lower rates of organ
dysfunction and the lower use of life-support invasive measures in the dementia cohort as
compared to dementia-free cases, may explain these findings. Additionally, even if in the mul-
tivariate model the adjusted size of the difference between the two groups–for both length-of-
stay and costs incurred–was reduced when the use of invasive therapeutic measures was intro-
duced as a covariate, notable differences remained. Interestingly, Lagu et al. [46], in their
recent retrospective population-study of 65s and over, found that patients with dementia
under invasive mechanical ventilation had shorter lengths-of-stay and lower hospital costs
than those without dementia.
Our data also show that the differences in these estimators between the two cohorts are
greater at lower ages. This is possibly because the gap between clinical attitudes for subjects
with and without dementia, regarding the use of life-support invasive measures tends to nar-
row with the advancing age of patients–with an overall reduction in therapeutic efforts [42, 43,
46,48,49].
Our results expand the still scarce information available about the impact of dementia on
elderly patients hospitalized with sepsis. This study used the nationwide official database of
hospital discharges of the Spanish National Health System. Data entry into this database is
mandatory by law, covers over 97 per cent of the all acute-care, public and private, hospitaliza-
tions nationwide and is subjected to regular audits to verify the adequacy and accuracy of the
coding used [17–18]. Thus, we consider that our results could be generalized. These results
could be of interest for decision-makers and the planning of care resources in an increasingly
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ageing society for which a greater prevalence of dementia and sepsis is foreseen in the near
future.
The limitations of our study are those inherent to investigations based on retrospectively col-
lected clinical-administrative data. Although there are national directives for the use of the ICD-
9-CM coding system, this may not have been uniform across all hospitals of the national health
network and we cannot rule out coding errors despite regular audits making major errors
unlikely. However, we have limited the study to a spread of recent years, as it is known that the
coding in Spain has improved over the last few years. A further limitation is the absence of diag-
nostic information about the severity of dementia [50, 51]. Accordingly, it is necessary to bear in
mind that all of these are hospital cases, and it has already been demonstrated that there is an
inverse relation between the severity of the dementia and the probability of being hospitalized
[52]. Moreover, we lack data about other socio-demographic characteristics like risky behaviour;
pharmacological treatments; economic, cultural or educational level. This impeded our ability to
better characterize the pattern of this cohort and stratify the results by severity of dementia and
other risk factors. Nonetheless, the inclusion of cases which covered all subjects at the population
level allows us to assume that none of the groups compared were selected with systematic bias.
Lastly, our analysis does not include non-hospitalized cases. Thus, the mortality data is in-
hospital mortality and prior studies have demonstrated that patients who survive a septic epi-
sode have a higher risk of death during the following months or even years [15, 53] which
makes the estimates conservative.
In conclusion, this study shows that dementia is present in a significant proportion of�65
patients hospitalized with sepsis, and that while the condition does not seem to come with a
higher risk of organ dysfunction, it both exerts a negative impact on hospital mortality and
acts as an independent mortality predictor. According to our results this impact is higher in
lower age-groups, groups with a lower comorbidity burden and in cases without organ dys-
function. In addition, it is associated with a significantly lower length of stay and hospital cost.
Further study is needed into the factors associated with the negative effect of dementia in
elderly patients with sepsis.
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Letters to the Editor
Beyond Statistical Significance: An Underrated 
Suicide Prevention Intervention
To the Editor: In their recently published report of a 
randomized trial, Vaiva et al1 found that suicide attempters 
allocated to a decision-making algorithm for suicide (ALGOS) 
were 26% less likely to reattempt suicide within 6 months after 
discharge than controls who received treatment as usual (TAU) 
(12.8% vs 17.2% relapses, respectively; difference between groups: 
4.4%, 95% confidence interval [CI]: −0.7%, 9.0%; relative risk: 
0.74; 95% CI, 0.54–1.01). Because the early postdischarge period 
entails exceptionally high relapse risk,2 the study’s main outcome 
was the difference in the percentage of reattempts during the first 
6 months of follow-up. The observed difference was described as 
“not significant” at the provided P value of .059 for the complete-
case analysis.
We would like to warn against concluding that the intervention 
was not effective, given that the conflation of “statistical significance” 
with decision-making is error-prone.3 In addition, notwithstanding 
concerns about arbitrary P value cutpoints, 2 key aspects of the 
study design and analysis should be considered when interpreting 
the results. First, their control intervention, a priority appointment 
after discharge combined with a referral to an outpatient clinician 
for follow-up, has proven effective at lowering relapse risk after 
suicide attempt in comparable contexts with universal health 
coverage.4 In fact, enhancing follow-up contacts with health 
providers is considered the single most effective clinical intervention 
to reduce suicide behaviors.5 Comparing any intervention to 
a highly effective TAU can be challenging, and yet there was a 
difference of over 4 percentage points in suicide reattempts among 
those randomized to ALGOS. Second, the 2 study groups differed 
substantially in their loss to follow-up (13.6% in ALGOS vs 18.4% 
in TAU at 13 months, P = .038). Given that treatment engagement is 
a key component of suicide prevention efforts,6 we cannot rule out 
the possibility that lost individuals may have higher relapse rates 
than the observed individuals. If that was the case, observed data 
would likely underestimate ALGOS effectiveness. Despite this, all 
reported analyses in the study were conducted in an intention-to-
treat (ITT) basis. Notably, ITT analysis tends to yield conservative 
effect differences between compared interventions, and, in the 
presence of loss to follow-up or lack of adherence (especially if it 
affects differentially the studied interventions, as is the case here), 
there is no guarantee that an ITT approach adequately estimates 
the clinical effectiveness of the study.7
Two strategies could have enhanced Vaiva and colleagues’ study 
report and should be considered in the future. From an analytic 
perspective, long-lasting trials with substantial loss to follow-up 
can benefit from being analyzed using several different approaches, 
including not only intention-to-treat, but also “as-treated” and 
“per-protocol” analyses, where effect estimates can be controlled 
by differential adherence and other potential post-randomization, 
time-varying confounders.7,8 Regarding the interpretation of 
results, an observed difference between study groups should be 
judged considering several aspects, including effect size, precision 
of the estimate, and features of the study design, rather than relying 
solely on statistical testing.3,9
Suicide is a major global health concern. Suicide attempt, its 
more reliable risk marker, is an increasingly frequent clinical entity 
that drives substantial burden for health systems and generates an 
enormous societal impact.10 Consequently, effective interventions 
aimed at lowering suicidal behaviors are a priority clinical need. 
Pragmatic clinical trials conducted in real clinical settings, like the 
study by Vaiva et al,1 usually entail methodological challenges that 
can lead to dilution of the effect.11 Nevertheless, results from the 
real world are sought after by policy makers because of their high 
external validity.11 We believe that, by estimating the effectiveness 
of a decision-making algorithm that improves clinicians’ ability 
to support people at high risk of suicide attempt, Vaiva et al are 
contributing valuably to suicide prevention.
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Letters to the Editor
Dr Berrouiguet and Colleagues Reply
To the Editor: We thank Martínez-Alés et al for their comments 
on our study1 in which we assessed the efficiency of the ALGOS 
brief contact intervention (BCI). Martínez-Alés and colleagues 
warn against statistical misinterpretations and concluding that 
the intervention is not efficient. It has long been asserted that the 
harms of statistical testing in more uncontrollable and complex 
research settings (such as “real world” suicide prevention) have far 
outweighed its benefits. As suggested by Martínez-Alés et al, we 
also performed an “as treated” analysis on the same sample.2 We 
also believe that the integration of web and smartphone technology 
may reinforce the efficiency of actual BCIs. Overall, these strategies 
could lead to dynamic monitoring of the risk assessment, leading 
to real-time, personalized interventions.3
Beyond the efforts to reach “statistical significance,” it is 
important to note that ALGOS results brought about an important 
change in French suicide prevention policy. After the ALGOS study 
was published, Duhem et al4 proposed assessing the efficiency of 
the algorithm as standard care for suicide attempters in 5 regions 
of France with different sociodemographic characteristics; this 
program is called VigilanS. The French Health Authority is 
currently supporting the establishment of VigilanS as a standard of 
care for all suicide attempters attended in emergency departments. 
VigilanS includes a multimodal suicide prevention program with 
long-term BCIs and crisis management. Furthermore, the program 
establishes a network of professionals working with different 
populations and in differing infrastructural conditions, which 
provides strong support for suicide prevention literacy in both 
care workers and at-risk populations. As affirmed by Martínez-
Alés et al, we believe that these efforts based on an “inconclusive” 
randomized controlled trial will have important benefits for suicide 
outcomes in France and provide an easily reproducible, efficient 
suicide prevention strategy.
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Abstract
Purpose of Review To examine current trends in suicide and self-injury in the USA, as well as potential contributors to their
change over time, and to reflect on innovations in prevention and intervention that can guide policies and programs to reduce the
burden of suicide and self-injury in the USA.
Recent Findings Suicide and non-fatal self-injury are on the rise in the USA. Reasons for such trends over time remain specu-
lative, although they seem linked to coincident increases in mood disorders and drug use and overdose. Promising innovative
prevention and intervention programs that engage new technologies, such as machine learning–derived prediction tools and
computerized ecologic momentary assessments, are currently in development and require additional evidence.
Summary Recent increases in fatal and non-fatal self-harm in the USA raise questions about the causes, interventions, and
preventive measures that should be taken. Most innovative prevention efforts target individuals seeking to improve risk predic-
tion and access to evidence-based care. However, as Durkheim pointed out over 100 years ago, suicide rates vary enormously
between societal groups, suggesting that certain causal factors of suicide act and, hence, should be targeted at an ecological level.
In the next generation of suicide research, it is critical to examine factors beyond the proximal and clinical to allow for a
reimagining of prevention that is life course and socially focused.
Keywords Suicide prevention . Suicide prediction . Machine learning . Ecologic momentary assessment . Brief contact
interventions .Multilevel epidemiology
Introduction
Suicide continues to be a central contributor to lives lost
across the globe and among the most common causes of
death, especially in young adults. The sequelae of suicide
for families and communities reverberate in grief, stigma,
and increases in psychiatric conditions. The present paper out-
lines current trends in suicide and self-injury in the USA, as
well as hypotheses and evidence regarding contributors to
changes over time in the suicide rate. Further, we examine
evidence for innovations in prevention and intervention that
can guide policies and programs to reduce the burden of sui-
cide and self-injury in the USA.
Trends in Suicide and Non-fatal Self-Injury
Among Adolescents and Adults
Suicide rates in the USAwere generally declining amongmost
age groups of adults throughout the late 1980s and 1990s [1].
However, since 1999, suicide rates began to increase in almost
all states and in almost every age group. Analyses from the
CDC indicate that from 1999 to 2016, suicides significantly
increased in 44 of 50 US states and that the rate of increase
was heterogeneous by location and demographics [2]. For
example, suicide increased by more than 30% in 25 states,
with the highest increase in suicide occurring in North
Dakota (an increase of 57.6%). However, states such as
Nevada, which already had the highest rates of suicide in the
country, did not observe a significant increase [2]. Trends
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towards increased suicide rates continued in 2017 [3], as the
overall suicide rate in the USA increased from 13.5 per
100,000 to 14.0 per 100,000.
While the rate of suicide is increasing across all age and
gender groups, there have been particularly high absolute in-
creases in suicide among men aged 45 to 64 (https://
www.cdc.gov/nchs/data/databriefs/db241.pdf). Relative in-
creases in suicide are greatest among those at young ages,
due in part to a lower overall base rate. For example, the
suicide rate among girls aged 10–14, among whom the suicide
rate was 0.5 per 100,000 in 1999, tripled by 2016 [4••].
Suicide is currently the second leading cause of death among
those aged 10–14, 15–24, and 25–34, with unintentional inju-
ry being the leading cause of death, indicative of the contri-
bution of both unintentional injury and suicide to the declining
life expectancy in the USA, given the young age of decedents
(https://www.nimh.nih.gov/health/statistics/suicide.shtml).
Available evidence indicates that regions of the USAwith
high suicide rates and high correlation among suicides per
geographic area are those with high elevation [5], as well as
those with high concentrations of demographic groups at risk
of suicide such as those with indigenous populations (https://
www.cdc.gov/mmwr/volumes/67/wr/mm6708a1.htm).
Further, the strength of correlation among suicides in particu-
lar geographic areas over time is also increasing, suggesting
that as suicides become more common, the overall size of
areas with particular high suicide rates is also increasing [6].
Occupational exposures also influence suicide: the risk is
markedly salient among members of the USmilitary, especial-
ly those exposed to active combat and traumatic events in the
field [7]. While members of the military historically had lower
death rates than the general population, including suicide,
death by suicide increased among US army members begin-
ning in 2004 [8], and rates are now approximately equal to the
general population, due to the unprecedented increases among
both civilians and military members [9].
The increasing trends in completed suicide lead to the
question of whether there are increases in non-fatal self-
injury as well, or whether the trends reflect rather lethality
of attempts. Available data indicate that non-fatal self-in-
jury is also increasing in the USA across age. Olfson et al.
examined self-reported suicide attempts across two cross-
sectional surveys of adults completed 10 years apart with
similar sampling frames and measures and found modest
increases in the rate of self-reported attempted suicide,
from 0.62% in 2001–2001 to 0.79% in 2012–2013
[10••]. Across demographic and clinical groups, those
with the highest increases included young adults aged
21–34, those with high school or less education, and those
with psychiatric disorders. Hospital-treated self-harm
events increased from 5.1 to 7.1 per 10,000 population
from 2001 to 2011 among middle-aged individuals, an
increase larger than any other age group [11]. Other
analyses of hospitalization data also demonstrate increas-
ing trends in self-injury [12–14].
Non-fatal self-injury is increasing among youth. The preva-
lence of adolescents reporting that they “seriously considered
attempting suicide” in the past 12 months in the USA increased
from 14.5% in 2009 to 17.2% in 2017, an increase that was
statistically significant (https://www.cdc.gov/healthyyouth/da-
ta/yrbs/pdf/trends/2017_suicide_trend_yrbs.pdf). However, it
should be noted that overall trends since the mid-1990s suggest
declines (e.g., prevalence was 29% in 1991). Emergency de-
partment visits and inpatient hospitalizations coded for suicidal
ideation or attempt across 49 children’s hospitals in the USA
increased from 0.66% of all encounters in 2008 to 1.82% in
2015 [15], and significant increases were observed across age,
gender, and race, with the largest increases observed for 12–14
and 15–17 year olds, girls, and non-Hispanic whites. Further,
among youth less than age 18 in the USA, emergency depart-
ment visits coded for suicide attempts and suicidal ideation
doubled between 2007 and 2015, from 580,000 to 1.12million,
with no corresponding increase in total emergency department
visits [16].
Trends in Mood Disorders
Among Adolescents and Adults
Mood disorders, particularly depression, are strong risk fac-
tors for self-injury and suicide. Psychiatric autopsy studies of
suicide decedents compared with living controls range in the
prevalence of mood disorders, with a median estimate based
on systematic review of 59% (range from 30 to 93%) [17].
Meta-analytic estimate from 3275 suicide decedents indicated
a pooled prevalence of affective disorders, including depres-
sion and bipolar disorders, of 43.2% [18]. Prospective data
from the Danish registry among those with contact with the
health system for a psychiatric disorder found an absolute risk
of suicide after first contact of 6.67% [19]. Given the increased
risk of suicide associated with depressive and other affective
disorders, it is also worth interrogating the evidence for recent
increases in mood disorders.
Mood disorders are substantially increasing in recent
years among adolescents, especially adolescent girls.
Mojtabai et al. found that the prevalence of DSM-IV major
depressive episodes increased from 8.7% in 2002 to 11.3%
in 2014 (P < 0.001), with a greater increase among girls
than boys [20]. Updated analyses of NSDUH through
2017 have demonstrated a continued upward trajectory of
MDE among girls [21••]. Independent data sources con-
firm that depressive symptoms have increased among girls
in national representative US studies, compared with no
significant change among boys [22••]. These national stud-
ies are augmented in building the evidence by other studies
among young adults, particularly those in college, among
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whom data indicate that anxiety and depressive disorders
are increasing across the past decade [23, 24].
The increases in the prevalence of affective disorders in
general population samples among adolescents are notable
given the recent history of this epidemiology. Sales of pre-
scription medication to treat depressive and related mood dis-
orders, among both adolescents and adults, increased substan-
tially starting in the mid-1990s [25], as did outpatient visits to
psychiatric clinics for treatment of depression [26, 27]. These
increases prompted questions about whether mood disorders
were increasing, or whether identification and ascertainment
of cases for treatment were increasing without any change in
the underlying incidence and prevalence. Available reviews
and meta-analyses published in the mid-2000s found no evi-
dence for increasing incidence and prevalence of mood disor-
ders in the community when prospective studies were ana-
lyzed [28, 29]. These reviews, however, were published be-
fore the recent, cross-study-consistent increases in mood dis-
orders in general population samples, which began around
2010, suggesting that a new evidence base is needed as we
enter a new era of mood disorders among US adolescents.
Evidence regarding changes in affective disorders among
adults is more mixed, but suggested sustained increases are
occurring predominately among those with low socio-
economic status. Case and Deaton found that among middle-
aged men with low education, the prevalence of non-specific
psychological distress has been historically increasing from
1997–1999 to 2011–2013 [30]. Goldman et al. documented
that life satisfaction, positive affect, and psychological well-
being decreased from 2011 to 2014 compared with 1995–
1996, and negative effect increased, but only for those who
are socio-economically disadvantaged [31]. National survey
data conducted annually has documented recent increases in
psychological distress among adults and increases in major
depressive episodes that are small in magnitude and primarily
confined to young adults [21••], especially those with low
levels of socio-economic status [20, 21••, 32]. These results
are supported by other national data also documenting in-
creases in moderate and severe depressive episodes, primarily
among those with the lowest levels of education [33]. The
range of increases is small, between 1 and 3 percentage points,
and inconsistent across all levels of the life course, suggesting
that continued surveillance is needed to determine whether
these increases reflect temporary and time-limited noise in
the data, or whether there is a sustained increase that may
underlie changes in suicide risk in the USA.
Why Are Suicide Rates Increasing
Among Adolescents and Adults?
The increases in suicide rates are occurring coincident with in-
creases in mood and affective disorders among adolescents and,
to an extent that is less well established, among adults. The
reasons that these disorders are increasing in the population, as
well as other potential reasons underlying suicide death, remain
speculative. Suicide rates are increasing in tandem with uninten-
tional injury deaths more broadly particularly due to opioid over-
dose, which was exponentially increasing since approximately
1999 in the USA (https://www.cdc.gov/nchs/data/health_policy/
AADR_drug_poisoning_involving_OA_Heroin_US_2000-
2014.pdf) [34], around the same time that suicides began increas-
ing [35••]. Opioid overdose and suicide deaths share demograph-
ic correlates such as a greater preponderance of males, indige-
nous populations, and those in middle age, but the trends are to
some extent discordant, given that there are different demograph-
ic groups that have had the largest increase in suicide compared
with opioid overdose. Yet, some mechanisms linking the two
epidemics could be that opioid use disorders increase both risk
of overdose and suicide; available evidence finds that suicide
among medical users of opioids increases with opioids dose
[36], that communities ravaged by opioid overdoses may have
collective trauma and psychological distress that would increase
risk of suicide [37•], and that the availability of opioids could
lead to greater access to lethal means. On the last point, there is
limited evidence; currently, poisoning accounts for a minority of
suicides in the USA (14.7% in 2015), and a minority of those
poisoning suicides involved opioids [2]. That said, the number of
deaths categorized as unintentional opioid overdoses that might
have been suicides is difficult to adjudicate, given that the inten-
tionality of death can be difficult to determine, especially among
those with opioid use disorders which can increase the risk of
suicidality.
Some have advanced the hypothesis that the increases in
suicides, as well as overdose, alcohol consumption, and
deaths due to alcohol, especially among middle-aged men
and those with low educations, are the outcome of a long
process that has included the erosion of a middle class with
job stability for low-skill work, among other economic factors
that may bring meaning to the lives of the working class [2,
37]. While such hypotheses are provocative, available analy-
ses have largely been unable to provide compelling evidence.
In a working paper by Ruhm [38], known measures of county
economic decline such as home prices and unemployment
predicted suicide, but explained less than 1% of the variation
in rates over time. Further, Masters et al. reanalyzed vital
statistics data by gender, age, and birth cohort and concluded
that drug overdose rates increased across a wide range of age
groups, especially those in young and middle adulthood, and
did not mirror trends for other “despair”-related death such as
suicide, suggesting that the drivers of opioid-related deaths in
the USAwere factors that could influence a broad range of age
groups simultaneously, but may be separate frommechanisms
that increase suicide rates [39].
Suicides would also be expected to increase with increased
access to lethal means. The leading method of suicide in the
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USA is with a firearm, responsible for 56.6% of male suicides
in 2015 and 32.1% of female suicides. Among men, suffoca-
tion is second most commonwith 26.1% of suicides, followed
by poisoning (9.5%). Among women, poisoning is slightly
more common than firearms as a means of suicide, at 33%,
followed by suffocation, responsible for 25.3%. While fire-
arms represent a plurality of suicide deaths in the USA, avail-
able data suggest that firearm ownership is decreasing in the
USA, rather than increasing [40]. Further, comparing causes
of suicide death between 1999–2007 and 2008–2015, while
increases in suicide occurred for both firearm and suffocation
suicides, the absolute and relative increase was higher for
suffocation than for firearm suicides (https://www.cdc.gov/
mmwr/volumes/66/wr/mm6610a2.htm). There is no evidence
to suggest that means to suffocation are increasing in the USA;
thus, increases in access to lethal means do not currently ex-
plain increases in suicide in the USA.
Innovations in Individual-Level Suicide
Prevention: the Who and the When of Suicide
Risk
Decades of research aimed at the identification of individuals
at high risk of fatal and non-fatal self-harm have yielded an
array of biological [41–43], behavioral [44], and social [45,
46] risk factors that decision-makers use, combined, for inter-
vention purposes. However, suicide risk factor identification
has contributed minimally to effective prevention efforts, and
suicide risk reduction remains a largely unmet clinical need.
Even the most widely used risk assessment scales, largely
based on suicide risk factors, lack enough sensitivity, specific-
ity, and predictive value to be clinically meaningful [47]: used
alone, these scales are not useful to estimate an individual’s
future risk of suicide [48].
Awell-known reason for the lack of impact of suicide risk
factor identification on suicide prediction is what Hawton
termed a “base-rate problem” [49••] that leads to an excess
of false positives in the clinical practice: on the one hand, most
accepted risk factors for suicide, such as mood and substance
abuse disorders or interpersonal conflict, are highly prevalent.
On the other, suicide behaviors and specially death by suicide
are relatively rare events over the lifetime of those classified as
high risk. As a result, most people classified as “high risk”will
never die by suicide, and a considerable amount of suicides
will take place among people classified as “low risk,” as
proved by substantial evidence from prospective studies. In
1983, Pokorny reported that, among a cohort of 4800 vet-
erans, only 3.7% of high-risk predictions corresponded with
true positives, and more than half of suicides took place in
low-risk patients [50], a finding that has been replicated sev-
eral times [51–53].
Notwithstanding, psychiatrists remain entrusted to conduct
suicide risk assessments in a scientifically sound manner—
e.g., using risk factors and scales, a phenomenon that
Undrill sees as an approach to the management of the “insti-
tutional anxiety” suicide risk generates [54]. Notably, Mulder
et al. have argued that risk categorization is not only clinically
futile but also potentially harmful, in that it may “confuse
clinical thinking” and lead to more coercive treatment options
for those labeled “high risk” and a parallel misallocation of
treatment intensity for those labeled “low risk” [55].
In the recent years, substantial attention within the field of
suicide prediction has shifted towards new machine learning
algorithms, derived from large databases of electronic health
records. Tools derived from regression trees, neural networks,
and other machine learning approaches have been shown re-
peatedly to outperform clinicians’ predictive assessments,
generating new hopes in the suicide prevention field.
Notable examples include Kessler and colleagues’ study fea-
turing over 50,000 American soldiers discharged after a hos-
pitalization [56], DelPozo-Banos et al.’s study using more
than 2600 suicide cases and 52,000 paired controls from the
UK [57], or Simon and colleagues’ study featuring 2,960,929
patients from seven American healthcare systems [58].
Critics with machine learning–derived predictive tools usu-
ally point out limitations regarding generalizability to different
settings and transparency in the model developing process.
The generalizability of predictions based on complex, data-
driven statistical approaches tends to depend on how similar
the training dataset is to the new population in terms of vari-
able distribution—different populations often require different
model calibrations. In a comprehensive review, Belsher et al.
simulated the variation of the positive predictive value of a
series of machine learning algorithms for suicide prediction
when implemented in hypothetical populations with different
suicide rates, reporting high classification accuracy but an
extremely low predictive validity in most populations [59].
This finding has somewhat “deflated some of the exaggerated
hopes” associated with big data analyses and machine learn-
ing statistical methods [60] and, more importantly, empha-
sized the need for more accurate data recording in the clinical
practice, wide availability of training datasets when legally
possible, and transparent sharing of the exact analytic methods
used in order to enhance the recalibration of a model before
implementing it in a different population [61].
Another, less explored explanation for the lack of clinical
impact of suicide risk assessments is that little is known about
when this risk is higher, although time-related considerations
would provide key insights for intervention planning. Most
consistently accepted risk factors correspond to correlates that
either remain stable over time, such as gender or family his-
tory of suicide [62], or take long periods of time to establish
and eventually resolve, like most psychiatric diagnoses or a
disadvantaged socio-economic status [63]. However, suicide
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risk factors interact over time in complex hierarchical net-
works that are inherently difficult to capture using solely
long-term assessments of the relation between baseline char-
acteristics and subsequent suicide. For example, while people
with schizophrenia with a low premorbid life adjustment tend
to show high suicide rates right after the onset of the disease,
their long-term suicide risk is low, as compared with counter-
parts with a better premorbid adjustment [64, 65]. In order to
effectively act on suicide risk, we need to better understand
short-term suicide risk factors and how they vary over time.
Suicidal ideation (SI), largely targeted as a way to prevent
suicide as it usually precedes suicidal behaviors [66], is prob-
ably the most important time-varying risk factor for suicide. SI
includes a spectrum of different experiences that range from
passive ideas of death, through structured suicidal ideation, to
the urge to attempt self-harm [67]. Most studies have mea-
sured suicidal thoughts using single-time-point measures, al-
though recent evidence shows that SI undertakes dramatic
within-person variations over short periods of time [68••].
Because single-point measures, like retrospective question-
naires, fail to capture such variation, past research has yielded
interestingly mixed results. For example, while Kessler et al.
estimated the risk of transition as 26% from ideation to an
attempt and as 72% from a plan to an attempt [66], Baca-
Garcia et al. found that passive and active suicidal ideation
entailed the same lifetime suicide attempt risk [69], and Lee
et al. estimated that, among suicidal ideators, making an at-
tempt was in fact more frequent than planning it [70].
New technologies provide innovative measures of time-
varying real-world determinants of suicide. In particular, com-
puterized ecologic momentary assessment (EMA) allows for
data collection “in the natural contexts of daily life” [71]. This
technique measures participant’s domains of interest (whether
these are emotions, cognitions, or behaviors) repeatedly, usu-
ally through smartphone-delivered assessments that can fol-
low a timely schedule, or depend on the occurrence of a
predefined behavior, or using both [72, 73••]. Hence, EMA
assesses exposures and outcomes in a real-time, real-world
manner and can accurately characterize daily suicidal thoughts
and their external and internal triggers [74]. In addition, EMA
assessments are technically feasible, enhance the participants’
compliance, and do not reactivate their negative thoughts [71].
Recent studies using this technology have successfully char-
acterized the mentioned variation in suicidal thoughts that
high-risk individuals can experience over short periods of time
[75] and linked it to predictors such as life challenges and
inner affect state changes [76, 77].
Apart from improving our ability to accurately deter-
mine who is at risk and when is this risk higher, the poten-
tial impact of suicide prevention efforts relies greatly on
the development, implementation, and scalation of effec-
tive prevention strategies. Despite remaining key knowl-
edge gaps, certain clinical strategies are considered
effective and recommended, especially among specific
subsamples of psychiatric patients with increased suicide
risk [78–80]. With respect to pharmacotherapy, clozapine
[81–83] and lithium [84–86] show the most promising re-
sults for preventing suicide attempts among people with
schizophrenia and bipolar disorder, respectively.
Psychosocial strategies for suicide risk reduction among
people at high risk often fall within two categories: inter-
ventions directed specifically towards suicide risk and in-
terventions aimed at intensifying their contact with mental
health care providers. Among the first group, several psy-
chotherapeutic interventions have been shown to decrease
the intensity and frequency of suicidal thoughts and/or be-
haviors, either among all people undergoing mental health
struggles or when tailored for clients with specific psychi-
atric diagnoses [87–89]. In general, these interventions en-
hance the client’s ability to cope with suicidal thoughts
through the acquisition and strengthening of specific strat-
egies and skills. However, psychotherapy for suicide be-
haviors has been called into question when compared with
more feasible programs aimed at simply enhancing contact
maintenance with providers over a sustained period of time
[90]. For example, in a recent RCT meta-analysis, the
WHO Brief Intervention and Contact (BIC), a program of
9 follow-up contacts significantly lowered the odds of sui-
cide after an attempt by 80%, whereas cognitive-
behavioral therapy (CBT) was not significantly protective
[91].
A key target for contact enhancement strategies is pa-
tients discharged from the hospital following a suicide at-
tempt, because they entail an exceptionally high risk of
subsequent suicide attempt and completion [92], and they
tend to experience barriers in their access to proper, outpa-
tient mental healthcare, favoring loss of adherence during
follow-up [93]. Motto and Bostrom pioneered this method
by randomly assigning 843 patients who refused follow-up
visits to either receiving a total of 24 letters over the fol-
lowing 5 years or a control group [94]. Two years after
inclusion to the study, suicide was less than half likely
among those who received the contact intervention, and
up to 25% recipients answered back with thankful expres-
sions. Accordingly, substantial attention has been put to-
wards these low-resource, nonintrusive brief contact inter-
ventions (BCI). In general, BCI use letters [95], postcards
[96], telephone calls [97], and/or a combination of all of
them [98] for contact maintenance. One particular brief
intervention, the widely implemented safety planning in-
tervention (SPI), includes prioritizing coping strategies,
addressing access to suicidal means, and enhancing out-
reach to professionals if suicidal urges emerge [99]. SPI
was recently combined with a telephone call strategy and
showed almost 50% fewer suicidal behaviors than treat-
ment as usual in a series of Veteran Affairs hospitals [100].
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Population-Level Suicide Prevention: Suicidal
Individuals Versus Suicidal Populations
Since Durkheim’s seminal book Le Suicide [101], it is accept-
ed that suicide rates are determined, at least partially, by causal
factors that act at an ecological level, “whose action is felt by
society as a whole.” Using Rose’s words, “why some individ-
uals have high blood pressure is a different question than why
some populations have more burden of high blood pressure?”
[102]. The use of group-level factors to model individual-level
outcomes has been common in epidemiology, including psy-
chiatric epidemiology, over the twentieth century. In an early
example, Faris and Dunham documented that rates of psycho-
sis were higher in urban areas of Chicago compared with rural
areas [103], leading to a century of hypotheses about environ-
mental determinants of schizophrenia risk [104].
Causal factors that are shared by a whole social group, such
as urban dwelling, have been coined “integral variables”
[105], and their effect cannot, by definition, bemeasured com-
paring individuals who are within the same group. Instead,
they require between-group comparisons using ecologic de-
signs that focus on groups of individuals as legitimate units of
analysis [106, 107]. Several examples illustrate how suicide
can be conceptualized from an ecological perspective: some
countries, such as Latvia, have 5 times higher incidence rates
than others, like Greece (https://data.oecd.org/healthstat/sui-
cide-rates6), which prompts questions about the economic
and cultural conditions that may be invariant across country
but that can be examined to understand risk. In the USA,
suicide rates in rural areas double those of urban areas [108].
Even within a city, like London, areas with higher ecological
indices of social deprivation entail higher suicide rates [109].
However, suicide prevention efforts have characteristically
tried to model suicide risk [110] and predict suicide relying
solely on individual-level correlates. As mentioned, several
current research initiatives seek to improve suicide prediction
through machine learning algorithms based on datasets that
include information from individuals’ medical records [58••],
speech analysis [111], and real-world behaviors measured
through cell phone geolocation [112].
In attempts to understand causation of suicide, researchers
often choose a frame of reference that includes a finite set of
potential causes [107] and depends mainly in their field of
knowledge: for example, a psychiatrist and a sociologist will
consider different potential causes. By discarding what is out-
side our frame of reference, we generate an asymmetry on the
way we look at things that permits cause-effect directionality
[112]. Hence, the frame of reference and the scope of interest
of the researcher determine which potential causes are consid-
ered [107], and complex systems with dynamic interactions
between ecological and individual factors and feedback loops
are usually reduced to a simpler thought model. As a result,
causal relations tend to be ascertained at a particular level of
organization, usually the individual one in the field of
suicidology, determined by the system delimited by our focus
(factors within the system can be identified and related), and
findings’ validity is often limited to such system.
However, “a system never exists in isolation” [107]. As a
result, there is growing interest in the study of how macro-
level characteristics affect outcomes independently of individ-
ual variables, as well as how both levels interact [113]. In
psychiatry, the interaction of the molecular, the individual,
and the social levels in shaping mental suffering, disease,
and illness was famously acknowledged by the late Engels’s
synthesis of the bio-psycho-social medical model [114].
Multilevel epidemiology has emerged as a response to this
interest, as both a thinking framework and a set of tools that
allow for the consideration of a hierarchy of multiple levels of
causation for epidemiologic analyses. Tools and analyses to
integrate and analyze a wide range of potential predictive fac-
tors through data science initiatives and machine learning are
growing [115–117••], with potential to aid in prediction tools
for suicide risk. These tools can be partnered with rich explo-
ration of the social and political settings with which suicide
risk also occurs in order to inform the broader environmental
factors that predict risk.
There are three broad categories of interventions aimed at
lowering the risk of suicide at the population level: universal
and specific education campaigns, regulations in mass media
coverage, and restriction of access to means.
Two evidence-based educational strategies stand out: the im-
plementation of school-based suicide prevention and intervention
programs [118, 119] and the identification and training of the so-
called “emergent gatekeepers” [120], people whomay have con-
tact with those with suicidal thoughts without having been
trained and designated as professionals (teachers, police, etc.).
The well-established influence of media reporting of sui-
cide stories on subsequent suicide rates [121–123], usually
referred to as the “Werther effect” and framed within the
broader behavioral contagion theory [124], has provided an
opportunity for intervention through a variety of reporting
recommendation guidelines [125]. In general, these guidelines
seek to foster responsible, non-sensationalist coverage of sui-
cide and related events.
Theoretically, media also plays a role in means restriction,
because it can reduce the population’s “cognitive-access”
[126] to suicide by purposely avoiding the coverage of key
news, like an emerging suicide method or the suicide of a
celebrity [123, 127]. However, by restriction of the access to
suicide means we usually refer to a series of evidence-based
interventions to physically prevent the population from
accessing potentially lethal means such as pesticides [128],
medications [129], suicide hotspots [130••], or firearms. The
means reduction approach builds on evidence suggesting that
ease of access influences the risk of attempting suicide [131],
especially in impulsive suicidal behaviors [132]—the most
  104 Page 6 of 11 Curr Psychiatry Rep          (2019) 21:104 
frequent type as nearly half suicide attempt survivors report a
suicidal process, the interval between the onset of a suicidal
thought and subsequent suicide attempting, of 10 min or less
[133]. Accessibility also impacts method choice: up to 85%
self-poisoning patients report that easy availability obtained
their choice of poison [134].
Method substitution is the flip side of this coin. Reducing
the access to lethal means tends to be even more effective if
the alternative method available for substitution has a lower
associated lethality, due to a lower inherent deadliness or to a
higher ability to abort mid-attempt. For example, firearms,
which can be found in roughly 33% of homes and account
for 51% of total suicides in the USA, have twice the associated
lethality of gas poisoning and 50 times that of drug overdose
[131]. Accordingly, several studies using a variety of epide-
miological designs have concluded higher risks of suicide for
people who live in a household with firearms [135], after
controlling for potential confounders [136], as well as higher
suicide rates in states where gun ownership levels are higher
[137].
Conclusion
In summary, suicide remains a substantial global contributor
to causes of death, especially among those at younger age, and
is increasing at an unprecedented rate in the USA. Non-fatal
self-injury is also increasing, and together, the trends in self-
injurious behavior raise questions about the causes, interven-
tions, and preventive measures that should be taken.
Prevention and treatment are often pointed towards high-risk
groups, such as those with repeated suicide attempts, who are
at increased risk of dying by suicide, but may miss the major-
ity of suicide decedents who do not come into contact with the
menta l hea l th care sys tem and act impuls ively.
Conceptualizing suicide and its causes as a multilevel process
that unfolds across the life course, with causes at higher geo-
graphic levels as well as individual levels, may be useful to
develop programs that can have the most impact on popula-
tion health, and innovative prevention and intervention pro-
grams that engage new technologies are in development but
require additional evidence. Suicides are preventable and trag-
ically destabilizing for individuals who recover from attempts,
and for families of those affected. In the next generation of
suicide research, it is critical to examine factors beyond the
proximal and clinical to allow for a reimagining of prevention
that is life course and socially focused.
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Dear Editor,
The shortened life expectancy of people living with 
severe mental disorders (SMD) [1] is partially determined 
by worse outcomes than the general population follow-
ing admission to intensive care units (ICUs) [2]. To better 
understand health care delivery for SMD patients within 
ICUs, we examined recent trends in use and outcomes 
of mechanical ventilation (MV) for critical patients with 
and without SMD.
Using the nationally representative Spanish Health 
Ministry’s National Hospital Database, we selected all 
records of adults aged 15–69 years featuring an MV pro-
cedure between January 1, 2000 and December 31, 2015. 
International Classification of Diseases 9th Edition Clini-
cal Modification (ICD-9-CM) codes for continuous inva-
sive MV were: 96.70 (unspecified duration), 96.71 (< 96 
consecutive hours), and 96.72 (≥ 96 consecutive hours). 
We excluded patients aged ≥ 70  years as people with 
SMD have 15 years shorter life expectancy [1] and Spain’s 
current life expectancy is 83  years [3]. Study groups 
were: SMD (ICD-9-CM codes 295–298: schizophrenia, 
episodic affective disorder, delusional disorder or other 
non-organic psychotic disorder) and non-SMD. Inci-
dence rates were calculated per 10,000 total discharges 
of patients aged 15–69 years. Long-term MV and in-hos-
pital mortality were defined as the proportion of proce-
dures lasting ≥ 96 consecutive hours and the case fatality 
rate (CFR), respectively, both per 100 MV cases. To study 
trends, we used joinpoint regressions. These generalized 
linear models allow for the estimation of average annual 
percentage changes (AAPC) with 95% confidence inter-
vals (95% CI) over a time period, assuming a Poisson dis-
tribution [4].
Of 338,189 records, 9195 (2.7%) included an SMD 
diagnosis. Between 2000 and 2015, the incidence of MV 
more than doubled among SMD patients, from 1.4 to 
3.3 procedures per 10,000 discharges (AAPC 4.6%; 95% 
CI 3.3, 5.9), while it remained unchanged in the non-
SMD group (0.04%; 95% CI − 0.4, 0.5) (Fig.  1a). Use of 
prolonged MV, conversely, increased only among cases 
without SMD (1.2%; 95% CI 1.0, 1.5) (SMD group: 0.4%; 
95% CI − 0.5, 1.3) (Fig.  1b). Finally, CFR decreased in 
both SMD ( − 1.8%; 95% CI − 2.9, − 0.7) and non-SMD 
patients ( − 1.4%; 95% CI − 1.7, − 1.2) (Fig.  1c). Nota-
bly, SMD patients were a median 5  years younger and 
included higher proportions of patients with no detected 
comorbidity according to the Charlson index (59.0% vs. 
44.6%, p < 0.001) and of admissions due to poisoning than 
the non-SMD group (63.3%, vs. 13.6%, p < 0.001), three 
characteristics that may help explain their lower overall 
mortality rate.
Our study is limited by potential coding inaccuracies. 
However, the quality of the data is audited regularly and 
errors, if present, would not affect differentially the two 
study groups. Also, although we used 13 diagnostic fields 
to detect SMD, some diagnoses may have been missed, 
potentially reducing between-group differences [5].
In conclusion, between 2000 and 2015, MV use 
increased only among SMD patients, and comparable 
decreasing trends in mortality were observed both in 
people with and without SMD. Future research should 
explore reasons for the observed increase of MV use in 
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the SMD group and examine these patients’ long-term 
prognosis following hospital discharge.
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Effect of dementia on the incidence, short-
term outcomes, and resource utilization of
invasive mechanical ventilation in the
elderly: a nationwide population-based
study
Carmen Bouza1* , Gonzalo Martínez-Alés2,3 and Teresa López-Cuadrado4
Abstract
Background: Though the prevalence of dementia among hospitalized patients is increasing, there is limited
population data in Europe about the use of life-support measures such as invasive mechanical ventilation in
these patients. Our objective is to assess whether dementia influences the incidence, outcomes, and hospital
resource use in elderly patients undergoing mechanical ventilation.
Methods: Using ICD-9-CM codes, all hospitalizations involving invasive mechanical ventilation in adults aged
≥ 65 years were identified in the Spanish national hospital discharge database covering the period 2000–2013.
The cases identified were stratified into two cohorts (patients with or without dementia) in which main
outcome measures were compared. The impact of dementia on in-hospital mortality and hospital resource
use were assessed through multivariable models. Trends were assessed through joinpoint regression analysis
and results expressed as average annual percentage change.
Results: Of the 259,623 cases identified, 5770 (2.2%) had been assigned codes for dementia. Cases with
dementia were older, had a lower Charlson comorbidity score, and less frequently received prolonged
mechanical ventilation or were assigned a surgical DRG. Circulatory disease was the most common main
diagnosis in both cohorts. No significant impact of dementia was observed on in-hospital mortality (adjusted
OR 1.04, [95% CI] 0.98, 1.09). In the cohort with dementia, the incidence of mechanical ventilation underwent
an average annual increase over time of 5.39% (95% CI 4.0, 6.7) while this rate was 1.62% (95% CI 0.9, 2.4) in
cases without dementia. However, unlike this cohort, mortality in cases with dementia did not significantly
decline over time. Geometric mean hospital cost and stay were lower among cases with than without
dementia (− 14% [95% CI − 12%, − 15%] and − 12% [95% CI, − 9%, − 14%], respectively), and these differences
increased over time.
Conclusion: This nationwide population-based study suggests no impact of dementia on in-hospital mortality
in elderly patients undergoing invasive mechanical ventilation. However, dementia is significantly associated
with shorter stay and hospital costs. Our data also identifies a recent marked increase in the use of this life-
support measure in elderly patients with dementia and that this increase is much greater than that observed
in elderly individuals without dementia.
Keywords: Dementia, Elderly, Mechanical ventilation, Incidence, Outcomes, Trends
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Background
Dementia is one of the greatest health problems among
persons aged 65 years or older worldwide. Because of
population aging and a lack of effective prevention and
treatment measures, it has been estimated that in the
foreseeable future, the number of affected persons will
double [1, 2].
The prevalence of dementia among hospitalized patients
is also increasing [3–5], but the balance of potential bene-
fits and harm of intensive care interventions in this popu-
lation is unclear. In fact, the last few years have witnessed
intense debate regarding life-support intensive treatment
in patients with dementia such as invasive mechanical
ventilation (MV) [6–9]. MV is a key component of the
management of critically ill patients with acute or chronic
respiratory failure. However, it is associated with a high
mortality [10], with short- and long-term complications
[11, 12], and requires a complex care level with a substan-
tial impact on hospital resources [13].
Despite these considerations, few studies have exam-
ined trends in its use in patients with dementia. The
scarce data available come from the USA and Canada
where several authors have reported a sustained in-
creased use of MV in patients with dementia in the past
few decades [14, 15] with clinical outcomes comparable
to those observed in patients without dementia [16].
Spain is a rapidly aging country and dementia preva-
lences are among the highest in the world (https://www.
alzheimer-europe.org/Policy-in-Practice2/Country-com-
parisons/2013-The-prevalence-of-dementia-in-Europe/
Spain). This determines the need to characterize the use
of MV and its trends in these patients since the use of
effective and safe therapeutic technologies and the ap-
propriate use of healthcare resources are priority objec-
tives in a quality health system. Accordingly, this study
sought to examine the characteristics of MV and its
recent trends in incidence, associated mortality, and hos-
pital resource use in patients ≥ 65 years with and without
dementia based on data from Spain’s national hospital
discharge database.
Methods
Study design and data sources
We performed a retrospective population-based study
using the Spanish Health Ministry’s National Minimum
Basic Data Set (MBDS). This official database gathers
information derived from discharge reports from all
acute-care hospitals in Spain. For each hospitalization,
demographic and clinical information is provided includ-
ing a main diagnosis, 13 secondary diagnoses, and up to
20 procedures coded at each center before patient dis-
charge according to International Classification of Dis-
eases, Ninth Edition, Clinical Modification (ICD-9-CM)
codes as well as corresponding diagnosis-related group
(DRG) codes. This information, whose registration is
mandatory by law in the National Health System, is con-
sidered to be representative of the national population
as the database covers over 90% of all annual hospital
admissions produced in our country [17].
To calculate incidence rates, we used population data
provided by the Spanish Statistics Institute [18]. Hospital
admissions data were provided by the Ministry of
Health, Resources and Welfare [17]. All data used are
anonymous so, according to Spanish law, the need was
waived for informed consent [19].
Study population: case definitions and identification
Hospitalizations involving subjects ≥ 65 years who re-
ceived MV from January 1, 2000, to December 31, 2013,
were identified using the ICD-9-CM codes: 96.70 (con-
tinuous invasive MV of unspecified duration), 96.71 (con-
tinuous invasive MV < 96 consecutive hours) and 96.72
(continuous invasive MV ≥ 96 consecutive hours). These
codes are considered specific, stable, and valid [20].
According to ICD-9-CM coding norms, one of these
codes is assigned to hospitalized patients who require
MV except if used during a routine surgical procedure.
Postsurgery MV is coded if lasting more than 2 days or
if the clinician reports its duration was longer than
planned. MV duration was measured from the moment
of endotracheal intubation [17].
Dementia is a clinical syndrome characterized by a
global, progressive cognitive impairment that generates
functional decline and disability [21]. A variety of brain-
damaging conditions, such as degenerative, vascular,
metabolic, or toxic brain disease, can lead to dementia,
and although the most frequent cause of dementia from
middle age to elderly is Alzheimer’s disease, most pa-
tients suffer from a mixture of different pathologies [21].
We defined dementia as the presence in any of the diag-
noses entered in the database of the ICD-9-CM codes:
290.0–290.9 (dementias), 291.1 (alcohol-induced persist-
ing amnestic disorder), 291.2 (alcohol-induced persisting
dementia), 292.82 (drug-induced persisting dementia),
292.83 (drug-induced persisting amnestic disorder),
294.0 (amnestic disorder in conditions classified else-
where), 294.1 (dementia in conditions classified else-
where), 294.2 (dementia, unspecified), 294.8 (other
persistent mental disorders due to conditions classified
elsewhere), 294.9 (unspecified persistent mental disor-
ders due to conditions classified elsewhere), 331.0 (Alz-
heimer’s disease), 331.1 (frontotemporal dementia),
331.2 (senile degeneration of the brain), 331.7 (cerebral
degeneration in diseases classified elsewhere), 331.82
(dementia with Lewy bodies), and 331.9 (cerebral degen-
eration, unspecified). Similar broad definitions of de-
mentia have been used by others [14] to improve case
detection.
Bouza et al. Critical Care          (2019) 23:291 Page 2 of 9
To assess the comorbidity burden, we used the Charl-
son index score validated by Deyo [22] and improved for
ICD-9-CM [23] according to secondary diagnoses. For
the purposes of this study, dementia itself was excluded
in the Charlson Index [24].
For every case, the main diagnostic group was assessed
according to the ICD-9-CM chapters: infectious disease
(001–139), neoplasms (140–239), endocrine diseases
(240–279), hematological diseases (280–289), neuro-
logical diseases (320–389), diseases of the circulatory
system (390–459), respiratory diseases (460–519), dis-
eases of the digestive system (520–579), diseases of the
genitourinary tract (580–629), diseases of the skin and
subcutaneous tissue (680–709), diseases of the musculo-
skeletal system and connective tissue (713–739), and
injury-poisoning (800–999).
Data analysis
We conducted a descriptive and comparative analysis of
cases with and without dementia, including demographic
and clinical information, comorbidity burden, and hos-
pital mortality, stay, and costs. Charlson comorbidity
scores are provided as a continuous variable and as cat-
egorical with 4 groups (0, 1–2, 3–4, > 4) of increasing
severity and impact on outcomes [25]. Categorical vari-
ables are expressed as absolute frequencies and percent-
ages while continuous variables are given as geometric
means and geometric standard deviation (SD), as geo-
metric means are less influenced by extreme values than
arithmetic ones. To test differences in categorical vari-
ables, we used Pearson’s chi-square test.
In-hospital mortality was estimated as the number of
deaths relative to the number of cases and expressed as
a percentage, or case fatality rate (CFR). To examine the
effect of dementia on mortality, stay, and costs, we con-
ducted regression models (logistic regressions for mor-
tality and linear regressions of log-transformed stay and
costs) and adjusted them in two multivariable models.
Model 1 was adjusted for baseline characteristics (age,
sex, Charlson index) whereas model 2 also included
the principal diagnosis at admission and MV duration.
Results are expressed as odds ratios (OR) with 95%
confidence intervals (for mortality) and geometric
means ratio with 95% confidence intervals (for stays
and costs).
We examined temporal trends in MV incidence rate
(per 100,000 people and per 10,000 hospital discharges),
proportion of MV cases with dementia, prolonged MV
(defined as a duration of ≥ 96 consecutive hours accord-
ing to the ICD-9-CM codification system), and CFR. To
this end, we used joinpoint regression models—general-
ized linear models that assume a Poisson distribution
[26]. In these models, any apparent trend can be statisti-
cally assessed through a Monte Carlo permutation method
[27]. Trends are presented as the average annual percentage
change (AAPC), a summary measure of the overall trend
over the study period. To compare the AAPC of both study
groups, we examined whether their regression mean func-
tions were parallel, allowing for different intercepts, using
the Pairwise comparison parallel test. In addition, we ana-
lyzed trends in length of stay and costs using Cuzick’s p-
trend test.
All tests were performed using the packages STATA
15 (StataCorp. LP, College Station, TX, USA) and
Joinpoint Regression 4.7.0.0. Significance was set at
p < 0.05.
Results
Out of the 19,979,322 hospitalizations in persons aged ≥
65 years produced over the 14-year study period, 259,
623 cases underwent MV. Of these, 5770 (2.2%) were
cases with dementia.
As may be seen in Table 1, in the dementia cohort,
the proportions of women and older age strata were
higher than in the cohort without dementia. The
Charlson score, however, was lower indicating a lower
comorbidity burden among those with dementia.
Among the main comorbidities, we should highlight a
greater presence of cerebrovascular disease in the
group of patients with dementia. Circulatory disease
was the most common main diagnosis in both co-
horts and was followed with disparate frequency in
each one by respiratory disease, injury-poisoning, and
digestive disorders. Conversely, cancer was much less
frequent in the cases with dementia. Registries includ-
ing dementia corresponded more to smaller hospitals,
and patients less frequently received prolonged MV
or were assigned a surgical DRG than in the non-
dementia group. The cohort with dementia showed a
slightly, yet significantly, higher in-hospital mortality,
and this difference was attributable only to cases
subjected to short-duration MV (Additional file 1:
Table S1). However, as may be observed in Table 2,
according to the logistic regression analysis adjusted
for age, sex, comorbidity burden, main diagnosis, and
MV duration, dementia had no significant impact on
in-hospital mortality.
Among the survivors, 78% of cases with dementia and
81% of those without dementia were discharged home
while 16.3% and 15.1% respectively were discharged to
long-term care centers.
Both geometric mean stay and hospital costs for the
dementia group were significantly lower than for the
non-dementia group (Table 2). Further, multivariate
analysis of the impacts of dementia on hospital resource
use indicated that dementia was associated significantly
with a shorter adjusted mean hospital stay and lower
mean hospital costs per case.
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Table 1 General characteristics of adults ≥ 65 years receiving invasive mechanical ventilation
With dementia Without dementia OR (95%CI) p value
5770 (2.2) 253,853 (97.8)
Gender women 2702 (46.8) 96,946 (38.2) 1.43 (1.35, 1.50) < 0.001
Age
65–74 years 1787 (31.0) 131,717 (51.9) Ref.
75–84 years 3166 (54.9) 108,990 (42.9) 2.14 (2.02, 2.27) < 0.001
> 84 years 817 (14.1) 13,146 (5.2) 4.58 (4.21, 4.99) < 0.001
Charlson Index score
0 points 1891 (32.8) 77,478 (30.5) Ref.
1–2 points 2932 (50.8) 124,467 (49.0) 0.97 (.91, 1.02) 0.235
3–4 points 734 (12.7) 37,678 (14.8) 0.80 (0.73, 0.87) < 0.001
> 4 points 213 (3.7) 14,230 (5.6) 0.61 (0.53, 0.71) < 0.001
Main Charlson comorbidities
Diabetes 1476 (25.6) 59,879 (23.6) 1.10 (1.03, 1.14) < 0.001
Cerebrovascular disease 1048 (18.2) 18,972 (7.5) 2.75 (2.57, 2.94) < 0.001
COPD 1005 (17.4) 54,918 (21.6) 0.76 (0.71, 0.82) < 0.001
Heart failure 836 (14.5) 47,921 (18.9) 0.73 (0.68, 0.78) < 0.001
ICD-9-CM main diagnosis
Circulatory 1751 (30.3) 98,683 (38.9) 0.69 (0.65, 0.73) < 0.001
Respiratory 984 (17.0) 39,379 (15.5) 1.12 (1.04, 1.20) 0.001
Injury-poisoning 910 (15.8) 27,338 (10.8) 1.55 (1.44, 1.67) < 0.001
Digestive 805 (14.0) 29,621 (11.7) 1.23 (1.14, 1.32) < 0.001
Cancer 364 (6.3) 29,229 (11.5) 0.52 (0.47, 0.58) < 0.001
No. of hospital beds
< 200 691 (12.0) 26,929 (10.6) Ref
200–500 1927 (33.4) 71,698 (28.2) 1.05 (0.96, 1.14) 0.302
501–1000 1774 (30.8) 87,898 (34.6) 0.79 (0.72, 0.86) < 0.001
> 1000 1378 (23.9) 67,327 (26.5) 0.80 (0.73, 0.87) < 0.001
DRG surgical 2455 (42.6) 145,001 (57.2) 0.56 (0.53, 0.59) < 0.001
Mechanical ventilation ≥ 96 h 1729 (30.0) 85,162 (33.6) 0.85 (0.80, 0.90) < 0.001
In-hospital mortality (CFR) 2992 (51.9) 123,445 (48.6) 1.14 (1.08, 1.20) < 0.001
Data presented as number of cases (%)
OR odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, DRG diagnosis-related group, CRF case fatality rate
Table 2 Impact of dementia on in-hospital mortality and hospital resource use
With dementia Without dementia Crude Model 1 Model 2
(%) (%) OR (95% CI) Adjusted OR (95% CI)
CFR 51.9 48.6 1.14 (1.08, 1.20) 1.05 (0.99, 1.1) 1.04 (0.98, 1.09)
Geometric mean (SD) Geometric mean (SD) Ratio of geometric means (95% CI) Adjusted ratio of geometric means (95% CI)
Hospital stay, days 11.16 (3.20) 14.01 (3.19) 0.80 (0.77, 0.82) 0.85 (0.82, 0.87) 0.88 (0.86, 0.91)
Costs, € 10,423 (2.34) 12,855 (2.40) 0.81 (0.79, 0.83) 0.83 (0.81, 0.85) 0.86 (0.85, 0.88)
Model 1: adjusted for sex, age, Charlson index
Model 2: adjusted for sex, age, Charlson index, main diagnosis, and length of MV
CFR case fatality rate, SD standard deviation
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Temporal trends
Rates of MV use referred to hospital discharges and the
general population underwent a significantly greater in-
crease among the subjects with dementia compared to
those without (Table 3). In patients with dementia, the
rate of MV use per 10,000 hospital discharges went up
from 1.76 in 2000 to 3.57 in 2013, with an AAPC of
4.7%. Meanwhile, in patients without dementia, the rate
of MV use per 10,000 hospital discharges went up from
114.5 in 2000 to 131.3 in 2013 with an AAPC of 0.91%.
According to the comparability test, trends of MV in de-
mentia and non-dementia cases were different (p value
for test for parallelism = 0.005). The population inci-
dence of MV in people with dementia rose from 3.1 to
6.9 per 100,000 inhabitants ≥ 65 years, yielding an AAPC
of 5.39%, while in the non-dementia group it increased
from 203.6 to 253.3, for an AAPC of 1.62% (Fig. 1). Ac-
cording to the comparability test, population incidence
trends in dementia and non-dementia were also different
(p value for test for parallelism = 0.03).
Table 3 also provides temporal trends in the use of
VM ≥ 96 h and in-hospital mortality (CFR), indicating
that subjects with dementia underwent no significant
changes over the study period, while in the non-
dementia cohort the use of prolonged MV increased
and mortality decreased. As shown in Fig. 2, cases
with dementia have not followed the descending trend
shown by the cases without dementia; rather, mortal-
ity has fluctuated over time.
Figure 3 illustrates that geometric mean hospital stay
in the cohort with dementia has steadily declined over
time, while it has been relatively stable in the cohort
without dementia. Geometric mean hospital costs per
case have risen markedly over the study period. This in-
crease has been nevertheless lower among cases with de-
mentia, and inter-cohort differences have persisted
(Fig. 3).
Discussion
The findings of this population-based study indicate that
the use of MV in elderly persons diagnosed with demen-
tia has shown a marked increase in Spain between the
years 2000 and 2013. Further, this increase has been
higher than that observed in their dementia-free coun-
terparts. They also reveal that while no impacts of
dementia on hospital mortality were detected, the de-
clining trend in mortality produced in patients without
dementia was not observed. In addition, compared with
subjects free of dementia, these individuals incur lower
hospital costs and length of stay.
As far as we know, this is the first study to characterize
the pattern of MV use in adults ≥ 65 years with and with-
out dementia in a European country. The demographic
and clinical characteristics of our cases are similar to those
described in the USA and Canada [14, 15], although de-
mentia appears as notably less frequent among those
receiving MV in our setting. Only 2.2% of hospitalized
adults aged ≥ 65 years undergoing MV had been assigned
a code for dementia, contrasting with the 15% and the
8.6% rates described in those studies. Our results show in
the cohort of patients with dementia a marked increase in
the incidence of MV with an average annual increase of
5.39%, which is much higher than the 1.62% observed in
the cohort without dementia. Notwithstanding, the in-
crease detected was markedly lower than that reported by
Lagu (11.4%) and by Borjaille (7.8%) in adults ≥ 65 years
with dementia [14, 15]. In part, these differences could be
explained by the very different healthcare systems and the
organizational models used for the care of critically ill pa-
tients between countries [28]. We should not forget that
in a healthcare setting, offer is an important regulator
of demand. Effectively in the USA, the increased use
of MV in patients with advanced dementia has been
linked to a greater availability of beds in intensive
care units [29]. In Spain, with its universal, equal-
access healthcare system, it is estimated that in 2010
there were some 9.6 ICU beds per 100,000 inhabi-
tants [30, 31] while in the USA this was around four
times this figure in 2009 [32]. But, in spite of these
differences, our data are in line with those reported
in North America and contrast with prior studies in-
dicating that acute care patients with dementia are
treated substantially less aggressively than patients
without dementia [8].
Table 3 Trend analysis
MV in cases with dementia MV in cases without dementia Parallelism test
2000 2013 AAPC (95% CI) 2000 2013 AAPC (95% CI)
Proportion (%) 1.51 2.64 3.8 (3.0, 4.5)† 98.5 97.4 − 0.1 (− 0.1, − 0.1)† P < 0.001
Hospital discharge rate (per 10,000) 1.76 3.57 4.71 (3.6, 5.8)† 114 131 0.91 (0.4, 1.4)† P = 0.005
Population rate (per 100,000) 3.1 6.9 5.39 (4.0, 6.7)† 203.6 253.3 1.62 (0.9, 2.4)† P = 0.030
MV ≥ 96 h (%) 24.6 28.4 − 0.8 (− 2.3, 0.7) 31.2 34.9 0.99 (0.7, 1.3)† P = 0.031
CFR (%) 55.9 50.2 − 0.30 (− 1.1, 0.5) 51.9 44.5 − 1.19 (− 1.3, − 1.0)† P = 0.10
MV invasive mechanical ventilation, AAPC average annual percentage change, 95%CI 95% confidence interval, CFR: case fatality rate
†Statistically significant
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Our dementia group showed an older age and higher
percentage of women, as described by others [16]. How-
ever, our cases had a lower comorbidity burden which
could be partly due to the different score system used as
there is still no standardized method to assess this issue
despite its important role in patient’s outcomes [33]. For
this study, we selected the Charlson comorbidity index
as it has shown a similar capacity to scales based on
physiological scores to predict mortality in critically ill
patients [34].
As expected, in-hospital mortality was really high in
both cohorts. But, a main finding of our study was the
lack of significant differences in CFR between both co-
horts once adjusted for remaining clinical-demographic
variables, meaning that dementia has not had a signifi-
cant impact on hospital mortality in individuals ≥ 65
years subjected to MV. This finding, which is in line
with the data reported by Lagu et al. [16], also suggests
the use of MV in persons with dementia in our country
complies (at least in terms of mortality as an effect
Fig. 1 Trends in invasive mechanical ventilation incidence rates in patients with and without dementia. The figure shows the changes observed
over time in incidence rates. The cohort with dementia reaches a greater increase than the cohort without dementia
Fig. 2 Trends in in-hospital mortality in MV episodes of patients with and without dementia. The figure shows the changes observed over time
in in-hospital mortality. Note that cases with dementia do not show the downward trend detected in the cases without dementia; rather, they
feature a fluctuating trend over the period of study
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measure) with the quality standard of its use in patients
≥ 65 years without dementia.
Our trends analysis, nevertheless, indicates that while
hospital mortality in the dementia-free cohort has stead-
ily declined over the 14 years examined, which is consist-
ent with literature reports [35], we observed no parallel
changes in the dementia cohort.
Something similar can be said about the trend ob-
served in the use of hospital resources. While some
studies have shown that dementia leads to longer mean
hospital stay and costs in older patients admitted
because of acute illness [3, 4], our finding is consistent
with more recent descriptions [16, 36] that these vari-
ables are significantly lower in patients with dementia.
Our study also reveals that this reduced resource use in
patients with dementia persists when the extent of MV
was introduced as a covariate in the adjusted multivari-
ate model. Additionally, trend analysis indicate that
mean length of stay difference has increased over the
years since while the mean hospital stay in cases without
dementia has remained stable, it has progressively de-
creased in cases with dementia.
Unfortunately, the database design prevents any causal
inferences or assessment of other reasons that could jus-
tify these trends, such as the existence of advanced
directives, family preferences, or clinical practices toward
the limitation of therapeutic efforts and the use, instead,
of comfort measures. We consider those data are funda-
mental and that it is necessary to study them in a pro-
spective way.
Our observations extend the scarce available informa-
tion on the incidence and short-term outcomes of the
use of invasive technologies such as MV in adults aged
≥ 65 years with dementia, and perhaps, they can be of
help in the existing debate about the use of these thera-
peutic measures in patients with dementia. Further,
given the national population-based nature of our data,
we feel they may be generalizable and of interest for
clinical decision making and healthcare resource plan-
ning in an increasingly aging society for which a greater
prevalence of dementia is foreseen in the near future
[15, 37, 38].
Limitations
Our study has several limitations we should mention.
When working with clinical-administrative data, sensi-
tivity to detect the variables of interest depends directly
on the discharge report completed by the responsible
physician. There is evidence to suggest that dementia
has been undercoded in discharge reports, especially in
mild or complex cases [39]. To minimize this limitation,
we used a broad definition of dementia in line with pre-
vious, similar studies [14, 16], even though these defini-
tions have not been validated against clinical charts.
Fig. 3 Trends in hospital resources in patients with and without dementia. a Over the period examined, geometric mean hospital stay has
decreased significantly in cases with dementia passing from 12.12 days in the year 2000 to 9.47 days in 2013. In contrast, in cases without
dementia, mean stay has remained stable passing from 13.63 to 13.26. b Over the period examined, geometric mean costs per case in the group
with dementia have risen significantly from 6305€ in 2000 to 11,384€ in 2013 and in cases without dementia from 7485€ to 15,583€
(both p < 0.001)
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Moreover, MV is a major procedure which is easily iden-
tified in a patient’s clinical record and whose ICD-9-CM
codes are stable and validated [20]. However, we did
not have access to staging information of our demen-
tia cases. Given that an inverse relationship has been
established between dementia severity and the fre-
quency at which patients are hospitalized and that
some clinical guidelines emphasize the need to treat
persons with dementia at their homes [37], it is likely
that our dementia cohort will contain a high propor-
tion of mild-moderate severity cases. Our data source
also prevents us from knowing other individual fac-
tors such as pharmacological treatments; the existence
of an advance directive or their socio-cultural or edu-
cational level which makes it impossible to further
characterize this cohort and stratify the results ac-
cording to these factors. Nonetheless, given the uni-
versal character of our national health system with
equal access to the whole population, aspects such as
the socioeconomic level have not influenced the re-
sults obtained. Likewise, given the regulation of our
national health system, we can assume that clinical
and coding practices have not been related to eco-
nomic incentives. Also, our database does not include
physiology-based scores of common use in ICUs, such
as APACHE or SAPS. Notwithstanding, Christensen
and colleagues have shown that the Charlson comor-
bidity index performs similarly to physiology-based
scores at predicting short- and long-term mortality
for ICU patients [34]. Finally, because of this study’s
retrospective nature, we cannot rule out that temporal
trends may, at least in part, be associated with differ-
ent treatment practices during the long period of
study. However, the population nature of our study,
its main strength, means we can assume a lack of se-
lection bias and can also extrapolate its results. In
addition, RECORD recommendations for reporting of
results were followed [40].
Conclusions
This nationwide population-based study reveals no
impact of dementia on in-hospital mortality in elderly
patients undergoing invasive mechanical ventilation.
However, dementia is significantly associated with
shorter stay and hospital costs. Our data also identi-
fies a recent marked increase in the use of this life-
support measure in elderly patients with dementia
and that this increase is much greater than that ob-
served in elderly individuals without dementia. This
data have important implications for clinical decision-
making and healthcare resource planning in an in-
creasingly aging society for which a greater prevalence
of dementia is foreseen in the near future.
Additional file
Additional file 1: Table S1. General characteristics and outcomes of
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